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The role of Sleep Disordered Breathing (SDB) in adult hypertension and cardiovascular 
morbidity is well established and increased blood pressure and cardiac remodeling has 
been demonstrated in children with severe SDB.  There is less evidence suggesting that 
milder forms of SDB are associated with cardiovascular anomalies. Therefore this 
thesis contains a series of studies which compares the underlying physiology, 
particularly vascular function in children with mild SDB with aged matched healthy 
non-snoring children. Children with SDB were recruited at the Women’s and 
Children’s Hospital, through the Ear, Nose and Throat surgical waitlist, prior to 
treatment to resolve their SDB. All children underwent an overnight sleep study to 
assess their SDB severity for each study. 
 
Chapter 1 is a literature review which provides a brief summary of the autonomic 
nervous system and the physiology of sleep. A synopsis of the disorder is also presented 
including information on diagnosis and treatment of the disorder. An in depth 
assessment of the literature pertaining specifically to studies measuring cardiovascular, 
autonomic and inflammatory response in children with SDB is summarized and the 
physiological pathways that lead to hypertension are explained.  
 
Chapter 2 assesses Flow Mediated Dilatation, a validated measure of endothelial 
function in healthy children ranging from 6 – 16 years. At the time of publication there 
were no studies using FMD in children as young as 6 years. This study shows a positive 
relationship between the time to reach maximal dilation after ischemia in the brachial 
artery and both age and body habitus. Younger children reached maximal dilation by 
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35s while older children reached maximal dilation by 60s+. This paper is important as 
it helped to determine the age range and analysis for the following study. 
 
Chapter 3 outlines the results of a study in young children with primary snoring aged 
5-9 years using FMD. We showed that both resting and hyperaemic velocity time 
integral (VTi; area under the curve of velocity over ejection time) was significantly 
higher in children referred for evaluation of SDB (n=23) compared with healthy 
matched controls (n=11). Other groups report similar results in blood flow velocity 
measured in middle cerebral arteries using transcranial Doppler in children with 
primary snoring. We also found that the brachial artery took approximately 20 seconds 
longer to fully dilate after induced hyperaemia in the children with SDB compared with 
controls. Of note is that both children with SDB and controls in our FMD study 
demonstrated similar rates of dilatation in the initial 30s, suggesting that endothelial 
function is preserved, but after 30s the groups diverged and children with SDB took 
longer to reach maximum dilatation. The time delay in maximum dilatation suggests 
augmented cell-to-cell connectivity as the dilatation process moves from the 
endothelial cells through smooth muscle, ending in the adventitial layer. 
 
Having defined vascular changes in medium sized vessels, in Chapter 3, Chapter 4 
investigates the vascular effects of SDB on the heart and major vessels using cardiac 
MRI in children aged 5-14 years including primary snorers/mild SDB and non-snoring 
controls. This study found a significant increase in peak systolic blood flow velocity in 
the ascending aorta in children with SDB (n = 12) compared to controls (n = 7). The 
increase in blood flow velocity was similar to increases reported by other groups (20-
30%) in cerebral blood flow and by our own group (Chapter 3). 
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A blood sample was also analysed from the children in this study. We used Flow 
Cytometry to measure cytokine expression of markers of inflammation - Tumor 
Necrosis Factor alpha (TNFα) and interferon gamma (IFNγ) which are known 
indicators of cardiovascular disease. We found that there was a significantly higher 
level of CD8 + cells expressing both TNFα and IFNγ. Consistent with the paradigm that 
cardiovascular changes are coupled with an increased inflammatory state, we also 
found a strong positive association between these immune-markers and peak blood 
flow velocity in the ascending aorta and CD8 + cells expressing IFNγ and TNFα.  Our 
findings support the interrelationship between mild SDB, abnormal vascular function 
and increased inflammation. While increased inflammatory pathways have been 
reported in children with severe OSA, this is the first time it has been shown in children 
diagnosed as primary snorers/mild SDB. 
 
Chapter 5 details the relationship between vascular changes observed in Chapter 3 
(increased blood flow velocity and time to maximal dilatation in the brachial artery) in 
relation to autonomic function. We measured sympathetic overactivity using digital 
pupillometry, and found that it was closely associated with the haemodynamic changes 
we observed on FMD evaluation of the brachial artery of children with mild SDB. We 
further undertook the novel step of examining the effect of sympathetic overactivity on 
the arterial wall by studying the dorsal lingual artery of children undergoing 
adenotonsillectomy, the accepted treatment for SDB. We found that sympathetic nerve 
fibre density of the vessel (measured by immunohistochemistry) strongly correlated 
with the degree of sympathetic overactivity on pupillometric testing and the functional 
measure from the FMD. To our knowledge this is the first time that functional vascular 
changes have been correlated to vascular histology in humans.  
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We also explored the association between the sympathetic nerve fibre density brachial 
artery blood flow velocity and FMD parameters, pupillometry and platelet aggregation 
(using whole blood samples). Platelet aggregation is a measure of endothelial integrity. 
Our results show that the children with increased brachial artery blood flow velocity 
also exhibited increased platelet aggregation in response to the collagen antigen, 
suggesting endothelial damage. Sympathetic nerve fibre density was also positively 
associated with increased platelet aggregation, in particular with the aggregation 
velocity. In addition, there was strong association between the pupillary light reflex 
variables and the platelet aggregation.   
 
Chapter 6 is an overall discussion that amalgamates the findings of each chapter and 
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1.1 The Importance of Sleep 
1.1.1 What is Sleep? 
Sleep is an essential part of human existence and, although a clear purpose of sleep is 
debated by many, the overwhelming consensus is that sleep acts as a restorative and 
conservation mechanism accompanied by a comparative loss of consciousness.  
 
 
“Sleep is commonly looked upon as a periodic temporary cessation, or interruption of 
the waking state, which is the prevalent mode of existence for the healthy human adult.”  
Sleep and Wakefulness, Kleitman, 1963  
 
Kleitman explains sleep as ‘a state of being’ that is required by all to maintain a healthy 
body and mind.  Dement, however further clarifies that, ‘sleep erects a perceptual wall 
between the conscious mind and the outside world,’ and that ‘a defining feature of 
normal sleep is that it is immediately reversible’ (p.17) (1).  
There are many theories of sleep. Collectively, these theories suggest that sleep is a 
multifunctional process and possibly the most complex biological mechanism. This is 
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because sleep requires great counter operative changes to occur for the process to be 
maintained uninterrupted over long periods of time.  Only five theories will be briefly 
reviewed here, however a comprehensive evaluation of the major theories of the 
function of sleep can be sourced from the “Principles and Practice of Pediatric Sleep 
Medicine”, Chapter 1, The Function, Phylogeny and Ontogeny of Sleep, by Stephen H. 
Sheldon.  
1.1.1.1 Restorative Theory 
The restoration theory was first proposed by Sherington in 1946, and explains the 
function of sleep as a state required to promote tissue growth and repair.  This theory 
suggests that many somatic and cerebral deficits associated with the awake state are 
restored/repaired during sleep. This allows for the recuperation process to occur and for 
normal daytime function to continue.  Evidence to support this theory includes: the 
rebound effect of increased slow wave sleep after sleep deprivation, the relationship 
between increased body mass with total sleep time duration; the release of growth 
hormones, and reduction of catabolic steroid release occurring in the first few hours of 
sleep. Lymphocyte proliferation and bone growth also increases during sleep and 
further supports the idea that sleep acts as a protecting and recuperative (repair) period. 
1.1.1.2 Energy Conservation Theory 
This theory simply explains sleep as a mechanism to conserve energy, as in mammals, 
total sleep time is inversely correlated with metabolic rate. It proposes that sleep 
imposes periods of ‘compulsory’ rest and reduces the activity cycle.  However, 
themoregulation continues during sleep in large mammals and the metabolic drop is 
only approximately 8-10% suggesting that as a ‘conserving mechanism’ sleep is very 
inefficient.  
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1.1.1.3 Learning Theory  
Recent debate in the sleep field suggests that sleep serves as an ‘ongoing support for 
neuronal function in the brain’, playing an integral role in learning and memory 
consolidation (2).  The relationship between sleep and memory consolidation is well 
recognized however the exact role sleep plays is not well defined, in that the underlying 
aspects of sleep (e.g. mechanisms) that aid cognition and memory remain unknown.  
1.1.1.4 Synaptic Efficiency 
Many studies have looked at the effects of sleep and sleep deprivation/restriction on the 
structure and function of synapses (3). These studies which include, molecular, 
electrophysiological and structural approaches have shown that even a few hours of 
sleep loss per night can alter the size, number and composition of excitatory synapses 
and also changes their rate of transmission. In addition, studies show that sleep loss 
affects the rate of long-term potentiation which may underlie the cognitive and memory 
deficits reported in studies looking at the impact of sleep loss/deprivation. For more 
details readers are directed to a recent review by Cirelli, (3). 
 
1.2.1.5 Metabolic Clearance  
More recently, Nedergaard, propose that sleep acts as a state that promotes metabolic 
and neurotoxic clearing from the brain. She noted that the brain produces large amounts 
of neurotoxins and metabolites but has no lymphatic vessels for their clearance, as 
occurs elsewhere in the body. Cerebral spinal fluid (CSF) and interstitial fluid act as a 
sink for waste (neurotoxins and metabolites) that need to be transferred out of the brain. 
They demonstrated that CSF clearance occurs via the interaction between glial cells 
and arteries and for interstitial fluid via veins. Known as the ‘glymphatic system’ the 
process is dependent on astrocytic aquaporin-4 water channels which absorb analogous 
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to lymphatic vessels. These channels eventually drain into the cervical lymphatic 
system and the metabolites are excreted via the kidneys or broken down in the liver. 
 
Using a fluorescent tracer injected into the subaracnoid CSF, researchers measured the 
glymphatic CSF influx in awake and sleeping rats (4). They noted a 60% increase in 
the cortical interstitial space in the sleep state of the rat and that there was a twofold 
faster clearance of tracer during sleep compared to awake state, which they suggest is 
evidence of metabolic/waste clearing during sleep. Furthermore they showed that the 
changes associated with the increased rate of cortical interstitial space/CSF fluid 
clearance were dependent on inhibition by the adrenergic signalling in the arousal 
mechanisms (locus coeruleus pathways). An adrenergic antagonists was microinjected 
into the cisterna magna to simulate what happens in sleep (reduced SNS activity). This 
induced a similar influx of CSF in the brain as was observed during sleep and their 
further investigation demonstrated that adrenergic signalling plays a pivotal role in 
modulating both the cortical neuronal activity and the volume of the interstitial space.   
They also discovered the phenomenon known as CSF pulsation which indicates that 
the brain receives a much greater blood supply and actually ‘throbs’ like a beating heart, 
which they suggest also plays a part in the clearance mechanism. This theory of sleep 
as a function of neuronal metabolite clearance fits with both the ‘the learning theory’, 
which suggests that sleep aids normal brain function, and development and also the 
‘restorative theory’ proposed by Sherington.  
 
As a whole these theories on the ‘purpose of sleep’ suggest that sleep is a critical 
determinate of health and wellbeing especially in childhood, where all the foundations 
of good health are set. Conversely, ongoing deviation from ‘normal’ sleep in childhood 
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is potentially accompanied with poor long-term health outcomes when you consider 
children spend approximately 50% of their childhood years asleep. 
 
Sleep is easily recognized.  Humans sleep in a recumbent position, their body becomes 
immobile, the eyelids close and deviate upwards and outwards and proprioception and 
other reflexes disengage (1). Sleep in other animals varies with some sleeping in the 
standing position, others with their eyes open while others hanging from their feet (1). 
The amount of time spent sleeping also varies, with the average human adult sleeping 
for 8 hour overnight, while other species such as the rats, considered polyphasic 
sleepers, only sleep for short periods of 1 – 2 hours. Newborn babies spend in excess 
of 16 h/24 h sleeping, but this decreases with age, with the time spent sleeping by the 
6th decade decreasing to an average of 6.5 hours.  
 
A significant transition occurs in the underlying physiology during sleep with a 
systemic relaxation of muscle tone and a reduction in  heart rate and blood pressure (5). 
Also, both respiratory rate and body temperature decrease, while melatonin secretion 
from the pineal gland increases (6). The rapid, low voltage, beta wave oscillations 
observed in electroencephalogram (EEG) while awake become slow, the eyes close and 
higher strength alpha waves are observed and then gradually replaced by lower-
frequency theta wave (1). The mind wanders and at this point a transition from the 
awake state to the sleep state occurs.  
 
1.1.2 Sleep Physiology 
1.1.2.1 Sleep Architecture/ Staging 
Sleep is first evident in the human fetus and premature infants from as early as the 25th 
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- 32nd week of gestation (7-9).  Sleep is an active and rhythmic neural process that 
involves crucial changes in the autonomic nervous system (ANS) regulation of 
cardiovascular tone and respiration (Figure 1.1).  The ultradian rhythm in sleep was 
first characterized by Aserinsky and Kleitmann when they observed bursts of eye 
movement alternating every 90-110min throughout sleep. The cyclic succession of 
brain activity during sleep has been classified into two main states of vigilance, rapid 
eye movement sleep (REM) (Table 1) and non-rapid eye movement sleep (NREM).  
The sleep ‘stages’ were first classified and used to ‘score’ staging in accordance with 
rules devised by Rechtschaffen and Kales, based on the waveforms evident in the EEG 
in 1968 (10).  
NREM sleep is further classified into four sleep stages (1-4), each with evidence of 
distinct psychophysiological changes, manifested in the EEG. The states are 
characterised by progressively slower frequencies and higher voltage activities that 
correspond to successively deeper states of sleep (Table 1.1).  In 2007, the American 
Association of Sleep Medicine (AASM)  amalgamated  stages 3 and 4,  and together 
constitute slow wave sleep (SWS) (11). NREM sleep is often referred to in the literature 
as synchronized sleep as the wave forms recorded from different sites on the scalp show 
synchronicity, be they slightly phase delayed.  NREM sleep makes up the largest 
proportion of sleep, collectively accounting for 75%, most of which is spent in SWS. 
SWS is more evident in the first half of the sleep period (Figure 1.1). 
Also evident in NREM sleep is the spontaneous appearance of cyclic alternating pattern 
(CAP) in the EEG trace. Considered a maker of sleep instability, the transient 
oscillations in the EEG, (A phase of the cycle) are followed by intervals of background 
activity (B phase of the cycle) (12). These phases are further subtyped by their level of 
synchronicity between the different regional EEG signals, (A1, synchronized, A2 both 
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synchronized and desynchronized and A3 only desynchonised).  A1 subtypes are 
associated with the build-up and maintenance of SWS, and are proposed to protect sleep 
continuity, while both A2 and A3 are involved in increased autonomic activity and are 
associated with arousability and the REM like state (13).  The origin of the CAP signal, 
is proposed to involve the autonomic nervous system (ANS). Ferri et al. showed  that 
periods of CAP during NREM sleep were associated with increased vigilance as 
measured using heart rate variability (spectral analysis for continuous 
electrocardiogram (ECG) recording) compare to parts of NREM with no CAP (14), 
suggesting that the origin of CAP involves activation of  ANS pathways. 
REM sleep accounts for the remaining 25% of sleep and is characterized by bursts of 
eye movements, back and forth under closed eyelids, muscle atonia, desynchonised low 
amplitude and high frequency EEG signals. Increased burst of theta signals, variability 
in heart rate, blood pressure and an irregular respiratory rate, increased bursts of 
sympathetic activity and increased upper airway resistance (Table 1.1) also occur in 
REM sleep. It is often referred to as desynchonised sleep or even paradoxical sleep and 







Figure 1.1: Shows a hypnogram from a child, blocks of blue denote slow wave sleep 
(SWS), green, Stage 2 NREM sleep, yellow Stage 1 NREM sleep and in red, rapid eye 
movement sleep (REM). Notice the large blocks of SWS at the beginning of the night 
and how it becomes less frequent as the night progresses while REM sleep increases 
with sleep duration. 
 
 
In adults the circadian rhythm (24 hour cycle) has a pivotal influence on sleep onset 
and sleep. Infants are born with an active superchiasmatic nucleus, (the circadian 
rhythm pattern generate in the brain) and initially their circadian rhythm is entrained to 
that of their mothers. By one month, infants begin to acquire their own circadian 
rhythm, however sleep remains polyphasic (ultradian pattern), with repeated 
awakenings, and feeding occurring throughout the day and night (15). As infants 
mature, sleep architecture and time spent asleep also changes dramatically, reflecting 
the ongoing development of the central nervous system (CNS) and its respective 
interaction with the environment and also sleep experience (15). Three states of sleep 
are characterised in newborn infants (16). They include ‘active sleep’, characterised by 
an irregular heart rate, rapid eye movements and low voltage irregular/ mixed EEG 
activity, ‘quiet sleep’, characterised by a regular heart rate and respiratory rate, high 
amplitude mixed frequency EEG and ‘intermittent sleep’, which is a combination of 
the two states (evident within and epoch (30s) of EEG).  






 NREM sleep is predominately regulated by 
parasympathetic nerve activity. 
 Heart rate decreases. 
 Breathing deepens and is regular. 
 Sympathetic tone is attenuated.  
 Blood pressure also decreases as the body transitions 
from S1 to SWS.  
 It makes up 75% of sleep in normal children with most 
time spent in S3 and S4. 
 As the sleep progresses from Stage 1-4 the signals 
become more synchronized. 
Stage 1 
 
 Evident at the beginning of sleep, light sleep. 
 Small proportions throughout ‘normal’ sleep cycle.  
 Low voltage, mixed frequency, highest amplitude in 2-
7 Hz band. (can reach values of 200mV and can have 
vertex sharp waves). 
 EMG shows lower tone than wakefulness. 
 Less than 50% alpha and mixed frequency is used to 
classify S1. 




 An absence of slow wave. 
 Evidence of both sleep spindles in the 12-14Hz band. 
 K complex waveforms are the main characteristics of 
Stage 2. 
 K complexes are sharp negative waveforms alternating 
with a slower positive surge.  
Stage 3 
 
 20-50% wave in the 2Hz band or slower and an increase 
in amplitude (voltage), to 75mV (delta waveform).  
 Both spindles and K complexes occur in Stage 3, 
however at a much lower rate than Stage 2. 






 Similar to stage 3, however the signal shows more than 
50% of waveforms in the 2Hz and slower and amplitude 
greater than 75mV (delta).   
 Muscle tone is reduced but not absent and cerebral 
blood flow is decreased to the frontal cortex. 
 There is greater synchronization between electrodes on 
the EEG.  
 Heart rate, blood pressure and respiratory rate are 
decreasing and upper airway resistance is increasing as 
time progress into S4.  Collectively S3 and S4 are 





 Characterized with generalized muscle atonia. 
 Increased cerebral blood flow to the frontal cortex. 
 Desynchronized EEG and variability in heart rate, blood 
pressure and respiratory rate.  
 Upper airway resistance increases as does sympathetic 
modulation.  
 Burst of eye movement, back and forth, under closed 
eyelids. Highlighted in purple. 
 The signal are more desynchronized compared to 
NREM sleep. 
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1.2 Sleep Disordered Breathing (SDB): Reaching a New Set-Point 
During sleep the upper airway patency is maintained by the balance of multiple interrelated 
physiological components, including the pharyngeal dilatory muscle tone, neurogenic tone, 
upper airway resistance, pharyngeal collapsibility, and intrapharyngeal pressure generated by 
the inspiratory muscles (17). Interruption of the balance between these components can result 
in narrowing or total obstruction of the airway causing an increase in airway resistance. This 
results in increased effort required of the inspiratory muscle to maintain the airway of sufficient 
patency to allow adequate gas exchange.   
 
Snoring is a primary indicator that there is resistance to airflow and is evidence of SDB. SDB, 
affects the respiratory load and its severity ranges from the most prevalence and least severe, 
known as primary snoring, to obstructive sleep apnoea where there is sufficient disruption to 
sleep and changes to critical ventilation parameters (see 1.6.3.2 for more details). As respiration 
is an essential physiological function, any deviation from its optimum pattern of functional 
processes alters the physiological mechanisms which are designed to maintain homeostasis at 
a constant milieu.  When the deviation is chronic, occurring on most nights, the set-point to 
meet homeostasis changes and a different pattern of physiological interactions are induced. 
Overtime, these recruited mechanisms become established and a new trajectory for the 
underlying systems develops. The transitory change is termed allostasis, from the Greek words 
‘allo’ meaning other and ‘stasis’ meaning state. Allostasis occurs all the time, when seasons 
transition, the body responds, e.g. by increasing fat storage during winter (thermal insulator 
and energy source) to protect us from the harsh cold weather and when food supply is limited.  
When spring comes, the extra kilos are shed, food is abundant again and we transition back to 
our summer selves. But what if winter continued longer than 3 months? What if winter did not 
come at all? Our bodies would adapt to the new norm and the new state would be the one that 
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was optimum for survival at that time. However, the long-term repercussions of this new state 
may in itself cause changes that are detrimental to the underlying physiology in the longer term. 
This unfavorable outcome is a result of allostatic overload and SDB can be viewed as an 
example of allostatic overload.  
 
1.2.1 Homeostasis, Allostasis, Allostatic Load and the Autonomic Nervous System 
‘Homeostasis’, first proposed by Canon in 1926 are the processes involved in the coordination 
of physiological responses that maintain the ‘milieu interieur’ of the organism within an 
optimal range required to sustain life. Typically these processes include the essential functions 
of life, such as pH balance, body temperature, glucose levels and oxygen tension. Allostatic 
processes support homeostasis and also promote the adaptation to stress exposure. In humans, 
the processes involved in establishing the new set-point are dictated by the central nervous 
system (CNS), which governs the contraction of striated and smooth muscle, and 
neuroendocrine/exocrine function. Activation of these processes can either amplify or reduce 
a particular process, for example, in blood vessels the ‘amplification’ may result in the dilation 
of blood vessels, in a particular vascular bed in response to reduced circulating oxygen or as is 
the case in brown adipose tissue vasculature in mammals during cold exposure(18). While at 
the same time a reduction in vascular compliance and vasoconstriction may occur to reduce 
blood flow to a specific tissue, for example the skin during cold exposure. These process occur 
as a concerted response to preserve the homeostatic balance and to optimise survival. 
1.3.2 Autonomic Nervous System (ANS) 
As the main focus of this thesis is the alteration in function of the autonomic nervous system 
during SDB, the next section will give a brief synopsis of the ANS and the function of these 
components during normal sleep.  
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The main regulatory arm of the CNS involved in allostasis is the autonomic nervous system 
(ANS). Although not completely autonomous, the system simultaneously executes both 
excitatory and inhibitory activation of a wide range of tissues, target organs, and blood vessels. 
Single unit cells, such as mast cells, are also influenced by ANS activation. The control of the 
ANS is complex and works as a group of interconnected reflex arcs which are primarily 
centrally mediated by the hypothalamus and lower brain stem nuclei (19).  The ANS regulates 
the body’s visceral functions including respiration, cardiovascular function, thermoregulation, 
neuroendocrine secretion, gastrointestinal and genitourinal functions. The regulation of these 
functions are mediated through efferent nerves, which respond to moment-by-moment status 
changes via the activation of feedback afferent sensory relays from chemoreceptors, 
mechanoreceptors, nocioceptors, thermoreceptors, baroreceptors and osmoreceptors. These 
afferent feedback loops terminate in the CNS where the reflex arcs are regulated. The ANS 
exerts its control via two efferent pathways, the sympathetic nervous system (SNS), considered 
the energy recruitment component and parasympathetic nervous systems (PNS), the restorative 
component (20). They are comprised of preganglionic neurons in the brain stem and spinal 
cord and postganglionic neurons, which synapse at the target organ (see Figure 1.2) (21).  
The role of the SNS, often misunderstood and misrepresented, is to facilitate the moment-to-
moment regulation of cardiovascular function during periods of high excitation (extreme 
stimuli) but it is also active in periods of rest, not just during ‘fight or flight mode’ (22). Despite 
many textbooks describing the components of the ANS in normal conditions as existing in a 
harmonious state of balance, the reality is that this is not the case. Throughout the day and night 
these components (SNS and PNS) work at different levels of activation and are not necessarily 
in balance or even synchronized. The different activation levels of the two components give 
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rise to different patterns of behavior.  An example of this is clearly demonstrated during sleep 
onset where the components of the SNS become less active, evident in vasodilation in the 
cutaneous vasculature, an indicator of SNS inhibition and somatic cooling, while the PNS 
dominates, reducing the heart rate, deepening respiratory effort and prolonging each breath.  
A major function of the sympathetic nervous system is the regulation of arterial pressure. It 
does this by rapidly adjusting vascular compliance by increasing/decreasing the diameter of 
resistance arteries and reducing sodium and water excretion by the kidneys (23). This allows 
the body to maintain adequate perfusion of organs in order to meet their metabolic 
requirements. Unlike motor neurons which activate when required to execute a purpose, the 
sympathetic nerves are always active to a varying degree and, hence, all innervated blood 
vessels remain under some degree of continuous constriction (22).  
Sleep is a major process where there is considerable change in ANS function compared to the 
awake state (24). The effect of chronic SDB disrupts the normal pattern of sleep and results in 
sympathetic over-activation, hypoxia, fragmented sleep, and intrathoracic pressure swings. 
These changes have be independently associated with atherogenesis and the development of 
cardiovascular disease (CVD) (25, 26).  Even the acoustic vibration from snoring has been 
suggested as a possible contributing factor by adding to the allostatic imbalance, (27) which is 
thought to increase the risk of cardiovascular dysfunction. Research in adults and children has 
demonstrated that SDB is associated with sympathetic over-activation, systemic vascular 
irregularities including endothelial dysfunction, inflammation and the production of reactive 
oxygen species (28). These physiological changes are also all factors implicated in the 
development of cardiovascular disease. 
SDB during childhood, where sleep is an important part of development and growth, may act 
as an increased burden on the underlying physiology by changing the ‘normal’ set points in the 
 38 
system. Over time, this allostatic overload will result in the development of pathological 
maladaptive processes, involving the ANS pathway, most of which will affect the development 





Figure 1.2: Autonomic neuronal output of (A) The sympathetic nervous system and (B) 
parasympathetic from the Central Nervous System.  
 Blessing & Gibbons Scholarpedia http://www.scholarpedia.org/article/Autonomic_nervous_system) 
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1.3 Autonomic Function and Sleep 
To assess the effect of SDB on the cardiovascular and ANS function in children we need to 
understand the typical function of these systems during sleep.  As previously mentioned, 
regular sleep involves cyclical changes throughout the night, which are coupled to different 
states of vigilance, associated with changes in autonomic function.  Heart rate, stroke volume, 
cardiac output and blood pressure are reduced during sleep and also show an alternating pattern 
with changes in sleep stages.  Although the purpose of these ‘state’ changes is still debated, 
what is clear is that the underlying mechanisms (blood pressure, heart rate) involved in these 
changes are affected in both adults and children with SDB (29).  A detailed evaluation of 
autonomic changes during sleep is outlined in Chapters 3, 4 and 5 of Pier Luigi Parmeggiani’s, 
Systemic Homeostatsis and Poikilostasis in Sleep. Is REM Sleep a Physiological Paradox? 
(30). 
1.3.1 Blood Pressure 
Regional blood flow is determined by both perfusion pressure (arterial pressure) and resistance 
to flow in the specific region (31). Arterial pressure measurement consists of two parts, the 
maximal pressure during the ejection phase (systole) of the heart cycle (systolic pressure) and 
the minimal value measured at the end of ventricular (diastole) (diastolic pressure). Although, 
blood pressure can fluctuate depending on behaviour, it is, however, tightly regulated and is 
maintained within a narrow range via a complex network of both short- and long-term 
feedback/feedforward control systems (32). The factors involve (i) the feedforward ‘central 
command’ mechanisms, which include the ANS innervation to the heart and blood vessels and 
are part of the generalized adaptive physiological response; ii) the intrinsic mechanisms which 
include size and location of the sinus node and structural components of the heart and 
vasculature (smooth muscle cells, elastin, collagen fibers); (iii) circulating hormones; (iv) local 
factors such as metabolites (ATP, lactate and pH) and endothelial cell integrity (31) and (iiv) 
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receptors involved in the feedback/reflex including the baroreceptors, which are sensitive to 
changes in arterial pressure and also receive input from peripheral vasculature chemoreceptors 
which respond to change in CO2/O2. Also included in the network are respiratory 
mechanoreceptors (lung afferents) (32) and vestibular receptors (inner ear) (33) which relay 
information of positional change. Together these components allow for the moment-by-
moment regulation of arterial blood pressure (34) and make up the ‘baroreflex’. The baroreflex 
provides an ongoing buffering system to dampen the effects of sudden fluctuations in blood 
flow caused from emotional stress, exercise and orthostatic change (34) (Figure 1.3) and is 
pivotal for the body’s ability to meet the metabolic requirement of each region, which may 
vary greatly (31). 
 
The baroreflex maintains both cardiac output and total peripheral resistance via the activation 
of ‘baroreceptors’ which are mechanoreceptors sensitive to stretch. These afferent nerve 
terminals are located in a small dilation in the adventitia of the internal carotid known as the 
carotid sinuses (transduces the signal via the glossopharyngeal nerve) and aortic arch 
(transduces the signal via the vagus nerve and/or aortic depressor nerve) (35). There are also 
baroreceptors in both atria, at the entrance of the major veins (superior, inferior vena cavas, 
pulmonary) called cardiopulmonary receptors.  An increase in arterial pressure, deforms the 
luminal wall and activates the baroreceptors, causing a depolarization and an increase in firing 
to the nucleus of solitary tract, which responds by initiating a sympathoinhibitory response via 
interneurons in the caudal ventral lateral medulla, that release γ-aminobutyric acid (GABA). 
This then inhibits the sympathoexcitatory neurons located in the rostral ventral lateral medulla 
(RVLM), which controls the tonic and reflex control of arterial blood pressure. The neurons of 
the RVLM produce noradrenaline and project direct to the intermediolateral cell column, which 
activates vasoconstriction to the muscle, mesenteric and renal blood vessels. The inhibition of 
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the RVLM neurons initiates the vasodilation of peripheral vessels, by withdrawal of the 
vasoconstriction, and hence minimizes the arterial pressure load and the pressure decreases.  
At the same time the NTS regulates the release of arginine vasopression and also regulates the 
heart via the activation of vagal preganglionic cholinergic neurons to the nucleus ambiguous. 
These neurons inhibit the automatism of the sinus node and influence the beat-to-beat 
innervation of the heart (34).  The summation of these activations result in changes in 
vasomotor and cardiomotor nerve activity and buffers the initial change to arterial pressure.  
 
The primary effect of the baroreflex is on total peripheral resistance via the RVLM’s activation 
of sympathetic vasoconstrictor neurons, arising in the submesencephalic brain stem region, 
including rostral preoptic region and raphe in the medulla (36). The preganglionic sympathetic 
neurons release acetylcholine, which elicits a rapid excitation of noradrenergic neurons in the 
sympathetic ganglia. They then release noradrenaline (NA) at their terminals located at the 
media/adventitia interface of resistance blood vessels. The NA then activates α-1 adrenergic 
receptors on the smooth muscle cells causing the muscle fibres to contract and vessels to 
constrict (37). The baroreflex activation alters peripheral vasomotor activity and blood flow in 
an organ-specific manner, with changes in the vascular bed of the kidneys, gut, skeletal muscle 
and human skin vasculature (38). 
Baroreceptor sensitivity (BRS) is functional in the latter weeks of gestation, and increases 
gradually as children reach puberty. In children both systolic and diastolic blood pressures 
increase with age and size, including height and less so BMI (39). BRS starts to decline after 
the second decade and is reported to decrease to almost zero in the 7th-8th decades (39).  
Vascular compliance is an important determinant of BRS, with reduced vascular compliance 
and arterial wall stiffening and in particular carotid distensibility associated with reduced BRS 
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Figure 1.3: The Baroreflex neural networks. In normotensive humans increased peripheral 
blood pressure triggers baroreceptors. The afferent signal travels to the brain stem and triggers 
the reflex response, which includes decrease heart rate through the vagus nerve and also inhibits 
the sympathetic preganglionic neurons to the heart, reducing ionotropic force (reducing stroke 
volume and cardiac output) and dilation of blood vessels, causing a reduction in blood pressure 
(pg 43) (42). 
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1.3.1.1 Blood Pressure During Sleep 
In humans, blood pressure is reported to reduce by 15-20mmHg during synchronized NREM 
sleep (24).  The largest decreases of arterial blood pressure occur as sleep stages transition to 
the deeper stages of sleep (S3/4) (43). There is evidence that arousals during NREM sleep 
result in phasic increases in blood pressure (44) while K complexes, which are evident in Stage 
2 and occasionally Stage 3, are also followed by a transient increases in blood pressure (45). 
Spectral analysis of continuous blood pressure assessments has shown a fall in the power of 
low frequency blood pressure variability during NREM, which is reversed during REM sleep 
(5).   
 
During desynchronized REM sleep blood pressure oscillates, both increasing and decreasing, 
with levels reported below that of NREM and at times even higher than during awake.  It has 
been proposed that the reduction in blood pressure during synchronized NREM sleep is as a 
result of reduced cardiac output. The changes experienced during desynchronized REM sleep, 
however, result as a consequence of both changes of total peripheral resistance and cardiac 
output (46), which suggests that the blood pressure increases and decreases experienced during 
REM sleep are mediated from autonomic control, e.g. periodic sympathetic activation.  
 
1.3.2 Heart Rate 
Heart rate is primarily determined by the depolarization of the Sino Atrial node (SA), the 
atrioventricular node, the intrinsic properties of myocardial cells, the geometries of the heart, 
compliance of the heart and vasculature and the Purkinje tissue (47). The heart rate reflects the 
net effect of the parasympathetic nervous system, which slows the heart rate, and sympathetic 
nervous system, which increases it.  The sympathetic neurons effect the innervation all the 
tissue of the heart via the release of NA and activation of cardiac β1-adrenoceptors while the 
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parasympathetic nervous system only innervates the SA and atrioventricular nodes, the atria 
and the ventricular conducting system, via the release of acetylcholine acting on nicotinic 
receptors (42). Sympathetic stimulation of the cardiac muscle also increases the rate of 
dromotropy, (transmission in cardiac conductive tissue) and inotropy (force of ventricular 
contraction). These actions act in unison to ensure that the level of adjustment in cardiac 
function meets the moment-to-moment requirements of the body. The rate of transmission, 
within the baroreflex  maintains the arterial pressure and is a key driver in maintaining cardiac 
output, while reflex adjustment also occurs in response to stretch from the great veins and atria 
by an increased in venous return (42). This results in an increase in heart rate so that output 
matches inflow with little change in contractility. Respiration also plays an important part in 
modulating heart rate. Increased tidal volume activates stretch receptors in the lung, which 
results in tachycardia and an increase in blood flow to meet respiratory demand. Activation of 
chemoreceptors (See 1.5.4) leads to a reduction in heart rate (bradycardia) via the medullary 
vagal output, with drops evident during periods of hypoxia, reducing cardiac output and 
increases the chances of survival.  
1.3.2.1 Heart Rate During Sleep  
Heart rate decreases when transitioning from awake to the sleep state, with the biggest decrease 
occurring in SWS (48). Baust & Bohnert demonstrated that the reduction in heart rate seen 
during the transition from the awake to synchronized NREM sleep is caused by an increase in 
vagal output (PNS) (49).  More recent studies suggest that the fall in heart rate is in part 
attributable to the circadian cycle (50) (51). 
 
In REM sleep, phasic increases in heart rate are evident. Iwamura et al., reported swings in 
heart rate during, desynchronized REM sleep that persisted after vagotomy thereby concluding 
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that the SNS innervation is responsible for the alternating heart rate. The fall in heart rate during 
REM are mediated by reduced SNS activation with reciprocal changes in vagal activity.  
1.3.2.2 Heart Rate Variability (HRV) 
The effects of SDB on the ANS can be evaluated using spectral analysis of the overnight 
electrocardiogram (ECG), known as heart rate variability (HRV). The analysis involves the use 
of algorithms that determine beat-to-beat fluctuations both in relation to time (time domain) 
and frequency (frequency domain) quantify the power spectral analysis of ECG segments (52) 
(See Appendix 3 for full list of HRV variables). Low frequency (LF) represents both 
parasympathetic and sympathetic activities while high frequency (HF) represents 
parasympathetic activity and the function of the vagus nerve. The ratio of LF to HF represents 
sympathovagal balance. Measuring HRV during sleep is the ideal time to assess the ‘baseline’ 
function of the ANS, in particular the PNS. 
1.3.2.3 Heart Rate Variability During Sleep 
For an in depth evaluation of HRV variables and their relevance to sleep and SDB, readers are 
directed to a comprehensive review by Stein and Pu (2012). In short, as sleep progresses to 
deep sleep the R-R frequency decreases and the HRV decreases with the biggest reduction 
associated with SWS with an increase in HF (increased PNS) and decreased LF (decreased 
SNS) and hence decreased LF/HF ratio.  Conversely during REM sleep the reverse occurs in 
the frequency domain variables, with decreased HF (reduced PNS) and increased LF (higher 
SNS) and increase LF/HF ratio. The increase in HF during SWS is associated with higher 
respiratory regulation (53) Aging has an effect on HRV during sleep with an increase in HR 
and lower HF during NREM sleep occurring as we age, suggesting a reduction in cardiac vagal 
activity during sleep as we age (39).   
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1.3.3 Respiration 
Respiration is regulated by two separate neural mechanisms. One set of mechanisms controls 
autonomic respiration, experienced while we are asleep and the other mediates voluntary 
control.  The autonomic control arises in the pacemaker cells in medulla. The rhythmic 
activation from the pacemaker cells is coupled to the motor neurons in the cervical and thoracic 
spinal cord, which innervate the inspiratory muscles (54). The cervical motor neurons activate 
via the phrenic nerve to contract the diaphragm and initiate inspiration, while the thoracic motor 
neurons activate the external intercostal muscles, and the signal transduces to the internal 
intercostal and other expiratory muscles.  
1.3.3.1 Respiration During Sleep 
Respiratory rate decreases and becomes shallower as mammals enter the early stages of NREM 
sleep from quiet waking. As NREM sleep stages progress respiration becomes more regular 
with the appearance of definite expiratory pauses, a small increase in tidal volume and a larger 
decrease in respiratory rate, resulting in reduced minute ventilation. The decreased frequency 
is accompanied by reduced oxygen uptake and a 10-20% reduction in carbon dioxide 
production, indicating a decrease in metabolic rate during NREM, especially in SWS.  Also 
evident are periodic fluctuations in the depth of breathing, especially in the early hours of 
NREM sleep. There is a successive reduction in tidal volume with each inspiration that ends in 
an expiratory apnoea and terminates with an exaggerated inspiration. This cycle repeats itself 
and is similar to the classical Cheyne-Stokes pattern of respiration. A 15-30% fall in alveolar 
ventilation is indicated by a mild increase in alveolar partial pressure of CO2 (PACO2) and a 
similar  increase in arterial partial pressure of CO2 (PaCO2), which is paralleled with small 
decreases in PaO2 and PAO2 and minor decrease in arterial pH (24). This results in both mild 
hypoxia and hypercarpnia throughout sleep, regardless of sleep stage.   
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Respiration during REM sleep is variable, with periods of hyperventilation (rapid breathing) 
interspersed with moments of regular and reduced respiration and apnoeas of varying lengths. 
Hence both the respiratory volume and rate can increase and decrease throughout REM sleep. 
Minute ventilation phasically increases to levels measured during the awake state but overall 
it remains lower.  The degree of hyperventilation is thought to be associated with the level of 
muscle activity and eye movements that occur periodically during REM sleep (24) and suggests 
that respiratory changes are secondary to internal changes in neuronal activity. It has been 
proposed that the hypoventilation during REM sleep is associated with reduced ventilatory 
drive rather than a change in mechanical factors, such as reduced upper airway patency (55). 
In addition, PaCO2 measurements decrease while PaO2 remains the same and can in some cases 
increase during REM sleep. The irregular breathing pattern is not affected during hypercapnia 
and is insensitive to afferent input including metabolic alkalosis, vagal block, and denervation 
of peripheral chemoreceptors (56). 
 
During sleep, respiratory parameters are critically dependent on both chemical and mechanical 
feedback reflexes (24).  When using mechanical ventilation to progressively increase tidal 
volume and thereby reduce circulating CO2 levels, this results in apnoea events. Conversely, 
increasing inspired CO2 levels eliminates both central and periodic breathing (57) because of 
the induction of increased respiratory drive. Gleeson et al. showed that in humans the level of 
circulating O2 and CO2 determines the ventilatory response and in particular, that the level of 
CO2 was the primary respiratory driver (58). Sleep stage also plays an important role in the 
sensitivity of the respiratory control system, with decreased ventilation and increased PaCO2 
during NREM sleep (24). Burlow et al., demonstrated that ventilation response to changes in 
CO2 is significantly reduced in  NREM compared to awake (59). 
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In sleep the airway patency is reduced, possibly due to the global reduction of neuronal activity. 
The collapsibility of the upper airway, a major issue in adults with SDB and possibly in children 
with SDB too, can be measured using pharyngeal critical pressure (Pcrit) and negative 
expiratory pressure (NEP) techniques (60). Pcrit is the critical pressure where maximal 
inspiratory airflow occurs while asleep and is the relationship between pressure and airflow 
through a dynamic tube (Starling resistor) (60). 
 
In NREM sleep, motor output to the respiratory pump muscles and upper airway is drastically 
reduced, resulting in a hypoventilation, with increases of between +2 and +8 mm HG arterial 
partial pressure of CO2 (PaCO2); a reduction in upper airway muscle compliance (hypotonicity), 
increased Pcrit and airway collapsibility in health adults (57). In adults, both tonic (postural) 
and phasic (inspiratory related) innervation are reduced during REM sleep as measured with 
electromyogram of the intercostal muscles (61). This alters chest wall compliance and reduces 
tidal volume. These experiments demonstrate the effects of the both the chemical and 
mechanical feedback reflexes on breathing patterns.  
 
1.3.4 Chemosensitivity 
Peripheral chemoreceptors in the carotid and aortic bodies are neurosecretory glomus cells. 
Carotid body chemoreceptors are sensitive to decreased O2, increased CO2 levels and decreases 
in pH in the circulating arterial blood, (62, 63) while aortic chemoreceptors are only sensitive 
to decreased O2 and increased CO2 levels. Activation of the chemoreceptors in the carotid 
bodies results in the release of neurotransmitters, acetylcholine, nitric oxide (NO) (64) and 
carbon monoxide (CO) (65). This transduces a signal that travels via the sinus nerve (carotid 
body) and aortic depressor nerve (aortic body) or chemoreceptor fibres linked with the vagus 
nerve. Activation in the carotid sinus simultaneously activates baroreceptors and the signals 
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travel via the glossopharyngeal nerve (38). These signals travel to the brain stem via the vagus 
and depending on the type of stimuli (pH, O2, CO2) will evoke a respiratory correction and 
regulate tissue perfusion accordingly.  Central chemoreceptors, in the brain (medulla, NTS, 
locus coeruleus, hypothalamus) also detect changes in arterial CO2 and regulated cerebral 
blood flow, pH and brain metabolism (66). The response to chemoreceptors is fast and 
modulates respiration on a breath-to-breath basis. In addition, activation is associated with 
regionally selective vasoconstriction, with bradycardia, reduced cardiac output and sometimes 
hypertension (p. 122) (38).  In the awake, normal breathing state, arterial CO2 (via pH) remains 
the primary determinant of ventilation.  
1.5.4.1 Chemosensitivity in Sleep 
 Early studies by Brebbia and Altshuler showed O2 consumption is decreased between sleep 
compared to wakefulness which demonstrates the reduction of metabolic rate associated with 
sleep. They found that O2 consumption was reduced in all sleep stages compared to 
wakefulness and that O2 consumption in REM sleep was higher than NREM consumption, 
which reduces as NREM stages of sleep increase (S1-3/4). However the reduction in O2 is only 
small and does not significantly alter saturation of haemoglobin (24). As previously mentioned, 
respiratory drive decreases in NREM sleep and circulating CO2 increases the most during SWS 
by between 10-20% (67). Ventilation response to increased CO2 is also moderately reduced in 
NREM sleep. This suggests that chemoreceptors (central and/or peripheral), which would 
normally activate to correct the increased concentrations of CO2 are blunted compared to the 
awake state and REM sleep.  In further support of reduced chemosensitivity in NREM sleep, 
Berthon-Jones and Sullivan using 7% CO2 in 40% O2, a rebreathing test, that was administered 
via nasal mask to evoke arousals in different sleep stages showed that males aroused at greater 
alveolar PCO2 during NREM sleep, compared to REM sleep and awake state. They found no 
differences in women in either sleep state compared to awake (68).  
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Selective denervation of the carotid chemoreceptors in the cat causes a decrease in arterial 
blood pressure during REM sleep (usually increased) but not denervation of baroreceptors. 
This suggests that the carotid chemoreceptors play a vital role in maintaining/increasing arterial 
pressure during REM sleep.  It may be the case that the drop in ventilation during NREM sleep 
and consequential increase in hypercapnia is part of the centrally generated sleep state that, 
over time, precipitates a level (CO2 increase vs O2 decrease) required to activate the 
chemoreceptors and hence reverse the consequences of time spent in the NREM sleep state and 
transitioning back to REM (69). The increase in circulating CO2 acts as a vasodilator, 
contributing to reduction of vascular resistance, which occurs predominately during SWS (24). 
1.3.5 Blood Flow, Peripheral Resistance and Thermogenesis 
Global, blood flow to the brain has been shown to be decreased during both REM and NREM 
sleep compared to awake. This suggests that cerebral autoregulation is altered during sleep, 
possibly resulting from systemic haemodynamic depression (reduced cardiac output and 
reduced total peripheral resistance occurring together) (30). Total peripheral resistance is 
reduced both in REM and NREM sleep compared to the awake state (70) and may account for 
the difference in global cerebral blood flow during sleep. Global cerebral blood flow is greater 
in REM sleep compared to NREM sleep by approximately 17% (71).  Paradoxically, some 
areas of regional flow in the brain are increased while others are significantly reduced during 
REM sleep compared to pre-sleep (Table 1.2). The increase in blood flow is not associated 
with changes in perfusion pressure, circulating CO2 or cerebral metabolic rate (72). The surges 
of regional brain blood flow coincident with periods of phasic REM and peaks in diaphragmatic 
EMG activity and possible phasic sympathetic activity. In the cat, the fall in arterial blood 
pressure during desynchronised REM sleep results from vasodilation of the splanchnic and 
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renal beds, while a reduction in muscle vascular conductance (vasoconstriction) occurs at the 
same time in peripheral vessels (73).  
 
During synchronized NREM sleep, in humans, and other mammals (rhesus monkey, rabbit and 
cat) skin temperature measured on the ear (pinna), hand/fingers is similar to the awake state. 
However contradictory reports of both hand volume and skin temperature have been reported 
is desynchronized REM, with one report suggesting increased hand volume and temperature, 
indicating considerable vasodilation during REM sleep (74).  Conversely, others have reported 
peripheral vasoconstriction in humans during REM sleep. NREM sleep, particularly slow wave 
sleep, is accompanied with bradycardia and small reduction in cardiac output, reduction in 
sympathetic tone in the muscles and reduction in systemic vasculature resulting from reduced 
systemic vascular resistance. Studies in the cat and humans have shown peripheral conductance 
and aortic flow are slightly reduced in synchronized NREM sleep, however during 
desynchronized REM sleep peripheral conductance was increased by 9% and, hence, results in 
a decrease in total peripheral resistance (30).  
 
 A small increase in hypothalamic temperature (0.2 ̊C) during REM sleep has been described 
by Parmegianni et al., (30). They propose that the increase in hypothalamic temperature (pre-
optic region specifically) is possibly due to increased metabolic heat produced from nervous 
tissue, arterial blood flow and the arterial blood temperature. They also speculate that the rise 
is associated with alterations of systemic haemodymanics observed through REM sleep, 
including the vasoconstriction to the cutaneous vessels and decreased cardiac output. More 
recently Ootsuka et al., speculated that the increase in brain temperature (hypothalamus) during 
REM sleep is associated with brown adipose tissue thermogenesis, which they showed in rats, 
follows a 90 – 110min ultradian cycle during the dark phase of the circadian cycle (when rats 
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are more active) (75). The authors proposed that the BAT ultradian rhythm is part of the Basic 
Rest Activity Cycle (BRAC), first proposed by Kleitman in the 1960s. Recent PET scan studies 
have shown that active BAT is still present in adults, however, whether the BAT ultradian 
rhythm plays an active role in the sleep cycle in humans is yet to be investigated (76). 
 
Table 1.2: Compares autonomic and cardiovascular function between the awake state and 
different sleep stages 
 
Cardiovascular Parameter REM NREM 
Blood Pressure 
Baroreflex Sensitivity 
 Tonic  and Phasic  
 
 Tonic and Phasic 
  
Heart Rate  
HRV 
 Tonic  and  Phasic  
 HF  
 LF   
  
 HF  





 Respiratory Volume and 
Frequency unstable 
 
 Respiratory Volume and 
Frequency stable 
 
Cerebral Blood Flow 
(77) 
 Global flow compared to 
pre-sleep awake,compared to 
post –sleep awake.
 flow in the pontine 
tegmentum, paralimbic areas, 
hippocampus, posterior cingulate 
cortex.
 to the dorsolateral prefrontal 
and frontal opercular cortices 
inferior partietal lobule 

 Global 26%  







Cutaneous Blood Flow   and  (phasic)  Same  
Mesenteric Blood Flow    blood flow when blood 
pressure increases 
 28% conductance 
 Vasodilation  
 Same flow, small 
increase in conductance, 
 Vasodilation 
Muscle Blood Flow   17% Iliac conductance 
  Vasoconstriction  
 Same Iliac conductance 
Renal Blood Flow  20%  in conductance 
 no change in blood flow  
 Same 





1.4  Sleep Disordered Breathing in Children 
 
Thirty years ago, Guilleminault et al., were first to describe SDB in children using 
polysomnography. They described similar abnormalities to those observed in adults with SDB 
such as respiratory pauses, restless sleep, difficulty breathing and oxygen desaturation. They 
also noted excessive daytime sleepiness, increased sweating, abnormal weight (both over and 
under-weight), morning headaches, nocturnal enuresis (betwetting) and decreased school 
performance in children with SDB. More importantly, they were the first to report a 
‘progressive development of hypertension’ in children who demonstrate ‘loud snoring 
interrupted by pauses during sleep’ (78). SDB occurs in all age groups including preterm 
babies and adolescents, however the disorder is most common in the 2-5 year age group (79). 
1.4.1 Prevalence 
Although there are many epidemiological studies in paediatric SDB, a clear picture of the 
number of children affected is still to be definitively determined.  The results of prevalence 
studies now available from North and South America, Europe, Australia, Africa and Asia 
collectively demonstrate that SDB in children is a common disorder which affects both 
developed and developing countries (80). Prevalence varies from country to country and even 
within country reports. These discrepancies are due to inconsistent measuring methods 
(breathing during sleep, clinical setting, parental questionnaire), small sample sizes and 
consistency with standardized classification of habitual snoring and also OSA. In a recent 
‘technical support report’, prevalence of habitual snoring was reported at between 1.5% to 
27.6% using subjective measures (parental reporting/questionnaires) in studies from around 
the world (See Table 1.3). The working committee concluded that at the severe end of the 
disorder, between 1.2%-5.7% of children have OSA (using data of three general paediatric 
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population studies (81-83)). The authors supported the need for more population based studies 
to further delineate gender, age and race distribution in SDB (84). Despite the range in 
prevalence reported, what is clear, is that SDB is a common, worldwide, paediatric disorder. 
Table 1.3: Prevalence of SDB around the World adapted from Marcus et al, 2012 (84) and 
Lumeng and Chervin, 2008. 
 
 
Region/Country No of 
Participants 
Frequency Reference Age 
Range 
Prevalence 
Asia/Oceana      
Australia 996 >4 /wk Zhang, 2004 (85) 4 – 12 15.2 
Australia 974 > 4/ wk Lu, 2003 (86) 2 – 5 10.2 
Australia 1650 Yes/no Valery, 2004 (87) 0 – 17  14.2 
Hong Kong 3047 > 6 / wk Ng, 2005 (88) 6 - 12 10.9 
Hong Kong 200 > every nt Ng, 2002 (89) 6.4 (4) 14.5 
Singapore 10279 > 3 / wk Chng, 2004 (90) 4 – 7  6.0 
Thailand 1008 Most nts Anuntaseree, 2001 (91) 6 – 13 8.5 
Thailand 755 Most nts Anuntaseree, 2005, (92) 9 – 10 6.9 
Korea 3871 > 3 / wk Shin, 2003 (93) 15 – 18 11.2 
New Zealand 1585 Yes/No Mitchell, 2003 (94) 1 – 6m 26.1 
Taiwan 179 Yes/No Liu,2004 (94) 10 – 19 y 26.3 
China 5979 ? Liu, 2005 (95) 2 – 12 y 5.6 
Europe      
Belgium 3045 Yes/No Spruyt, 2006 (96) 6 – 13 y 2.5 
France 25703 Often Delasnerie-Laupretre, 
1993 (97) 
17 – 20 y 4.6 
Germany 1144 Frequently Schlaud, 2004 (98) 9.6 y 10.1 
Greece 3680 Always Kaditis, 2004 (99) 1 – 18 y 4.2 
Greece 1821 > 3 / wk Alexopoulos, 2006 (100) 5 - 14 7.4 
Iceland 454 Often Gislason, 1995 (101) 6mo – 6 
y 
3.2 
Italy 895 Always Brunetti, 2001 (102) 3 – 11 y 4.9 
Italy  2209 Often Corbo, 2001 (103) 10 – 15 y 5.6 
Italy  447 Often Castronovo, 2003 (104) 3 – 6 y 34.5 
Italy 1615 Often Corbo, 1989 (105) 6 – 13 y 7.3 
Portugal  976 Frequently Ferreira, 2000 (106) 6 – 11 y 8.8 
Russia 200 Yes/No Kelmanson, 2000 (107) 
 
2 - 4 mo 5 
Spain 100 Often Sanchez-Armengol, 2001 
(108) 
12 – 16 y 14.8 
Sweden 325 Always Hultcrantz, 1995 (109) 4 y 6.2 
Sweden 1844 > 3 / wk Smedje, 1999 (110) 5 – 7 y 7.5 
United Kingdom 6811 Almost 
always 
Kuehni, 2008 (111) 1 - 4 7.9 
United Kingdom 782 Most Nts Ali, 1993 (112) 4 – 5 y 12.1 




     
Iran 2900 > 3 / wk Bidad, 2006 (114) 11 – 17 y 7.9 
Nigeria 909 snore Alabi 2012 (115) 3 – 16 y 34.2 
Turkey 1211 Always Kara,  2002 (116) 6 – 13 y 2.4 
Turkey 1198 > 3 / wk Sogut, 2005 (117) 3 – 11 y 3.3 
Turkey 2147 Often Ersu, 2004 (118) 5 – 13 y 7.0 
Turkey 1784 Often Akcay, 2006, (119) 4 – 17 y 4.1 
North America      
United States 1014 Always Johnson, 2006 (120) 13 – 15 y 6 
United States 1038 > Half time Archbold, 2002  (121) 2 – 14 y 17.1 
United States 5728 >3 / wk O’Brien, 2003 (122) 5 – 7 y 11.7 
United States 944 > 3 / wk Montgomery-Downs 
2006 (123) 
2wk – 2 
yr 
5.3 
United States 1494 > 1 / wk Goodwin, 2003 (124) 8 – 11 y 10.5 
United States 3019 > 3 / wk Gottlieb, 2003 (125) 5 y 12 
United States 141 Yes/No Weissbluth, 1984 (126) 4 – 8 mo 12.0 
South America      
Brazil 988 Frequent/al
ways 
Petry, 2004 (127) 
 
9 – 14 y 27.6 
Argentina 2210 Frequently Perez-Chada, 2007, 
(128) 
9 – 17 y 9 
Ecuador 806 Often/ 
Always 
Tafur, 2009 (129) 
 
6 - 12 15.1 
 
1.4.2 SDB Risk Factors 
The etiology of SDB is multifactorial (25).  Factors that affect airway flow include the skeletal 
and soft tissue anatomy of the upper airway, neuromuscular tone of the pharyngeal striated 
muscles and suction pressure generated by the inspiratory pump muscles.  Studies in both 
adults and children have demonstrated significant differences between the upper airway of 
children with SDB and non-snorers and even considerable variability between those with SDB 
(130).  This section will focus on enlarged tonsils and adenoids tissues which is the main risk 
factor of SDB in childhood, however a description of the other upper airway factors and further 
evaluation of the risk factors in children with SDB is supplied in Appendix 1.  
1.4.2.1 Tonsils and Adenoids 
The soft tissue of the upper airway consists of the palantine tonsils, adenoid, fat pads (located 
in the parapharyngeal area) and musculature. Although the size and composition of soft tissue 
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is primarily determined by genetic factors, other factors include inflammation, infection and 
infiltration of various storage/metabolites can alter their size (131). It has been proposed that 
the mechanical movement (vibration from snoring) of the tonsil may cause hypertrophy of the 
tissue and inflammation of mucosa, increasing the size of the tonsils and hence further 
obstructing the airway in children with SDB (132). Adenoid and tonsillar hypertrophy remains 
the major cause of sleep disordered breathing in children (133), as they narrow the pharynx.   
 
Located at the roof of the nasopharynx, the adenoids are a mass of lymphoid tissues, that secrete 
mucus as part of a protective mechanism, and traps inhaled infectious agents via the nose, 
transferring them to the pharynx (134). In addition, the lymphatic tissues produce antibodies 
and act as an immune barrier.  They are absent at birth but become noticeable by 6 months, 
reaching a maximal size between the ages of 2-10 years.  The tissue then progressively 
decreases in size as children reach adulthood.  Normal adenoid size ranges between 7 – 12mm  
and adenoids larger than 12mm are considered abnormal and in children with SDB, the 
adenoids are often significantly larger (mean = 13.46mm) compared to age matched controls. 
Enlarged adenoids in children can result in nasal obstruction, mouth breathing, ongoing nasal 
congestion, middle ear infection, snoring and fragmented sleep.  
 
The palantine tonsils are soft tissues located in between the glossopalantine and 
pharyngopalantine arches. They are aggregated lymphoid tissue encased in a mucus membrane, 
which also act as an immune protective barrier. The adenoid and tonsils continue to grow 
throughout childhood and reach their maximal size just before the onset of puberty. In the 
clinical setting, children with OSA are more likely to have enlarged palantine tonsils compared 
to children without OSA.  Inflammation induced adenotonsillar hypertrophy, leading to clinical 
OSA, has been noted in children under 1 year of age  (135) and chronic infections are thought 
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to promote lymphoid hyperplasia, and increase their size (28). Although the link between 
enlarged T&A and SDB is well accepted, and their removal by adenotonsillectomy (T&A) 
reduces their SDB severity, what is less understood is the lack of association between the size 
of the tonsils and adenoids assessed both clinically and using imaging and the severity of SDB.  
 
Several studies have demonstrated the efficacy of adenotonsillectomies to treat snoring and 
OSA using both parental report measures and polysomnography (136). However why 
approximately 33% of treated children who have no other risk factor (e.g. obesity etc.) continue 
to snore has not been effectively addressed (137). This suggests that the role of the upper airway 
characteristics (e.g. muscle tone, muscle composition) need further examination. 
1.5.3 SDB Diagnosis  
1.5.3.1 Clinical Assessment 
The most widely used method to diagnose paediatric SDB is a clinical history and physical 
examination, with more than 90% of T&A undertaken on this basis with no objective testing 
employed. Large tonsils and adenoid tissues upon examination and the parental report of 
snoring, restless sleep, breath holding plus excessive daytime sleepiness, hyperactivity and/or 
aggressive behaviour would be enough to proceed to surgical intervention even when the 
polysomnography (PSG, see 1.5.3.2) is normal (138). However, history and physical 
examination are considered to have both low sensitivity and specification with a predictive 
accuracy of 30-50% (139) and cannot accurately determine the level of severity of SDB.  In a 
meta-analysis determining the reliability of clinical evaluation alone to predict SDB in children 
versus polysomnography from 12 studies, Breitzke et al., concluded that the  otolaryngologists 
were more likely to clinically over diagnose OSA compared to using PSG, OSA criteria (140).  
 
The current guidelines of the American Association of Sleep Medicine (AASM), advocate that 
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the best diagnostic tool to assess SDB severity is an overnight polysomnography (PSG), which 
simultaneously measures a suite of physiological parameters known to be alter during sleep in 
children with SDB and especially during respiratory stress (84). 
1.5.3.2 Polysomnography (PSG), Overnight Sleep Studies 
Polysomnography (PSG) is a simultaneous overnight assessment conducted in a clinical setting 
which requires the evaluation of multiple physiological parameters including EEG (usually 
measured at 6 locations, C3-A2, C4-A1, and F3-A2 F4-A1, O1-A2 and O2-A1), left and right 
electrooculogram (EOG), sub-mental, diaphragmatic and leg electromyogram (EMG) and 
heart rate by electrocardiogram (ECG). These signals, as well as continuous infra-red video 
recording, are used to determine sleep staging. (141) Oronasal airflow by thermistor and nasal 
pressure, respiratory movements of the chest and abdominal wall using uncalibrated respiratory 
inductive plethysmography (RIP) and arterial oxygen saturation (SpO2) by pulse oximetry are 
used to measure respiratory events. (141)  Position sensors are also used to determine body 
orientation during sleep as obstructive events are more common in the supine position 
compared to the lateral prone positions. (142) Children are continuously monitored via infrared 
camera by a pediatric sleep technician, who also documents observations of sleep behavior, 
which include the presence or absence of snoring.  
 
Considered the gold standard method of assessment for SDB, PSG differentiates between 
primary snoring and OSA and hence can be used to determine SDB severity. In addition, it can 
identify central apnoea (cessation of breath but no obstruction) and also can evaluate the 
efficacy of treatment. (143)  Obstructive apnoeas, are classified as a cessation of airflow of at 
least two breaths, with or without oxygen desaturation and typically followed by an 
exaggerated recovery breath, known as a hypopneas (25). Apnoeas result in a significant 
oxyhemoglobin desaturation and terminated by a CNS evoked arousal. An obstructive 
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hypopnea, is a lesser reduction in ventilation, and is characterized as a 50% decrease in in 
airflow associated with a 3-4% desaturation and/or arousal.  Normative sleep data in children 
have shown that obstructive hypopneas and apnoeas are rare and that the desaturation level 
seldom drops below 90% (144). The most commonly used measurements of severity of SDB 
are derived from the PSG variables. They include the Apnoea Hypopnea Index (AHI), and the 
Obstructive Apnoea Hypopnea Index (OAHI) are the number of episodes per hour of sleep and 
Oxygen Desaturation Index (ODI). These values are then used to classify the severity. 
1.5.3.3 Determining Severity From Polysomnography 
The spectrum of SDB severity in children is classified into three distinct categories. As the 
categories increase in severity so does the detrimental physiological impact of the disorder 
(145). They include: 
 Primary snoring, where there is parental report of frequent snoring but less than 1 apnoea or 
hypopnea per hour of sleep measured during an overnight PSG; no abnormal gas exchange 
(hypoxia, hypercarbia) or sleep fragmentation (145) (146). Although considered a benign 
condition, recent reports of reduced neurocognition and abnormal blood flow (147) and 
vascular function (148) challenged this accepted assumption. 
 Upper airway resistance syndrome, frequent snoring, flow limitation (progressive increased 
inspiratory negative intrathoracic pressure) (149) and frequent respiratory effort related 
arousals (RERA), resulting in sleep fragmentation without gaseous exchange abnormalities 
(11), no or few apnoeas, hyponeas or oxygen desaturation.  
 Obstructive sleep apnoea syndrome (OSA) at the severe end of the continuum is further 
divided in to three sub-categories, (mild, moderate and severe) which are indicative of the 
number of obstructive events and sleep fragmentation. Specifically it is characterized by at 
least 1-5 (mild), or 5-10 (moderate), and in excess of 10 (severe) events of either partial or 
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total upper airway obstruction (apnoeas/hypopneas) per hour of sleep, abnormal ventilation, 
increased arousal and abnormal sleep architecture (145).  
 
One limitation of the current AASM scoring criteria is that it does not take into account the 
association between the severity of OSA and the level of oxygen desaturation (both number, 
duration and percentage reduction). Many studies, in both adults and children have negative 
associations between increased oxygen desaturations, neurocognition and cardiovascular 
outcomes.  
 
1.5.3.3 Obstructive Events, Sleep Staging and Sleep position  
The general consensus is that  50% of obstructive events and their duration occur during REM 
sleep compared to NREM sleep in children with OSA (which constitutes approximately 22% 
of total sleep time) (150-153).  The opposite prevalence is found in adults with OSA, with the 
majority of events reported in NREM sleep.  It has been suggested that the reduction in muscle 
tone and increased arousals in response to an apnoea during REM sleep increases the 
occurrence of obstructive events.   
 
Many studies in adults report that most obstructive events occur in the supine position 
compared to both lateral and prone position. More than 30% of SDB in adults is considered 
‘positional OSA’, where obstructive events are only evident in the supine position.  Most is 
related to obesity (154). It has also been postulated that the impact of gravitational force may 
push the soft tissues (tongue, soft palate) to the back of the throat, minimizing the size of the 
airway (154).  Zhang et al., showed that AHI was higher in children with OSA that sleep in the 
supine position compared to children with OSA that slept in the lateral positions. Despite more 
obstructive events in the supine position, they observed that sleep architecture was not effected 
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and that supine obstruction and AHI were more associated with age, (with less of an association 
between position and obstruction in younger children).  They also showed that oxygen 
saturation nadir, an important criteria in diagnosing OSA that is not currently recognized in the 
current AASM scoring rules, was independent of sleep position. They also recommended that 
children with SDB not sleep in the supine position.  Verginis et al., also showed that up to a 
third of children showed a predominance of NREM sleep obstructive events, especially in older 
children, which coincided with higher arousal indices and less severe desaturation episodes 
(151). This suggests that the profile of SDB changes as children mature and increase in body 
habitus.  
1.5.3.4 Efficacy of Polysomnography 
Both the economical cost and validity of PSG measurement was questioned by authorities in 
paediatric sleep (142). The main concern is the lack of association between the PSG outcomes 
and adverse effects such as neurocognition and behavioural function, which are considered the 
main sequelae of paediatric SDB.  Brietzke et al., proposed that either the current PSG 
thresholds need to be redefined and/or new testing criteria needed to be developed (possibly in 
conjunction with the PSG) that link both the adverse effects of SDB and measures derived from 
the PSG.  They also highlighted the growing number of studies that showed children who were 
classified as primary snorers, without hypoxemia/hypercapnia, and obstructive events, using 
the PSG, were also likely to exhibit neurocognitive deficits and learning difficulties (140).  
 
Further to this argument is the cost associated with such a labour intensive test which requires 
the Sleep Technician to monitor the child overnight (12 hour shift), a technician to score the 
test (2-6 hours) and a sleep physician to report the test. There is also the added cost of 
consumables, all of which makes it a very expensive test that can only be accessed by few.  
Stradling and Davies argued that the considerable variability in sleep apnoea from night to 
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night and even over the longer time course (from month to month, year to year) means that 
SDB severity is not accurately assessed with a single nights of PSG (155). 
 
1.5.4 Overnight Oximetry 
A cheaper and mobile option that can be used in the home setting to diagnose SDB is the pulse 
oximetry. It is currently used by many medical sleep facilities where PSG is not available. 
Pulse oximetry measures continuous changes in oxygen saturation throughout the night and 
has been shown to have a 97% positive predictive value in children aged over 12 months, 
however a negative result cannot rule out OSA in as many as 50% of those with a negative 
result (156). Nixon et al., claim that the overnight pulse oximetry can be used to estimate the 
severity of OSA and, hence, reduce the diagnostic and therapeutic process in the children that 
need intervention the most (157). A recent evaluation of the literature by Kaditis, Kheirandish-
Gozal and Gozal has highlighted both the positive and negative aspects of using oximetry in 
children suspected of having SDB (158). They propose that specific guidelines i.e. those using 
the McGill oximetry score are followed when using oximetry to diagnose SDB severity.  
1.5.5 Questionnaires and Parental Report 
A comprehensive study by Spruyt and Gozal in 2011, evaluated 183 subjective tools 
(questionnaires) used to assess sleep and behaviour in children (159).  Only two questionnaires, 
which are currently used worldwide, will be discussed here, however, it is recommended that 
the aforementioned reference is used for further information of the available tests and their 
relative reliability/validity. 
1.5.5.1 The Sleep Disturbance Scale for Children (SDSC) 
The Sleep Disturbance Scale for Children (SDSC) is a questionnaire devised by Bruni et al. in 
1996. The SDSC has good re-test reliability and validity (160). It is quick to complete (10 min) 
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and consists of 26 questions which are then amalgamated to produce 6 subscales that include 
Disorders of Initiating and Maintaining Sleep, Sleep Disordered Breathing, Disorders of 
Arousal, Sleep-wake Transition Disorders, Disorders of Excessive Somnolence and Sleep 
Hyperhidrosis (161). The scores are measured on a 5-point Likert scale and the questionnaire 
is aimed for children aged 6.5 – 15.3 years.  Importantly, the subscales comply with the 
categories and diagnostic classification of sleep and arousal disorders set by the Association of 
Sleep Disorders Centres and the Psychophysiological Study of Sleep (159).  
1.5.5.2 Quality of Life 
Studies have shown that children with SDB have significantly reduced quality of life in all 
severity types (143, 162) which improves once children receive T&A surgery to resolve the 
obstruction (163, 164).  Quality of life questionnaires have been devised and translated so they 
can be used worldwide. The Total OSA-18 is a questionnaire completed by caregivers that is 
specific for SDB, and consists of 18 items grouped in five domains.  Scores for each item range 
from 1-7, with lower collective scores indicating better quality of life. The last question is a 
global rating for quality of life where lower score equate to lower quality of life.  Although 
these questionnaires are important in expressing the impact of SDB on sufferers and their 
families, they are not tools that can accurately determine the severity of SDB (143) and are 
recommended to be used in conjunction with the PSG parameters and questionnaires such as 
the SDSC.   
1.6 SDB Non-Cardiovascular Deficits 
SDB in children has been reported to reduce daytime functioning.  Excessive daytime 
sleepiness, neurocognitive impairment and behavioral issues have been shown by parental 
report and cognitive testing measures (165).  Sleep fragmentation and intermittent hypoxia 
during critical periods of development in early childhood such as during neuronal pruning and 
myelination of neuronal fibers (6 months - 3 years +) may have long-term consequence to brain 
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function. (166) For a more comprehensive evaluation of non-cardiovascular deficits, readers 
are directed to Appendix 2. 
1.7 SDB Treatment and Management 
1.7.1 Adenotonsillectomy (T&A) 
Adenotonsillectomy was initially primarily performed to treat recurrent infection from 
streptococcal tonsillitis. With the increased awareness of SDB in children, it has now become 
the main initial therapy, with more than 50% of cases performed in the US, for obstructed 
breathing (167). 
 
In children with adenotonsillar hypertrophy and SDB, T&A is the most effective treatment. 
Benefits included better sleep quality, daytime behaviour and quality of life.  A comprehensive 
meta-analysis of the literature using PSG to evaluate the efficacy of T&A as treatment for OSA 
showed that AHI reduced by 12.4 events per hour and oxygen desaturation index decreased by 
-7.5% per events per hour as did arousal index by 6.1 events per hours (168). Using a random 
models-effects analysis, researchers showed that 51% of patients had an AHI < 1 and 81% had 
an AHI < 5 post surgery. Only 34% of obese children reduced the AHI to levels less than one, 
however this was not significantly different from values reported in the non-obese group.  
When data was set using an AHI < 5 as an improvement index analysis, only 61% of obese 
children compared to 87% of non-obese children reduced their respiratory events to this level.  
Overall, this suggests the efficacy of the treatment benefited most children with SDB, however, 
consistent with the consensus in the literature that suggests that obesity is a risk factor for 
ongoing obstruction despite T&A.  
Also, published this year are the results of Cochrane ENT Group, which evaluated T&A or just 
tonsillectomy as treatment for SDB, compared to watch and wait policy or CPAP (169).  They 
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concluded that children who had surgery reported better quality of life and less symptoms 
compared to those managed by watch and wait.  Quality of life remained the same between 
children who had surgery and children using CPAP at 12 months.  The results of the Epworth 
Sleepiness Scale were similar at 6 months between groups, however, at 1 year the children who 
received surgery reported lower scores of sleepiness, compared to children using CPAP and 
watch and wait.  
 
Complications of T&A surgery for paediatric SDB are as uncommon but increased in children 
with severe SDB compared to surgery performed for other purposes. Delayed discharge has 
been reported by groups in 1.3% - 2.3% of SDB paediatric patients and 3.2% – 3.7 % have 
secondary complications requiring readmission (170). Non-respiratory complications are the 
least reported complications, they include dehydration, hemorrhage and fever. While 
respiratory complications are reported in 5% - 23% of patients with SDB post operatively and 
may reflect children who do not immediately respond to the treatment.   
 
In the joint Position paper produced in 2008, by the Paediatric and Child Health Division of 
the Royal Australasian College of Physicians and the Australian Society of Otolaryngology 
Head and Neck Surgery, which reviewed current Tonsillectomy and Adenotonsillectomy in 
children in Australia and New Zealand, it was estimated that the overall adenotonsillectomy 
rate is approximately 3-7 per thousand, however, the epidemiological data suggested that the 
rate should be closer to 20 - 30 per thousand. This suggests that Australian children with SDB 
are severely under-diagnosed and under-treated (171). 
1.7.2 Nasal steroids and Antileukotrienes (Anti-Inflammatories) 
Nasal steroids have been recently introduced as a treatment for SDB in children as it can reduce 
the size of the adenoid and tonsils.  The efficacy of nasal spray therapies, however, is 
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questionable. One study showed no change after a 5-day course of prednisone therapy in SDB 
severity, however, Demain and Goetz reported a reduction in adenoidal size and improved 
symptoms of nasal airway obstruction after 24 weeks of topical nasal corticosteroid use (172).  
Brouilette et al., showed that six weeks of regular use of fluticasone, a nasal glucocorticoid 
spray decreased OAHI by five events per hour in compared to placebo. (173) 
 
Montelukast, a Leukotriene (LT) modifier, acts as a LT receptor antagonist. It is used to prevent 
the inflammatory response in asthma and allergic rhinitis in young children (174). In an elegant 
series of experiments Goldbart et al., showed that Montelukast given over a 16 week period 
reduced both adenoid size (measured using lateral X-ray films) and obstruction (measured 
using PSG) in children with mild SDB. Furthermore they showed a higher abundance of the 
LT1 and LT2 receptors in the tonsil tissue of children with SDB compared to non-snoring 
controls, indicating increased inflammation in this tissue.  They hypothesized that LT 
production in the tonsillar tissue may promote cell propagation signaling pathways and hence 
lead to hyperplasia of the lymphoid tissues.  They suggest that the use of the LT blocker retards 
to proliferation signaling and results in the reduction of tissue volume. (174)  
 
More recently, Kheirandish et al., showed that the combined use of Montelukast and intranasal 
budesonide in children with residual OSA (post T &A treatment) was effective in improving 
and in some cases normalizing the SDB (175).  
 
1.7.3 Continuous Positive Airway Pressure (CPAP) / Bi-level Positive Airway Pressure 
(BiPAP) 
CPAP is the most common treatment utilised in adult SDB, however it is less commonly used 
in children.  It is mainly used when children cannot be treated surgically (some craniofacial 
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disorders), or for residual OSA when surgery (T&A) has not successfully resolve the upper 
airway obstruction (176).  CPAP involves the application of continuous positive pressure to 
increase ventilation throughout the night by splinting open the upper airway (177). A 
continuous flow of air distends the airway via a nasal/nasal oral/ face mask using a small 
compressor.  It acts as a pneumatic splint and maintains airway patency, increases the residual 
capacity and prevents oxygen desaturation even when obstruction may occur.  Studies have 
shown improvements in PSG parameters, oxygen saturation levels, and reported sleepiness and 
snoring in children using CPAP (178).  BiPAP is similar to CPAP in that it delivers an 
inspiratory pressure, however expiratory pressure is lower, therefore, reducing respiratory 
work.  Randomised studies have shown no significant difference in benefits or for adherence 
between methods.  CPAP use in children requires ongoing review of pressure as the child grows 
(176, 179), as the pressure of the mask can cause changes to the growth profile of the midface 
(180). 
1.7.4 Orthodontic Treatment 
The association between the craniofacial and orthodontic development with SDB has only 
recently been appreciated. A narrow upper airway associated with maxillary constriction and 
mandibular retrusion is common in children with SDB.  Some dental treatments are being 
offered in children with this profile, including oral devices such as rapid maxillary expanders 
(RME), mandibular retro-positioning and modified monoblock (176). Depending on the degree 
of irregularity in alignment RME methods recommended include orthodonitic, orthosurgical 
and surgical expansion.  Orthodontic expansion uses a fixed oral appliance and expansion 
screw anchored on selected teeth.  Periodically the expansion screw is adjusted to expand the 
midpalatal suture causing the maxillary bones to increase their span.  This process can take up 
to 1 year and can improve nasal breathing (176).  Recent post treatment studies have shown 
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that the positive effects of RME are still evident after 3 years, however, residual SDB was 
evident in nearly 70% of the cohort (181).  
1.8 The Cost of Sleep Disordered Breathing 
In adults, SDB is a substantial economic burden both to the individual and greater community. 
Health care utilization is a powerful determinant of morbidity in both adults and children. The 
increase in early onset cardiovascular morbidity in the adult cohort is coupled with a loss of 
occupational productivity, decrease in quality of life, increased risk of motor vehicle accident 
and dependence on social welfare both for living and medical expenses (182). Undiagnosed 
SDB individuals use twice the amount of healthcare resources, including physician services 
compared to controls.  A cross-sectional study in the US, found that in the year prior to 
diagnosis, patients with OSA spent $2720 annually, compared to $1384 for non-snoring, age 
and sex matched controls. Also, they showed an association between AHI and annual medical 
costs (183).  
 
In children, Tarasiuk et al., reported a similar pattern of overutilization of Canadian health care 
services prior to diagnosis of OSA in children with almost a two fold increase in annual cost 
per year compared to control children (184). Children with OSA had 40% increase in hospital 
visits within the first 4 years and by the second year of life drug prescriptions were 70-200% 
higher in OSA groups compared to controls (184).  The main cost burden increase in children 
under 5 years was associated with in-patient admissions and emergency room visits, which 
accounted for 50% of the annual costs. It was suggested by the authors that the costs attributed 
to lower respiratory tract disease may actually arise from under-diagnosed OSA and that there 
was a need for earlier diagnosis and treatment.   
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1.9 Association Between SDB and Cardiovascular Disease 
1.9.1 Cardiovascular Dysfunction in Adults (Summary) 
The negative effects of SDB on cardiovascular function in adults is well documented.  There 
are many studies that report increased adverse cardiovascular events, such as heart failure, and 
mortality. A study of 6132 participants, showed that SDB in middle-aged and older individuals 
was independently associated with systemic hypertension and was evident in both sexes and in 
different ethnicities (185). It has been reported that adults with SDB are 2-3 times more likely 
to suffer a stroke compared to community controls (186).  A recent meta-analysis suggests that 
aortic aneurysm and aortic dissections are also higher in adults with OSA (187). Furthermore, 
an independent association between OSA and increased prevalence of aortic and high-risk 
carotid atheroma prevalence has also been established in adults with SDB (188). An association 
was also found between central aortic stiffening and OSA in participants with hypertension 
independent of obesity and intra-abdominal adiposity.  Heart failure is commonly reported in 
adult patients with OSA and encompasses a range of dysfunction from asymptomatic 
cardiovascular disease, to left ventricular failure. Changes in diastolic function are also 
common in OSA and a major risk factor for cardiac associated mortality (28).  There is 
evidence of damage to the minor arteries as Ip et al., showed impaired endothelium-dependent 
flow-mediated dilatation in peripheral vessels (brachial artery) compared to health aged match 
controls. In addition, they demonstrated that endothelial function normalized with just 4 weeks 
of compliance with CPAP treatment (189). 
1.9.2 Cardiovascular Dysfunction in Children  
A consistent pattern of changes in cardiovascular function and vascular tone is emerging from 
the limited studies conducted in children with SDB.  Cardiovascular measurement in children 
is limited to non-invasive tests which include, (i) echocardiography to determine both 
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functional (M mode) and structural changes (2-dimentional) of heart and blood vessels has 
been used in the majority of cardiovascular studies in children with SDB (190); (ii) blood 
pressure taken before and after PSG and over 24 hours using an ambulatory system; and (iii) 
the use of flow mediated dilatation (FMD) a functional measure of arterial endothelial integrity 
using Doppler Ultrasound. 
1.9.2.1 Cardiac Muscle Changes 
Early studies of cardiac changes in children with OSA, using electrocardiography, reported 
varying degrees of right ventricular hypertrophy and cor pulmonale (135). In 1988, Tal and co-
workers, using radionucleotide ventriculography, found that 37% of children aged between 9 
months and 7.5 years (27 children) with OSA had a significant reduction in right ventricular 
ejection fraction and that 67% of treatment group had wall motion abnormalities. Both 
abnormalities improved within 2 months of surgery (191).  Gorur et al., using 
echocardiography (both M-mode and 2D imaging) and overnight oximetry to determine 
severity,  showed structural cardiac anomalies including increased right ventricle mass and left 
ventricular end-diastolic dimension and decreased left ventricular compliance in 33 children 
aged between 3 – 10 years with SDB and adenotonsillar hypertrophy. Cardiac structural 
changes improved significantly in most children after T&A (192).  More recently, Ugur et al., 
using echocardiography and tissue Doppler imaging, showed that the early phase diastolic 
velocity and the ratio of early to late phase diastolic velocities recorded both at the mitral and 
tricuspid annulus moving towards the base, away from the apex, were all significantly 
decreased in children with OSA compared to controls.  All parameters normalized 6 months 
post T&A surgery (193).   
Amin et al., were first to show increased left ventricular mass was positively associated with 
SDB severity (AHI) (194).  Further work by this group showed changes in left ventricular 
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diastolic function (left ventricular filling) in children with SDB, with a dose-dependent 
decrease in left ventricular systolic performance with increasing severity of SDB (195). Kaditis 
et al., also showed lower left ventricular systolic function in children with moderate to severe 
SDB compared to primary snorers (196). Brain natriuretic peptide (BNP) is a cardiac hormone 
secreted by the ventricular myocardium in response to pressure overload and ventricular 
volume expansion.  Increased expression of this peptide is an indicator of both left and right 
ventricular overload and ventricular hypertrophy.  Brain natriuretic peptide (BNP) is increased 
in adults with OSA and has recently been shown to be increased in children with SDB with 
enlarged tonsils/adenoids, compared to control children (197).  Kaditis et al., showed that BNP 
levels were increased in children with OSA compared to primary snorers.  The increase in BNP 
was inversely related to SpO2 nadir and oxygen desaturation (≥ 4%) (198). Oran et al., also 
showed a 33% increase in BNP and increased pulmonary arterial pressure in children with 
severe SDB. Both variables normalized after T & A treatment (197).  
1.9.2.2 Blood Pressure 
There are now many studies reporting abnormal blood pressure in children with SDB compared 
to controls or primary snorers. (199-202). (Table 1.4)  Amin et al., demonstrated higher 24-hr 
blood pressure and faster heart rate in children with SDB, compared to matched controls.  
Changes in blood pressure were associated with left ventricular remodeling. Importantly, they 
found that the blood pressure changes (elevated morning systolic blood pressure) were evident 
in children classified as mild SDB (203). Leung et al., reported increased daytime systolic 
blood pressure and found both systolic and diastolic pressure in children with OSA were also 
increased during sleep (204).  In support of these previous studies, The Tuscon Children’s 
Assessment of Sleep Apnoea study also found elevated resting systolic blood pressure. More 
recently, postoperative assessment of blood pressure in children with SDB have shown that 
blood pressure variables normalize in non-obese children after treatment (199, 205). Naiboglu 
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el al., using Doppler echocardiographic demonstrated that pulmonary arterial pressure 
increased in children with OSA (severity determined by questionnaire and ENT adenoid/tonsil 
size assessment) compared to non-snoring controls.  All but two children with OSA returned 
to normal pulmonary arterial pressures after T&As (206).  This recent study mirrors the results 
of a similar study by Yilmaz  et al., which demonstrated increased pulmonary arterial pressure 
in children with OSA that normalized once children had surgery (207). Further supporting the 
positive cardiac effects of T&A as treatment for SDB in children was the recent meta-analysis 
conducted by Weber et al., which showed improvement in both pulmonary arterial pressure 
and cardiac structure 6 months after surgery (208). The studies included in the meta-analysis 
did not report on the potential confound effects of comorbidities such as obesity and 
echocardiographic variables, however, both the Tuscon Children’s study and a large study, 
conducted in Taipei, by Kuo et al, showed that blood pressure improvement was limited in 
obese participants (205). 
Pulse transit time (PTT), is a measure of vascular compliance (arterial distensibility) which has 
been shown to be reduced in adults with SDB. Decreased arterial distensibility is considered a 
strong predictor of cardiovascular risk in hypertensive adults.  Vascular compliance changes 
are also noted in children. Kwok et al., reported increased daytime systemic blood pressure and 
reduced arterial distendibility in children with primary snoring compared to healthy age 
matched control (148). Nisbet et al., more recently measured PTT during different sleep stages 
and found that children aged 3 - 5 years with moderate to severe OSA had lower PTT during 
REM sleep compared to primary snorers and mild SDB. The results of the study are somewhat 
confusing as there was no difference in PTT between normal control children and those with 
severe OSA (209).  
Table 1.4: Listed are blood pressure studies conducted in children with SDB. Some studies 
have used non-snoring controls, however many have used children with primary snoring. In 
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addition, blood pressure was measured using different techniques which may account for the 





Reference Subjects Measurement 
Increased diastolic blood 
pressure 
Marcus et al., 1998 (202) PS (26), OSA (41) 
Age not balanced 
Oscillometric  
Increased systolic blood 
pressure (morning) 
Bixler et al., 2008 (83) Control (517), Mild SDB 
(175), M/Severe (8) 
Age 5 – 12  
Oscillometric 
(triplicate) 
Increased systolic and 
diastolic pressure 
(morning) 
Li et al., 2008  
 
 
Li et al., 2009 (210) 
 
 
Kohyama   et al., 2003 (211) 
 
 
Kwok et al., 2003 (148) 
 
 




Guilleminault et al., 2004 (213)  
 
 
Amin et al., 2008 (203) 
 
 




Xu et al., 2012 (200) 
 
Control (127), Mild (133), 
M/Severe (46), Age 6 – 13 
 
Control (56), PS, (46), OSA 
Mild (88), Age 6 – 13 
 
AHI < 10 (16) AHI > 10 
(7), Age 4 - 11 
 
 
Control (30), PS (30), Age 
7 – 13  
 
PS, (21), Mild (17), 
M/Severe (22) Age 5 – 17 
 
 
Control (30) SDB (271) 
Age 7 – 12 
 
Control, Mild, Severe (140 
total) Age 7 – 13  
 
 
Control (36), PS (61), Mild 
(133), M/Severe (21),  
Age 7 – 13 
 
PS/Mild SDB (38), 
M/Severe (107) 
 
24h Ambulatory BP 
 
 

























Increased systolic and 
diastolic pressure (sleep) 
Leung et al., 2006 (204) 
 
Amin et al., 2008 (203) 
 
 
Horne et al., 2011 (214) 2013 
(215) 
 
Mild (79) M/Severe (17) 
 
 
Control, Mild, Severe (140 
total) Age 7 - 13 
 
Control (36), PS (61), Mild 
(133), M/Severe (21),  














1.9.2.3 Vascular Endothelial Damage 
The endothelium consists of the single layer of cells that line all blood vessels and is the source 
and target of many growth factors and vasoactive mediators and a key regulator of vascular 
function (216). Alterations in endothelial function are reported to occur as the first detectable 
change in the development of atherosclerosis (217) and are associated with a higher incidence 
of cardiovascular events and increased progression of atherosclerotic disease.    
Endothelial dysfunction and arterial wall thickening, the earliest stages of atherosclerosis, 
begin in childhood.  Children with diabetes, (218) obesity (219) or hypercholesterolaemia, 
(220) who are at significantly greater risk of developing atherosclerotic disease as adults, have 
detectable endothelial dysfunction and arterial wall thickening, before overt signs of 
atherosclerosis are apparent (220). In adults with OSA, endothelial dysfunction is a precursor 
of atherosclerosis and hypertension (217). 
 
Endothelial dysfunction has been reported both in adults and children with SDB (216, 221). 
Gozal et al. using a modified hyperemic test with a laser Doppler sensor to measure cutaneous 
microvasculature reperfusion blood flow in the metacarpals demonstrated a delayed return to 
baseline blood flow (took 40% longer) in children with OSA compared to non-snorers (222). 
In this same group of children, sCD40L, a marker of inflammation and increased risk of CVD, 
was elevated in the OSA group. This marker was weakly associated with AHI and SpO2 nadir. 
Both SCD40L and vascular function returned to almost normal levels after treatment with 
T&A.  Further to these studies, Kheirandish-Gozal et al. using a similar hyperemic test showed  
that the time it took to reach peak flow (Tmax) was delayed in children with OSA compared 
to non-obese non-snoring control children (223). They also noted an association between that 
inflammatory marker, high-sensitivity CRP and Tmax, implying a relationship between 
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delayed arterial dilation (cell-to-cell signaling) and inflammation. A modest association 
between Tmax and circulating endothelial progenitor cells (EPCs), a marker of vascular injury 
was also demonstrated. Unfortunately, EPCs counts, although lower in the OSA group, were 
not significantly different compared with control children values.  The authors offered the 
opinion that vascular response in children with the OSA was variable as there was 
heterogeneity within the group response. They also suggested that the underlying inflammatory 
and possibly paracrine processes may play a pivotal role in maintaining vascular integrity, 
suggesting an interaction between the vascular response, ANS function and immune systems.  
They also proposed that children with delayed vascular results may have a blunted chemokine 
recruitment response. Also, adding to the current controversy with severity measures derived 
from the PSG and their inability to predict vascular morbidity, none of the PSG derived 
variables were associated with any of the vascular markers outlined above to be present in the 
OSA group. 
1.9.2.4 Flow Mediated Dilatation (FMD) 
The most widely used non-invasive test of endothelial function using high resolution 
ultrasound is flow mediated dilatation (FMD) (224). FMD measures brachial artery responses 
to a mechanical increase in blood flow, which induces an endothelium-dependent increase in 
vessel diameter through the release of endothelial derived nitric oxide.  The most basic form 
of the test requires the use of a linear ultrasound Doppler transducer to image the brachial 
artery, 10cm above the elbow during rest to determine a resting brachial artery diameter. This 
is then followed by a resting image in the B-mode, to determine resting blood flow velocity 
(peak systolic velocity and velocity time integral), and resting heart rate. The blood flow to the 
forearm, is occluded using a blood pressure cuff, so as to induce hypoxia in the tissue distal to 
the ischemic site. The occlusion remains for 4 minutes in children (5min in adults) causing 
vasodilation and decreases vascular resistance in the distal vessels. The cuff is then released 
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and the reinstated blood flow induces hyperemia and increased shear stress, which activates 
the mechanoreceptors on endothelial cells at the site of imaging. The activation of 
mechanoreceptors releases nitric oxide (NO), which instigates the dilation process. The dilation 
response is recorded and, traditionally the 60s time point post cuff deflation is used in 
comparative tests to determine differences in endothelial function (Figure 1.4).  This suggests 
that the response is dependent on an intact endothelium, and the release of NO, however, more 
recent studies question the validity of this belief (225) (226, 227).   
 
Traditionally, endothelial dysfunction is reflected by an impaired FMD response at 60s, 
however studies looking at the impact of different stimuli (increased and decreased time during 
ischemia; placement of the cuff) (227) suggest that the endothelial dependent mechanism (NO 
release) involved in the dilatation is only partially responsible for the recorded dilatation 
response. This opens the possibility that mechanisms other than NO endothelial release are 









Figure 1.4: Top Left: FMD is a non-invasive procedure that uses Doppler ultrasound to 
measure changes in brachial artery diameter after a post-ischemic reperfusion. Top Right: 
Image of the brachial artery during B-mode functional evaluation of blood flow parameters 
which include peak systolic velocity (PSV), velocity time integral (VTi, area under the curve, 
peak systolic velocity x ejection time), heart rate (HR). Bottom left; the brachial artery, red 
lines measure the luminal diameter at ten sites per frame, over three minutes (15 seconds pre-
cuff release and 165 seconds post). Bottom Right; shows the data vessel diameter over time 
(180s). Variables determined from the data include, time to maximal dilation (s), maximal 
dilation (largest dilation value – baseline value/baseline x 100 (%)) and FMD at 60 seconds, 




Although the exact mechanisms of FMD are currently being debated, the consensus is that 
FMD reflects the arterial capacity to self-regulate blood vessel tone in response to localized 
stimuli such as the increase in a physical or chemical activator and can be used to determine 
differences in vascular dilatation response. A study in adults with OSA with no clinical 
evidence of cardiovascular disease, using in vivo vascular endothelial cell harvesting and FMD 
measurements reported significantly decreased expressions of proteins that regulate basal NO 
production, reduced FMD and endothelial progenitor cells (EPC), all markers for endothelial 
function. Conversely, nitrotyrosine and cyclooxygenase-2 (COX-2), measures of oxidative 
stress, were significantly greater in patients with increased respiratory events during sleep 
(228). This suggests that there is damage of the endothelium and NO release in adults with 
OSA even if there is no physical evidence of cardiovascular disease.  
Recently, four groups, two from China and two from Italy, showed reduced dilation response 
using flow mediated dilation (FMD) in children with SDB.  Chan et al., showed reduced 
dilatation in children aged between 6 – 18 years. The percentage diameter difference from 
baseline was 0.4%. This reduction normalized 6 months after T&A surgery (229).  In normal 
children the average dilatation change from baseline diameter is 0.01mm (8%). A mean 
difference of only 0.4% would equate to a diameter difference between groups of only 
0.005mm, which is within the margin of error for the test. In children with diabetes and/or 
obesity the difference from baseline is approximately 4%, which is considered evidence of 
endothelial pathology.   In a recent study, Li et al., measured FMD in children ranging from 6 
-18 years. They found significantly reduced dilation at hyperemia (dilation of vessel after just 
after cuff removal) and at 60 seconds, (the time point considered to be the maximal NO 
dependent dilation response) in primary snorers (230).   
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Loffredo et al., also recently showed reduced FMD in both children with OSA and primary 
snoring compared to non-snoring children (231). The reduction in FMD, approximately 4%, 
was similar to those shown by other groups measuring endothelial dysfunction in obese 
children (232). This group was also able to demonstrate an inverse relationship between 
reduced FMD measurement and enhanced NADPH oxidase (SNOX2dp), which is essential for 
modulating endothelial function and an indicator of oxidative stress (231). T&A in the children 
with SDB normalized these variables six months after surgery. 
 
Collectively, these studies suggest that the cardiac structure and function and vascular function 
in children with SDB is altered and that the current treatment, T&A, may normalize these 
changes. 
1.10 Arterial Compliance – Why Do The Arteries Stiffen? -  Cardiovascular 
Autonomic Interactions 
1.10.1 Vascular Physiology 
Given the evidence of both cardiac and vascular function changes in both adults and children 
with SDB, understanding how the increased SNS activity modulates the decrease in vascular 
compliance and ventricular hypertrophy is the focus of the next section. A brief description of 
the vascular anatomy is supplied however a more in depth description can be found in Chapter 
8, ‘The Autonomic Nervous System and its Effectors’, Brading 1999 (42).  
The aorta and other arteries are made up of three distinct layers, the intima, media and the 
adventitia (Figure 1.5 & 1.6). The intima consists of the endothelial cells that line the lumen 
and the elastin layer (tunica) adjacent to these cells.  It is surrounded by the medial layer which 
contains smooth muscle cells, little elastin and some collagen fibres. The outside layer, the 
adventitia is mainly composed of collagen, small amounts of elastin and precursor cells such 
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as fibroblasts and myofibroblasts.  Also in this layer are immune cells such as monocytes and 
macrophages. Most arterioles contain a single layer of smooth muscle cells in the media, 
however some larger arterioles may have more layers of smooth muscle cells.  
1.10.2 Vascular Properties, Windkessel Effect and Blood Flow  
The large arteries proximal to the heart contain the largest amounts of elastic fibres with up to 
40% composition of elastin contained in the thoracic aorta. As arteries radiate to the periphery 
they progressively reduce the composition of elastin and increase the contribution of smooth 
muscle cells and collagen fibres and, hence, are classified as muscular arteries. The elastic 
properties allow the vessels to distend during systole, when intraluminal pressure is increased, 
acting as an ‘elastic buffering system’ (233). As the left ventricle ejects approximately 60-
100mls of blood into the aorta, 50% of the stroke volume is propelled through the arterial 
system, while the remaining 50% is absorbed/stored by the distention of the artery. During 
diastole no further blood is ejected and the aortic valves close, aortic pressure drops, the vessel 
recoils and its elastic properties forces the absorbed volume into the circulating blood flow, 
forming an almost complete continuous flow despite the rhythmic actions of the heart. This 
elastic function was named the Windkessel function by Weber in 1827.  Another important 
factor in maintaining blood flow is the capacity of the vessel to transfer the pulse wave during 
systole, where it reflects with the peripheral circulation (at points of anastomoses) and returns 
to the aorta during diastole forming a dicrotic wave, which is dampened by the Windkessel 
function. 
In the clinical situation, reduced vascular compliance and stiffening and, hence, a loss of 
Windkessel function results in an increase in systolic blood flow velocity and pressure, 
increased shear stress at the luminal surface, a decrease in diastole pressure and increased left 
ventricular afterload and drop in subendocardial blood supply during diastole.  Reduced 
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vascular compliance also affects the pulse wave velocity, which increases and the reflective 
wave then shifts from early diastole to reverberate during late systole, further affecting systolic 
pressure and afterload (233). The heart has to then compensation for the increase in flow 
velocity by accelerating the blood mass of the stroke volume within the aorta and arterial 
system to match the returning venous blood flow. Hence a deviation from optimal vascular 
resistance and vascular capacitance, via vascular remodeling, has pathological consequence on 





Figure 1.5: Top cross section of  the dorsal lingual artery, shows nuclei of the endothelial cells (yellow arrow, 
blue dots) on the inside of the lumen, the intima layer (blue arrow) consisting mainly of elastin and shows 
fenestrate (convolutions in the layer), the media consists of smooth muscle cells, (red arrows), and adventitial 
layer  (white arrows). Note the blue nuclear staining in the adventitial layers are a composite of different cells 
some are fibroblasts while others with duel staining with smooth muscle actin are myofibroblasts. Other cells in 
this layer include immune cells, including macrophages and monocytes. Green arrows indicate sympathetic nerves 
fibres which are immunoreactive to tyrosine hydroxylase. Note in the lower image that the small vessel cross 
section shows high TH immunoreactivity.  Control of tissue perfusion occurs mainly via the activation of 





Figure 1.6: Shows H&E staining of the dorsal lingual artery of the left tonsil. Note the compact 
layer of smooth muscle cells (black bracket) aligning the endothelial cells (black circle). Top 
right insert shows the same vessel (next section stained with immunofluorescence for tyrosine 
hydroxylase, green (sympathetic nerves), nuclei stain, blue (precursor cells, fibroblasts and 
myofibroblast and immune cells) (white arrows), smooth muscle actin, red, medial layer. Blue 
arrows shows the same area in the previous section done in H&E staining. Bottom left insert: 









Figure 1.7: Left is the dorsal lingual artery, red stain is smooth muscle actin, green is tyrosine 
hydroxylase, (sympathetic nerve fibres) (50x). Right is a collateral of the dorsal lingual artery, 
green stain tyrosine hydroxylase, red stain is Calcitonin Gene Related Protein (CGRP) a potent 
vasodilator (200x).  
 
1.10.3 Blood Vessels, Sympathetic Adrenergic Innervation and Vasoconstriction 
Many factors influence the degree of vasomotor function of blood vessels. They include the 
intrinsic myogenic tone in the smooth muscle cells, the effects of locally produced and 
circulating vasoactive substances and the degree of activation of the nerves innervating the 
smooth muscle. The innervation to the vascular smooth muscle will be covered in the following 
paragraphs.  
Almost all blood vessels are innervated by postganglionic sympathetic adrenergic nerves, 
however some vascular beds also have a preganglionic parasympathetic innervation. The 
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sympathetic nerves cell bodies are located in the paravertebral ganglia of the sympathetic 
trunks and the post ganglionic fibres exit either by (i) the sympathetic trunks into the spinal 
nerves, where they supply the blood vessels to the limbs, or (ii) sympathetic nerve fibres accrue 
also along the arteries where fibres emerge with the paravetrebral ganglia to form plexuses 
around the arteries and supply the branches to the vascular smooth muscle (42).  
The sympathetic adrenergic nerves run along the adventitia layer and varicose terminal 
branches infiltrate the smooth muscle layers, with the majority of innervation occurring on the 
outer layer of smooth muscle cells (Figure 1.7) (42).  These nerves release noradrenaline (NA), 
which activate post-synaptic receptors. The typical activation results in slow contraction of 
smooth muscle that spreads passively through interconnected gap junctions from the outer 
towards the inner smooth muscle cells. As well as NA, a number of peptides have been shown 
to be expressed by postganglionic neurons, including ATP, neuropeptide Y (NPY) and, in some 
cases, adrenaline. This suggests that the sympathetic nerves are comprised of different 
subgroups, which modulate the vasomotor function via co-transmitter release. The activation 
of these nerves can also be influenced by local factors, for example when circulating adrenaline 
levels are high, sympathetic nerves terminals can re-package the neurotransmitter and release 
it when it is required during prolonged stress response. Conversely, in some vascular beds 
acetylcholine released from inhibitory nerves can counter the effects of the sympathetically 
mediated vasoconstriction and promotes vasodilation.  
Contraction of the smooth muscle alters vessel wall compliance more than narrowing of the 
lumen and hence vessels can have the same luminal diameter but have less distensibility (42). 
Vascular SNS activation plays a major role in controlling blood pressure and blood flow when 
other factors have caused alterations in flow to individual vascular beds, e.g. increased 
metabolite production. The largest influence on peripheral resistance occurs with the 
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sympathetic activation at the level of arterioles (Figure 1.6), and also at the level of veins to 
ensure correct venous return. Even at the capillary level, SNS activation has been shown to 
play a pivotal role in controlling blood flow in the brain (234), but it is unclear whether the 
same mechanism works in peripheral capillaries.  
At rest, the post ganglionic vascular sympathetic nerves are tonically active, and cause periodic 
spontaneous vasoconstriction and reduced vascular compliance, but  most contraction occurs 
in response to increased activation mediated as a baroreflex response (42). In some vascular 
beds activation of vascular sympathetic nerves results in vasodilation, such as the case in brown 
adipose tissue (42). This dichotomy in function arises because of (i) the combined activation 
of different adrenergic receptor types, some of which promote constriction (α1, and α2) while 
others (β2 and β3) promote dilation, (ii) presynaptic receptors that can exaggerate or dampen 
the post synaptic  response by modifying neurotransmitter release (both in pre-ganglionic and 
post ganglionic synapses) (iii) the co-release of other peptide neurotransmitters, such as 
Calcitonin Gene Related Protein (CGRP) in post-ganglionic neurons (Figure 1.7) (42). 
Collectively, these factors modulate the effect of sympathetic activity in specific vascular beds 
and depending on the rate of activation may influence the composition of these receptor types 
and peptide production/release by terminals at these sites. 
1.10.4 Vascular Remodeling 
As research in both adults and children have highlighted the increased risk of cardiovascular 
issues and in particular hypertension associated with SDB, the following section will focus on 




Vascular remodeling, recognized for the past 40 years is an adaptive ubiquitous process which 
occurs in response to changes in blood flow dynamics, neuronal/endocrine function 
(sympathetic overactivity, renin-angiotensin system (RAS))  response and vascular injury 
(penetration, trauma – counter coup concussion etc.) (235). In hypertension there is evidence 
of remodeling in both large and small arteries (236). There are two types of remodeling, the 
first is ‘inward eutropic remodeling’ where both the lumen and outer diameters of the small 
arteries are decreased but the media/lumen ratio is increased and the overall cross-sectional 
area of the media is unaltered. The second, ‘hypertrophic remodeling’ occurs when there is 
increased media thickness that encroaches on the lumen and hence increases the media cross-
sectional area and media/lumen ratio (normally observed in larger vessels) (236). In mild 
hypertension, there is evidence that structural alterations, by way of increased medial thickness 
to lumen diameter ratio, in the resistance vessels precedes endothelial dysfunction and cardiac 
remodeling (236, 237) and may be the first indicator of organ damage. All participants in a 
study looking at stage I hypertension exhibited small arterial remodeling, while only 60% had 
evidence of endothelial damage, and 45% left ventricular hypertrophy (236). In the follow-up 
study of these patients those with the highest media:lumen ratios reported increased incidences 
of cardiovascular events (237). This suggests that endothelial damage reported in hypertension 
may be secondary to small arterial remodeling and that the remodeling may have better 
prognostic significance.  
In vitro studies have shown that prolonged vasoconstriction to small arteries results in inward 
eutrophic vascular remodeling (238). The proposed mechanisms that promotes inward 
eutrophic remodeling are not well defined, however, a combination of growth, fibrosis and 
peripheral apoptosis and/or ‘vasoconstriction embedded in an expanded extracellular matrix 
are thought to be involved’ (237, 239).  Given that increased ongoing sympathetic activity has 
be reported in both adults and children with SDB, it may be the case that, especially in children, 
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early signs of cardiovascular disease is occurring in the minor arteries by way of inward 
eutrophic remodeling.  
1.10.4.1 Growth, Fibrosis (Collagen), Peripheral Apoptosis and the Medial - Adventitial 
Layer 
The role that the adventitial layer plays in vascular remodeling and hypertension has only now 
been recognized. The adventitial layer of arteries plays an integral part in arterial growth as 
cell differentiation of fibroblasts to smooth muscle cells (SMC) and the production of 
extracellular matrix proteins (ECM, (collagen and elastin)) occur here. Vascular motor tone is 
also mediated via interactions between the peripheral vascular SMC and sympathetic nerve 
terminals which infiltrate the adventitial and also interact with ‘progenitor’ cell types 
(fibroblasts and myofibroblasts) (240) and ECM (241).  
 
Sympathetic activity promotes hypertrophy of SMCs in the medial layer, via the activation of 
α1-adrenoceptor (242) and its interaction with other cells in the adventitia. Angiotensin II (Ang 
II), the effector molecule of the renin-angiotensin system (243), is a potent vasoconstrictor and 
is also a strong promoter of smooth muscle cell proliferation. Ang II also increases smooth 
muscle cell size and ECM protein synthesis and is considered an indicator of vascular 
remodeling (244). Whether the Ang II’s hypertrophic effect occurs directly with action to the 
smooth muscle cells or indirectly as a result of its action as a vasoconstrictor and potentiator 
of sympathetic activity is yet to be determined (244).  
 
Also, activation of α1-adrenoceptor promotes adventitial fibroblast proliferation. In adventitial 
fibroblasts and myofibroblasts the production of ECM proteins is increased when exposed to 
noradrenaline (NA) (245) and influences both SMC and adventitial fibroblast migration and 
movement towards the inner vascular layers (246). Hence, increased sympathetic activity may 
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promote greater smooth muscle cell proliferation, more collagen and elastin production and 
compact the layers of the arteries, from the outside, eventually moving inward in the smaller 
arterioles. This over time causes the reorganization of the layers and effects the temporal ability 
to dilate SMCs during hyperemic stress, possibly by hindering the propagation process 
involving cell-to-cell communication through the layers of smooth muscle cells and promote 
reduced arterial dilation capacity. Increased fibrosis at the medial/adventitial layer may also be 
responsible for the peripheral apoptosis reported in inward eutrophic remodeling, by 
interrupting SMC connectivity. 
 
The major component of arterial walls is collagen, making up 20-30% of vascular protein.  
Collagen is a fibrillar component that can change the passive pressure and diameter in arteries 
and results in stiffening of the vascular wall. In vascular injury, adventitial collagen can 
increase to in excess of 50% of the vessel wall and in hypertension vascular fibrosis via the 
deposition of extracellular matrix proteins, especially collagen which is a major contributing 
factor (239). There are five types of collagen found in blood vessels and an important aspect 
of collagen is its orientation and organization and the ratios of the subtypes, which are 
influenced by resident cells, vascular smooth muscle, and fibroblasts which can compact and 
organize collagen (247). In rat models of hypertension there are reports of increased collagen 
synthesis in the arterial wall (mesenteric arteries, cerebral microvessels, pial arteries and basilar 
arteries) and collagen was also increased in the subcutaneous resistance arteries of humans with 
essential hypertension (239).  
 
Another important aspect of the outer vessel layer is the interaction between adventitial 
fibroblasts, Endothelin 1 (ED1) and collagen, which may also explain the arterial stiffness 
observed in hypertension. Adventitial fibroblasts are involved in the production and release of 
 91 
ED1 when stimulated with Ang II (248). The release of ED1 invokes contraction in smooth 
muscle  and also contracts adventitial collagen fibers (249), promoting collagen type I 
proliferation, the production and release of reactive oxygen species (ROS) in the adventitia and 
attracts immune cells into the outer vessel wall. Collagen may stiffen the arterial wall and hence 
increase total peripheral resistance by (i) encroaching the inner layers of the arteries and 
reducing the luminal diameter as it increases in volume or (ii) by reducing its compliance by 
contracting its fibres in response to ED1 or (iii) both. 
 
The adventitia has been shown to be the primary site of ROS production in different animal 
models and ROS can affect endothelium-dependent relaxation by reducing the efficacy of NO 
and the number of endothelial cells (248). In addition, increased infiltration of inflammatory 
cells in the adventitia layer of both large and small arteries has been observed in hypertension. 
Together this suggests that in hypertension, oxidative stress and inflammation, possibly 
mediated via the actions of the sympathetic overactivity and its role in Ang II production, may 
promote vascular remodeling and stiffening in both large and small arterial vessels. 
Furthermore it links the association between increased sympathetic activity and the possible 
activation of inflammatory pathways.  
1.10.4.2 The Effects of Increased Sympathetic Tone on Vascular Function 
Increased vasoconstriction and/or reduced compliance results in an increase in haemodynamic 
pressure, shear stress and blood flow velocity, all of which associated with vascular 
remodeling. Blood flow velocity increase is considered the most powerful promoter of vascular 
remodeling as it influences the production of extracellular matrix proteins, cell proliferation, 
apoptosis and low grade inflammation in all three layers (236).  Regulation of flow is 
maintained by endothelial derived dilation mechanisms including increased release of ATP or 
substance P to counteract the increase in luminal shear stress (250). This results in the release 
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of nitric oxide, a potent vasodilator and decrease in the release of endothelin-1 (ED1) a potent 
vasoconstrictor (251), relaxing the contraction in the smooth muscle cells and causing the 
arterial diameter to increase, thereby reducing blood flow velocity and dissipating luminal 
shear stress. 
1.10.4.3 Downstream Effects of Increased Sympathetic Tone - Shear Stress 
Prolonged systemic increases vasomotor tone, reduces vascular distensibiliy and also increases 
total peripheral resistance. This results in increased shear stress at the luminal surface.   In vivo 
studies show that increased sheer stress from haemodynamic forces modifies endothelial cell 
structure and function (252). These induced changes include increased macromolecule 
permeability and expression (lipoprotein); leukocyte adhesion and recruitment near 
bifurcations and altered endothelial cell/nuclei shape (ellipsoidal) in the direction of flow in 
regions of laminar flow and a disrupted cell pattern at regions of disturbed flow. In vitro studies 
in cultured monolayers of endothelial cells have shown direct evidence of force and time 
(prolonged increased force exposure) induced shape changes in cell-shape and alignment, 
which are reversible when force is normalised (253). These changes have also been shown to 
influence actin-containing stress fibres and cytoskeletal components of endothelial cells. 
Biomechanical force applied to endothelial cultured cells has also been shown to up-regulate 
prostacyclin; growth factors, coagulation and fribrinolytic components and extracellular matrix 
proteins (EMC) and vasoactive mediators including Ang II (253). The interaction between 
haemodynamic pressure and endothelial cells plays an important part in vascular remodeling, 
angiogenesis, regulating growth, inflammation and the coagulation pathway (254). However, 
whether the changes to the endothelial function occurs secondary to changes in the medial and 




Increased sympathetic overactivity has been described in all degrees of severity of SDB in 
childhood and may result in increased peripheral resistance and, thus, promote vascular 
remodeling in children with SDB, making them vulnerable to systemic hypertension over time.  
Chronic vasoconstriction precipitates low-grade inflammation and vascular fibrosis and 
promotes Ang II and growth factors to smooth muscle proliferation and extracellular matrix 
remodeling. These changes may alter cell attachment via the accumulation of extracellular 
fibrillar components and contribute to changes in both the cellular and vessel wall architecture 
which may lead to abnormal intracellular transduction to the smooth muscle cells, loss of gap 
junction connectivity and also contribute the restructure of the medial layer. It may also 
significantly alter the composition of the adventitial layer surrounding the vessel and lead to 
inward eutrophic remodeling. Over time these changes make the vessels more contracted, 
compact, and rigid, and less sensitive to required adaptive changes in pressure load, resulting 
in increased shear stress and damaging endothelial cells and compromising baroreflex 
sensitivity and the vessels ability to accommodate an increase in shear stress. What started as 
an adaptive process to meet the homeostatic requirements (O2/CO2 balance) may overtime 
develop into a maladaptive systemic phenotype that compromises vascular function and 
thereby effects the developing vessels and contributes to the cardiovascular disease state 
reported in adults with SDB. 
1.11 Sources of Sympathetic Overactivity 
As previously mentioned, SDB is associated with increased respiratory effort, sleep 
fragmentation and intermittent hypoxia, all of which cause surges in sympathetic nerve activity. 
The increase in sympathetic activity causes transient peripheral vasoconstriction, increasing 
peripheral vascular resistance and cardiac output leading to increase blood pressure (255, 256) 
(Figure 1.8). This next section will focus on the impact that respiratory effort, sleep 
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fragmentation and hypoxia have on vascular development and autonomic function, in particular 
the role they play in sympathetic overactivity.  
1.11.1 Respiratory Effort 
Obstruction to the airway results in an increased ventilatory response with the  generation of 
large pleural pressure swings (19). It has been suggested that the afferents from mechanical 
receptors in the thorax and upper airway contribute to the increase in sympathetic activity and 
are responsible for the vascular changes observed in SDB (19). Interestingly, the respiratory 
rhythm pattern generator is centrally coupled to the activity of pre and postganglionic arterial 
sympathetic nerves, which exhibit intermittent bursts of varying amplitude and frequency (19, 
257) (258). Therefore, increased effort generated by the negative intrathoracic pressure during 
inspiration required when the airway is obstructed, even partially, changes the sympathetic 
firing rate on pulmonary arterial vessels. Changes to the vascular sympathetic firing rate 
influences the contraction of the vascular smooth muscle cells and has been characterized in 
cardiovascular disease, including hypertension and heart failure.   
 
In hypertensive rats exposed to increased sympathetic activity, there is evidence of amplified 
sympathetic respiratory coupling (259) and a 2-3 increase in action potential per respiratory 
burst. In recent modeling of this phenomenon, Briant et al., suggested that the repeated 
respiratory modulation in burst pattern produced a significant increase (10 fold) in contraction 
of vascular smooth muscle cells (258). This suggests that the changes in breathing pattern are 
directly associated with modulation of sympathetic activity on arterial vessels and that the level 
of vascular compliance is directly associated with changes in the way we breathe. Over time 
the ongoing activation results in  long-term facilitation (LTF) induced in the phrenic motor 
neurons (sustained change) independent of changes in chemoreceptor activation (260). It has 
been suggested that respiratory LTF may thereby induce sympathetic LTF and contribute to 
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the development of hypertension. Repeated alterations to the respiratory generator pattern will 
over time change both the structure and, hence, function of the sympathetically mediated 
vessels and may account for the increase in pulmonary arterial pressure previously reported by 
researchers in adults and children with SDB. This supports the idea that snoring alone, which 
is evidence of resistant airflow and hence increased respiratory work, with no classically 
defined obstructive events, is enough to increased sympathetic activity at the vascular level. 
The resistance in airflow and increase in respiratory work also alters the cardiac rhythm, 
resulting in an increase in left ventricular afterload and a decrease in left ventricular preload.  
Together the net effect reduces stroke volume. Coupled with the intermittent vasoconstriction 
arising from vascular sympathetic activity, it further increases the afterload burden on the left 




The increase in respiratory effort also has flow on effects in the aorta where the increase results 
in increased aortic blood pressure that stretches the aortic wall, where blood pressure surges 
and shear stress on the vessel wall are the highest and, in response, promoting dilation (187).  
The increase in systolic pressure has been shown to accelerate the fragmentation of fibrin and 
collagen accumulation in the vessel wall, promoting aortic stiffening. The responding stretch 
(shear stress, and/or dilation) is thought to play an important role in the genesis of 
atherosclerosis.   
 
Most, but not all, respiratory obstructive events result in a cortical arousal to restore pharyngeal 
patency and protect the body from prolonged hypoxemia (261). Whether the arousal results 
from hypoventilation or upper airway narrowing and occlusion is unclear. In dogs, arousal from 
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SWS is significantly delayed when the carotid bodies were removed, reaching desaturation 
levels of < 60%, (262).  This does not explain the occurrence of arousals, which occur at the 
end of brief apnoeas or hypopneas that do not affect blood gas concentrations. One suggestion 
is that mechanoreceptors in or near the airway are activated by increased respiratory drive. This 
theory was test by Yasuma et al, in dogs. They tested the effects of respiratory load during 
isocapnic hypoxia (induced by rebreathing) and found that arousals also occurred at high SaO2 
levels in the loaded condition, suggesting mechanoreceptor activation also mediated arousals 
(263). This suggests that increased respiratory drive alone can cause surges in vascular 
sympathetic activity, independent of chemosensitivity and total obstructive events. 
1.11.2 Hypoxia 
Acute and chronic intermittent hypoxia (IH), as observed in post obstructive events, trigger 
peripheral chemoreceptors, which initiate an immediate cardiovascular and respiratory 
response that includes an increase in blood pressure and sympathetic activity, and persists after 
hypoxic events have ceased.  This effect has been shown to still be present 60 minutes after 
hypoxic exposure and is independent of respiratory drive (62).  
Osani et al, demonstrated reduced respiratory drive and chemosensitivity in adult participants 
with OSA in response to a hypoxic withdrawal test (264). Subject were asked to breathe air 
from a tube that was lower in O2 and higher in CO2 than normal atmospheric concentrations. 
This induced a mild hypoxic/hypercapnic state.  When participants used domperidone, a 
dopamine antagonist, it resulted in an increase in hypercapnic ventilation (CO2 increased) and 
hypoxic withdrawal response (O2 decreased) response in OSA patients compared to controls.  
Dopamine is proposed to reduce chemoreceptor sensitivity and suggests that adults with OSA 
may have abnormal dopaminergic mechanisms (increase in ‘dopamine’ production and 
circulation/neural circuitry activation/receptors). They also showed a negative relationship 
between awake hypoxic ventilation response and severity of desaturations during sleep in OSA 
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patients.  Researchers suspected that ‘frequent asphyxia’ during sleep may result in adaptation 
and hence blunting of chemoreceptors. Whether the reduction in chemosensitivity occurs as an 
adaptive response to preserve sleep continuity or is an anomaly of the chemoreceptors 
themselves remains to be determined.   
 
Chemoreceptor activation also produces vascular changes by releasing a number of factors in 
to the blood. They include vasoconstrictors Ang II, circulating catecholamines and vasopressin. 
In addition, vasodilators such as NO are thought to be released to counter the effects of 
vasoconstrictors and hence decrease the effect on blood pressure.  This has been demonstrated 
in rats, using telemetry, which shows that blood pressure initially increases to IH and is quickly 
followed by both hypotension and bradycardia. This also demonstrates the synergistic 
relationship between the chemoreflex and baroreflex (62).  
 
Exposure to IH during early development in rodents has also demonstrated that the effects 
predispose animals to early hypertension as they mature even when the IH is limited to the 
early weeks of life.  Chu et al., demonstrated the deleterious effect of intermittent hypoxia on 
mice pups exposed for the first four weeks of life (265). They noted stunted growth in the first 
4 weeks of development but that after cessation of intermittent hypoxia weight gain increased 
to normal standards. After 14 weeks (10 weeks post intermittent hypoxia exposure) mean 
systolic blood pressure (24 hours) was higher in previously exposed mice but no differences in 
both diastolic and heart rate were observed compared to non-exposed animals. Baroreflex 
measured using the sequence analysis technique and heart rate variability (SD1 and SD2 from 
ECG) were also compromised while awake and during sleep in the exposed group. Laser 
Doppler post-ischemic reperfusion response was also reported to be altered at 12 weeks. Ang 
II protein and angiotensin-convertin enzyme mRNA where also increased suggesting the 
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dysregulation of the RAS. This is an important group of experiments as it suggests that the 
early exposure to hypoxia, at least in rodents, leads to sustained cardiovascular changes that do 
not normalize once exposure has ceased.  
 
Lin et al., demonstrated significant structural remodeling in the Nucleus Ambiguus and its 
connections to primary neurons with a significant reduction in the cardiac ganglia after 
exposure to IH (266). In addition, they described reorganization of vagal efferent projections 
to the Nucleus Ambiguus with evidence of swollen axons, enlarged terminal varicosities, 
terminals which did not form close contact with primary neurons in the cardiac ganglia. These 
morphological changes are considered to be ‘anatomical substrates’ for ANS dysfunction. 
Authors proposed that these central changes may precipitate remodeling in peripheral ganglia 
including cardiac neurons and terminals in the heart. 
1.11.3 Sleep Fragmentation 
Whether the adverse cardiovascular changes noted in adult SDB are solely the result of the 
ongoing effects of bouts of oxygen deprivation and resulting changes in metabolite 
concentrations (e.g. increased lactate) throughout the night or whether it arises from autonomic 
dysfunction associated with increased arousals which in most cases (75%) (267) occur in 
tandem with  respiratory obstructive events to restore airway patency has been debated. 
Guilleminault was first to speculate that habitual snorers, who showed little if no evidence of 
obstruction other than the snoring, may have cyclical increases in upper airway resistance 
culminating in arousals from sleep, thereby causing sleep fragmentation and daytime 
dysfunction (268, 269).  Since then, research assessing the effects of sleep fragmentation 
without evidence of abnormal O2 desaturation has suggested that the loss of sleep continuity 




Arousals during sleep are abrupt, transient, reflex responses in the CNS that are evident on the 
EEG and coincide with increases in autonomic parameters including heart rate, cardiac 
contractility, blood pressure, and ventilation (271).  The American Association of Sleep 
Disorders (ASDA) definition of an arousal in the EEG trace is characterized when a sudden 
frequency change towards faster rhythms (alpha, beta and theta) occurs momentarily and 
replaces the previous sleep stage. In normal humans, the average duration of these events is 
15s occurring often throughout total sleep time (272) and increasing in frequency with age 
(273). Arousal pathways are evoked by both external (acoustic) and internal (reduced oxygen 
saturation) stimuli.  There are also ‘autonomic arousals’, where there are transient increases in 
autonomic parameters but no cortical changes on the EEG (274). These are often referred to as 
‘subcortical arousals’. Similar to the ‘startle and orientating’ response in the awake state (275), 
an arousal during sleep also involves a similar patterned response which includes vasodilation 
in skeletal muscle and vasoconstriction in the splanchnic area, kidneys and cutaneous vessels 
(271). The consequence of increased vasoconstriction to the peripheral vessels induced by an 
arousal, is an increase in arterial stiffening, which increases both blood flow velocity and the 
pulse wave travels faster and results in reduced pulse transit time (PTT) (276). Pitson and 
Stradling, explored the relationship between changes in autonomic parameters and markers of 
SDB, including AHI, micro arousals and oxygen desaturations. They showed an increase in 
blood pressure (PTT of > 15ms lasting for more than 5s and less than 45s) and rises in heart 
rate correlated with respiratory arousals, micro arousals, AHI and SaO2 dips. The strongest 
correlation occurred between both autonomic parameters (PTT & heart rate rises) and SaO2 
dips (r = 0.71) and EEG micro arousals (r = 0.65) demonstrating the interrelationship between 
these physiological parameters.  
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1.11.3.1 Sleep fragmentation, effects on sleep, performance and subjective measures 
Sleep fragmentation is a common complaint in clinical disorders including SDB (277), restless 
leg syndrome (278), post-traumatic stress disorder (279), narcolepsy (280) and mood disorders 
(281) (282). It has been proposed that sleep fragmentation, caused by external stimuli (noise, 
tones) or internal stimuli (apnoea, periodic leg movement), reduces the recuperative value of 
sleep even though total sleep time is not reduced (270) (283) and NREM sleep is unaffected. 
The quality and depth (increase in delta power), however, is significantly reduced both in 
human (284) and animal studies (282).  The physiological effects of sleep fragmentation are 
the same as those experienced after partial and total sleep loss. All three result in reduced 
alertness, excessive daytime sleepiness, performance deficits and changes in sleep architecture 
associated with a rebound in sleep recovery (270) (285, 286). Sleep fragmentation effects 
autonomic balance and neuroendocrine function (287) and is associated with increased blood 
pressure (288) and disrupted lipid metabolism (289). The effect of sleep fragmentation on 
performance varies with age with greater impairment in both mood and cognitive performance 
in younger participants with just one night of fragmented sleep (286, 290).  
 
Phillip et al., showed that different arousal threshold was evident between sleep stages and 
from the beginning of sleep compared to the last third of the night (291). They also 
demonstrated that there was an increase in arousal threshold during SWS (3 fold) compared to 
REM sleep and stage 2 NREM sleep in the latter stages of sleep. Guilleminault has found 
blunted arousal thresholds in patients with upper airway resistance syndrome and there was a 
significant impact to the defense mechanisms, with more repetition of fragmentation as the 
night progressed (291). He reported that end inspiratory negative esophageal pressure was 
more profound in SWS and arousals occurred more often in the presence of negative esophaeal 
pressure.  In another study, Guilleminault et al., showed no relationship between 
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polysomnographic measures of sleep that are characteristic of oxygen deprivation, such as 
respiratory arousals, oxygen desaturation and objective measures of sleepiness (multiple sleep 
latency test) (292). They concluded that changes to sleep architecture and sleep disturbance 
was a better predictor of daytime sleepiness. Colt et al., came to the same conclusion when 
they looked at the effects of sleep disturbance compare to hypoxemia in OSA patients. Their 
study also showed that apnoea related variables did not reflect excessive daytime sleepiness 
(293).   
 
The impact of sleep fragmentation, SDB and blood pressure was assessed in a population-based 
study and showed that sleep fragmentation was independently associated with increased 
morning systolic blood pressure (288). This study suggests that sleep fragmentation alone 
maybe sufficient to explain the cardiovascular deficits associated with milder forms of SDB 
that have been reported in children.  
1.11.3.2 Sleep Fragmentation in Animal Models 
Sleep fragmentation studies in animals have observed significant changes to the development 
of cardiovascular, nervous and immune systems. In the rodent, the hippocampal long-term 
potentiation associated with ‘memory formation’ and declarative memory was absent after only 
24hr of sleep fragmentation. Furthermore, spatial learning (hippocampal-dependent water 
maze test) was impaired. Researchers speculated that sleep fragmentation may result in loss of 
N-methyl-D-aspartate (NMDA) receptor-dependent LTP in the hippocampal CA1 region 
(282).  In mice, Baud et al., showed that sleep fragmentation impacted both brain specific and 
general metabolism. Food intake was increased without affecting body weight and an increase 
in sustained brain temperature during fragmented sleep was observed. At the end of a two week 
exposure, mice exhibited glucose intolerance and an increase in circadian peak level of 
glucocorticoids (294).  
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The underlying, physiological consequence of ongoing sleep fragmentation has been 
comprehensively examined by the Gozal group in Chicago, USA. Their development of a 
mouse model of sleep fragmentation has allowed for a better understanding of the 
consequences of interrupted sleep on the cardiovascular system. They demonstrated that 
chronic sleep fragmentation induced an increase in expression of nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase, a marker of oxidative stress produced by most 
mammalian cells, including neurons (295). Mice subjected to sleep fragmentation (SF) took 
longer to locate hidden platforms compared to normal mice and NADPH null mice subjected 
to sleep fragmentation. SF mice also exhibited a decline in spatial learning and an increase of 
depressive-like behaviours and anxiety and also expressed increased P47phox and P67phox 
subunits of NADPH oxidase compared to the other groups.  Cortical and hippocampal tissue 
showed an increase level of lipid peroxidation, an accepted marker of oxidative stress. 
Researchers proposed that chronic sleep fragmentation increases oxidative stress and that their 
results of increased NADPH-mediated oxidase and its relationship to impaired cognitive 
function (not seen in the NADPH null mice) was evidence of the detrimental effect of sleep 
fragmentation without obstructive events or infection. This group of researchers were also able 
to demonstrate a relationship between sleep fragmentation and a time-dependent increase in 
insulin resistance. They proposed that sleep fragmentation upregulates oxidative stress and 
inflammatory pathways which induces insulin resistance.  
 
Following from these experiments this group of researchers observed an increase in 
hyperphagia in mice soon after exposure to sleep fragmentation (296). In addition, an 
endothelial function test, using a laser-doppler in the dorsal tail vein, showed that both peak 
flow and time to return to baseline perfusion values were increased in mice exposed to sleep 
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fragmentation from as early as 8 weeks and onwards.  Both systolic and diastolic blood pressure 
increased at about the same time.  Histological tests of the aorta in these same mice exposed to 
sleep fragmentation showed significant elastic fiber disruption and fiber disorganisation in both 
the arch and thoracic aortas, however there was no evidence of altered aortic wall thickness. 
The aortic walls showed 3.7 fold increased infiltration of foam cells and macrophages, 
particularly in the aortic root sections compared to controls. They propose that sleep 
fragmentation, a hallmark of SDB and other sleep disorders may be a harbinger of 
cardiovascular disease often reported in patients.  
 
In larger mammals (dogs),  Brooks et al., showed that long-term sleep fragmentation alone 
resulted in similar blood pressure changes observed in dogs that were subjected to a similar 
number of hypoxic/obstructive events (297). They concluded that the altered response to 
obstructive events observed in OSA are more likely to be attributed to the effects of the sleep 
fragmentation and arousal that is evoked by the event rather than the asphyxia, drop in oxygen 




Figure 8: The mechanisms associated with endothelial dysfunction and vascular damage in 
obstructive sleep apnoea (298) 
 
1.12 SDB and Autonomic Dysfunction – What is the Evidence? 
Autonomic dysfunction has been proposed to be central to the cardiovascular changes observed 
both in adults and children with SDB. The next section will discuss current measures of 
autonomic function and look at the current literature supporting the hypothesis that autonomic 
dysfunction is central to cardiovascular changes observed in SDB. 
1.12.1 Measuring Autonomic Function 
Cardiovascular dysfunction precipitated by an imbalance in autonomic control can result as 
tachycardia, bradycardia, paroxysmal or sustained hypertension and orthostatic hypotension, 
which is often related to increased blood pressure in the supine position (299).  In adults, 
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autonomic evaluation includes a thorough clinical history together with the autonomic 
symptoms profile questionnaire to provide a subjective composite score of autonomic function. 
The domains include orthostatic tolerance, reflex syncope, sexual failure (adult men), urinary 
and gastrointestinal complaints (diarrhea, constipation), excessive sweating, vision and 
vasomotor dysfunction and sleep disturbance (21). Objective measure of autonomic function 
however rely on the measurement of indirect reflex responses using physiological or 
pathological stimuli. These include cardiovascular tests that evoke a change in heart rate, blood 
pressure and respiratory rate. The Valsalva manoeuvre, handgrip, deep breathing, cold face 
test, pupillary light reflex and tilt table (head tilt) all assess heart rate and blood pressure 
changes in response to a specific manoeuvre. Using continuous measures of heart rate (ECG) 
and blood pressure, autonomic dysfunction of the cardiovascular system and hence the integrity 
of the parasympathetic and sympathetic drive can be assessed.  
1.12.1.1 Catecholamine Concentration 
The measurement of catecholamine levels is also used as a surrogate maker of autonomic 
function. Catecholamine, (L-DOPA, dopamine, noradrenaline and adrenaline) are the major 
neurotransmitters associated with ANS control and they can be easily measured using assays 
from urine, plasma and serum samples. The accuracy and reliability of catecholamine 
concentrations have been questioned as their release is not exclusive to sympathetic neurons. 
These measures rely on catchecholamine spillover and, hence, the rate of removal of 
transmitter (mediated by separate processes to release) does not allow for an accurate 
assessment of total SNS activity (22). 
1.12.1.2 Muscle Sympathetic Nerve Activity  
Sympathetic nerve activity measured in muscle (MSNA) and in skin nerve activity is 
considered the most direct measure of sympathetic outflow (300). Vasoconstriction evoked by 
sympathetic fibres to the arterial vessels is measured using microelectrodes inserted in the 
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cutaneous tissue of the peroneal or medial nerve. This allows for the assessment of baroreflex 
as it measures the reduction in burst firing evident during diastolic blood pressure. Activity to 
the muscle increases via inhibition of arterial baroreceptors, or activation of chemoreceptors or 
nociceptors (22). Hence, using both MSNA and continuous blood pressure monitoring together 
gives an optimal understanding of changes in ANS function (300). Unfortunately this technique 
is considered invasive (painful) and is not used in children.  
1.12.1.3 Pupillometry (Pupil Light Reflex (PLR)) 
The ANS controls the pupil’s response to light via the two iris muscles (radial and sphincter), 
which are composed primarily of smooth muscle cells. Light causes the constriction of the 
sphincter muscle via the activation of parasympathetic neurons located within the cephalic 
position of the oculomotor nucleus (Edinger Westphal (EW) or pupilloconstrictor neurons) 
(Figure 1.9).  The PLR pathway begins when the stimulus activates the ganglion cells in the 
retina, which transverse to the optic nerve and synapses in the pretectal area. The EW cells are 
rapidly firing ‘pacemaker cells’, which increase their firing rate as light intensity increases. 
The EW cells also maintain the mid-position of the pupil in ambient light and are inhibited by 
the arousal centres of the brainstem (301).  
 
There are two types of cholinergic synapses (muscarinic and nicotinic) controlling the pupillary 
sphincter muscles and both types are found in the ciliary ganglion (301, 302). The radial muscle 
(the weaker of the two muscles) is innervated by sympathetic neurons and activation causes 
dilation by pulling outward on pupillary margin, via α1-adrenergic receptors. 
 
Although the PLR is a quick response, that is difficult to measure using non-digital methods, 
the recent development of portable infrared pupillometry is becoming increasingly used in 
research areas which include, psychiatry, emergency medicine, cognitive science and sleep 
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medicine (301, 303, 304). The technique requires the control of ambient light and the room 
needs to be free of distractions, e.g. monitors, televisions, etc. Age also alters the size of the 
pupil by 0.4mm per decade after the age of 16 years. Opoids, cognitive load and mood can also 
effect the size of the PLR (301). Variables of the PLR include the baseline pupil diameter, 
constricted diameter, constriction latency, constriction and dilation velocity and constriction 
duration. The automated and portable pupillometers have good interobserver agreement with 









Figure 1.9: Top, Anatomy and pharmacology of the pupil light reflex. Bottom, illustrates the 





1.12.1.3 Heart Rate Variability 
Refer to section 1.3.2.3 
1.12.2 Evidence of Autonomic Dysfunction – Adults 
Somers et al., showed increased sympathetic burst frequency in adults with SDB while they 
were awake compared to controls and non-snore obese participants (306).  They also showed 
that large burst of sympathetic activity synchronized with apnoeas and oscillations in blood 
pressure during sleep. When apnoeas ceased, sympathetic firing also ceased abruptly, however, 
blood pressure increased reaching 240/130 mm Hg in some participants. Muscle tone also 
returned and brief arousals were evident on the EEG.  The overall sympathetic activity during 
sleep increased by 125% compared to the awake state in the SDB participants, which increased 
to almost 200% during apnoea events.  Treatment with CPAP reduced sympathetic activity by 
30%, during sleep, which was lower than the original waking activity in SDB participants and 
closer to that of non-snoring controls.  
1.12.3 Evidence of Autonomic Dysfunction – Children 
It has been proposed that the ongoing impact of SDB during childhood development may 
remodel both vasomotor tone and autonomic response mechanisms (307).  Measuring 
meaningful changes to autonomic function is difficult, as it requires continuous monitoring of 
either heart rate and/or continuous blood pressure during a stress challenge. Hence there are 
limited studies in children with SDB.  
1.12.3.1 Tilt-table, Valsava Ratio, Deep Breathing and PAT 
Guilleminault et al., used the orthostatic challenge (tilt table test) to evaluate autonomic 
function in children with SDB aged 7 – 11 years compared to controls. The test measured 
continuous blood pressure and heart rate changes while being tilted.  Generally there is an 
initial drop in blood pressure followed by an increase in heart rate and a normalization 
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occurring approximately 1 minute after tilt.   They demonstrated reduced initial tachycardia 
and a greater drop in blood pressure in children with SDB compared to controls.   
Using a battery of autonomic tests including the head up tilt table, the Valsalva maneuver 
(forced breathing test) and a deep breathing test (both reflect parasympathetic activity), 
Montesano et al., also demonstrated a greater change in blood pressure during initial tilt in 
children with SDB (308). They also showed an association between Valsalva ratio and 
increased AHI. Furthermore, heart rate changes during the deep breathing challenge were 
decreased in children with OSA and positively correlated with SpO2 nadir. 
O’Brien & Gozal, also used pulse arterial tonometry (PAT) to demonstrate increased 
attenuation of the PAT signal (sympathetic discharge-induced) and, hence, increased peripheral 
resistance during a breathing challenge (3 sighs) (15%) and also cold pressor test (9%) in 
children with SDB during wakefulness compared to controls (309).  
1.12.3.2 Catecholamine Concentrations 
Although considered an indirect marker of sympathetic activity, the reporting of morning 
urinary catecholamine is a non-invasive measure of sympathetic nerve activity. An increase in 
both plasma and urine noradrenaline has been shown in adults with OSA (310). Kaditis et al., 
showed a 40% increase in noradrenaline in children with OSA compared to non-snoring 
controls (311).  In a larger cohort of primary snorers compared to children with OSA, Snow et 
al., showed a 22% increase in morning urinary noradrenaline concentration and 30% increase 
in adrenaline. Both studies showed that the increase in adrenaline was positively associated 
with an increase in OAHI/AHI but only the Kaditis group showed a positive association with 
SpO2 nadir and ODI. Kelly et al., showed a strong association between Normetanephrine 
(metabolite of noradrenaline) and AHI, SpO2 nadir and time spent with SpO2 less than 90% 
(312).   
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Conflicting results have been observed in two recent studies using 24 hour urine collection 
methods. O’Driscoll et al., demonstrated increased noradrenaline (12%), adrenaline (80%) and 
dopamine (13%) in children with SDB aged 3-12 years compared to non-snoring controls 
(313).  Similar to other groups, they reported positive associations with noradrenaline and 
adrenaline with OAHI, AHI and 4% ODI.  Nisbet et al., however did not observe group 
differences in any catecholamine concentrations captured over 24 hours in preschool children 
with SDB compared to controls (314).  
1.12.3.3 Baroreflex Sensitivity 
McConnell and colleagues measured continuous blood pressure, just before and throughout 
sleep using photoplethysmography in children aged 7 – 13 years (315).  They reported a dose-
dependent increase in the magnitude of initial pressure change in baroreflex events and more 
variability with events compared to controls (primary snorers), who had more ‘constant’ 
pressure changes throughout the night. Also evident was an association with nighttime systolic 
blood pressure and left ventricular mass index.  Consistent with adults with SBD, they also 
documented reduced heart rate variability and blood pressure variability (baroreflex sensitivity) 
in the children with OSA compared to controls.  Researchers suggested that children with both 
mild and severe OSA have a reduced heart rate response to blood pressure changes and thus 
possible abnormal autonomic cardiovascular control.  
1.12.3.4 Blood Flow Velocity 
Cerebral blood flow velocity (CBFV) in both children and adult SDB participants has been 
shown to be increased compared to healthy controls. Urbano et al., demonstrated decreased 
recovery of blood pressure and CBFV and cerebrovascular conductance in adult SDB who 
underwent orthostatic and hypercapneic challenges to assess autoregulatory capacity (316). 
They suggested OSA patients had impaired compensatory responses to cerebral hypoperfusion 
and the possibility that cerebral autoregulation may also be compromised by SDB. In children, 
 112 
Hill and associates (2006) reported increased mean CBFV (120 cm/second) in primary snorers 
age 3-7 years compared to healthy matched controls (84 cm/second) in the middle cerebral 
arteries using Transcranial Doppler (147). Their analysis also suggested a possible relationship 
between CBFV and indices of cognition and behavioural function.  
1.12.3.5 Heart Rate Variability  
HRV analyses have been performed in the framework of PSG, in both children and adults. 
Shiomi et al. (1996) found alterations in the very low frequency oscillations of HRV in adults 
with OSA, which might be caused by the abnormal, aperiodic breathing patterns that 
accompany obstructive sleep apnoea (317). Gula et al. (2003) found significant changes in the 
low-to-high frequency ratio suggesting an increased sympathetic activity in moderate OSA and 
a disturbed sympathetic-parasympathetic balance in severe OSA (318). Spicuzza et al. (2003) 
found changes in both high and low frequency bands which might also be interpreted as a shift 
in the sympathetic-parasympathetic balance towards sympathetic activation in patients with 
OSA (319). More recently, Walter and associates (2012) demonstrated reduced total power, 
low (LF) and high frequency (HF) during REM sleep in 7-12 year old children with SDB 
compared to matched controls. LF/HF ratios were also lower during SWS in all severities of 
SDB compared to control (320).  In addition, treatment of adult OSA with the most effective 
current therapy (continuous positive airways pressure or CPAP) not only reduces hypoxaemia 
and arousals during sleep, but also attenuates cardiac sympathetic tone (255), suggesting that 
increased sympathetic outflow may underlie deficits associated with sleep disordered 
breathing.  
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1.13 SDB and Inflammation – What is the Evidence? 
1.13.1 Inflammation and Autonomic Regulation 
The interrelationship between the immune system and CNS has only been recently explored 
(321). In the past, the two areas of research were independently explored despite knowing that 
the lymph organs are innervated by sympathetic nerves for more than a century. Recent work 
has demonstrated integrative autonomic-immune physiological responses, with many signaling 
components from each of the systems, Immune, and CNS (particularly the ANS aspect) 
modulating the response of the other system. Central microinjections, electrophysiological 
studies, peripheral nerve recordings and other molecular techniques have been used to 
investigate the autonomic-immune systems interaction (322). For an extensive review of these 
interactions, the recent review by Kenney & Ganta, ‘Autonomic Nervous System and Immune 
System Interactions’ is recommended (322). 
 
Many cytokines influence the regulation of various physiological processes, including sleep, 
neuroendocrine function, neural development, ANS responsiveness and temperature 
regulation. The effects of these cytokines on ANS function, in particular sympathetic nerve 
discharge and parasympathetic activity, has been demonstrated in animal studies. For example, 
micro-injections of interleukin 1β (IL-1β), has been demonstrated to alter SNS innervation to 
visceral organs and different brain regions, while vagotomy alters SNS regulation to the 
kidneys, spleen and lumber and also cytokine production. This suggests that a complex 
interaction occurs between inflammatory cytokines and SNS and PNS regulation. In both 
animals and human studies, various inflammatory cytokines have been shown to affect the 
cardiac sympathetic afferent reflex (323) and are associated with changes in heart rate 
variability (324).  They include Interleukin 6 (IL6), tumor necrosis factor-α (TNFα), C-reactive 
protein (CRP) and interferon-γ (IFNγ).  
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The reciprocal response, where the ANS is activated, demonstrates the bi-directional 
relationship between these two systems. For example, heat stress has been shown to be 
associated with an increase in cytokine gene expression for both IL-1β and IL6 from the spleen, 
which is attenuated when the splenic nerve is denervated in the rat (325). Also, microinjections 
of Ang II, a regulator of cardiovascular function and sympathetic nerve outflow results in 
increased IL-1β, IL2, IL5 and TGF β1 (326).  
 
 
1.13.1 Evidence of Inflammation - Adults 
Systemic inflammation is a hallmark of both SDB and CVD. Many studies report increases in 
C-reactive protein (327), IL6, fibrinogen, Tumor Necrosis Factor-α (TNFα) intracellular 
adhesion molecule-1 (ICAM), vascular cell adhesion molecule-1 (VCAM-1), leptin (328), P-
selectin, leukocyte superoxide and soluble circulating adhesion molecular in adults with SDB 
(216) (329) and are evidence of inflammation and endothelial dysfunction. 
 
Some studies have shown adiponectin, a marker produced by mature adipocytes is reduced in 
adults with OSA both in the morning and evening while others have shown no difference or 
increased levels (330). Adiponectin inhibits glucose processing in the liver and increases 
oxidation of fatty acids. It also plays and important role as an anti-inflammatory as it inhibits 
NF-kB production, which in turn reduces IL6 production and promotes the production of IL10, 
an anti-inflammatory cytokine (330). IL6 is a mediator of atherogenesis which can induce 
chemokine and leukocyte recruitment during oxidative stress and both TNFα and IL6 inhibit 
adiponectin production (216).  TNFα (331), NF-kB (332)  and IL6 have all been shown to be 
increased in adults and children with SDB (333-336) suggesting a possible synergy between 
the inflammatory pathways and those involved in vascular repair (remodeling).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 115 
 
Whether the increased inflammatory response demonstrated in adults with SDB arises from 
‘infection’ and, hence, activation of the immune response or from increased sympathetic 
activity associated with increased respiratory effort, sleep fragmentation and arousals have not 
been addressed in the literature. However, treatment with CPAP in adults has been shown to 
reduce both the number of respiratory events and also circulating CRP levels, suggesting the 
underlying inflammatory response may occur in response to increased sympathetic activity 
(337). 
1.13.2 Evidence of Inflammation – Children 
There are limited studies investigating the inflammatory response in children as they require 
blood samples to properly assess expression levels of markers. However, morning plasma 
TNFα levels have been shown to be increased and positively correlated to the frequency of 
respiratory arousals and level of sleepiness in children with SDB. Plasma levels reduced after 
T&A, matching the reduction in respiratory events and level of sleepiness assessed in children 
three months post-surgery (338).  Levels of IFNγ, considered a key factor in the progression of 
atherosclerosis (339), were also found to be increased in children with OSA (331). Fibrinogen 
another inflammatory marker associated with cardiovascular disease, was demonstrated to be 
increased in snoring children but was not associated with any of the current PSG measures of 
severity (340).  
Many studies in children have shown increased levels of C-reactive protein (CRP) (334, 341-
343), but not all (198). A review by Gozal et al. has proposed that CRP may provide a potential 
biomarker for OSA (341). Their posit is supported by the meta-analysis conducted by Ingram 
and Matthews who demonstrated that collectively, the results of eight studies, which compared 
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pre-treatment to post-treatment CRP levels in children with OSA, showed that CRP levels 
significantly reduce after surgery (344). 
 
Kheirandish-Gozal et al. demonstrated that children with delayed hyperemic dilation response 
(reduced vascular responsiveness) and OSA, were more likely to exhibit reduced CD14+ 
monocytes and increased CD16+ cells and hence reduced CD14:CD16 (ratio). In addition they 
found that CD16+ cells expressed higher levels of the chemokine, Fractalkine (CX3CL1), 
which induces chemotaxis in monocytes and is associated with vascular disease (192, 345). 
Interestingly, they noted a strong inverse correlation between the CD14:CD16 and the time to 
maximal dilation during the hyperemia test (Tmax) and that CX3CR1 levels were inversely 
associated with nitric oxide production, demonstrating the interaction between the 
inflammatory response and vascular function.  
More recently, Israel et al. showed increased expression from tonsillar and adenoid tissue of 
both NF-kB, a transcription factor and regulator of immune response, and IL-1α, a pro-
inflammatory cytokine, in children with OSA compared to age matched control (346).  In the 
rat model of SDB, intermittent hypoxia induces both NF-kB and TNFα expression in vascular 
tissue. Increased TNFα down-regulates endothelial nitric oxide production, which in turn 
impairs endothelium-dependent vasodilation (347). Together these studies suggest an inter-
relationship between vascular changes and inflammation in children with SDB independent of 
infection. 
1.14 Conclusion 
Sleep is an important determinant of health and wellbeing and good sleep during childhood is 
vital for development and learning. There is evidence that SDB at the severe end of the 
spectrum is associated with reduced neurocognition and changes in cardiovascular function. 
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More recently, studies are suggesting that even children diagnosed as primary snorers using 
current AASM criteria are not protected from these changes. Given that more than 10% of 
children experience some level of SDB during the formative years and that most will not be 
diagnose or treated (less than 10%) the impact to their underlying physiology needs to be 
property understood so as to determine, (i) if and which children need treatment and (ii) 
whether the treatment is effective in reversing these changes. If the cardiovascular effects of 
childhood SDB persist, an important potential modifiable risk factor for adult cardiovascular 
disease may remain under-recognised and untreated and contribute to the early manifestation 
of cardiovascular deficits that can burden the individual and community at large. Therefore, 
understanding the underlying components that precipitate the changes in cardiovascular health, 
be they the impact of increased sympathetic activity and vasoconstriction of the peripheral 
vessels or the impact of an overactive inflammatory response or both, need to be better 







1.15 Aim of Thesis 
The overall aim for this thesis is to compare vascular and inflammatory response in children 
with healthy age matched children who do not snore. PSG was used to determine SDB severity 
in all studies. FMD (brachial artery) and MRI (aorta) were used in separate studies to measure 
vascular responsiveness of both minor and major vessels. Flow cytometry of T-cell lymphocyte 
was used to examine the inflammatory response between the two groups.  
 
Children with SDB in the study donated their tonsil tissue to be examined. Hence a second aim 
of the study was to look at markers of sympathetic activity on arteries from the tonsils (dorsal 
lingual artery) and determine if there is a relationship between changes in vascular response, 
platelet aggregation (endothelial damage) and pupil light reflex (autonomic function) which 
are reported to be affected in adults and children with SDB. 
 
Hypothesis 1: Children with SDB will have impaired vascular function (brachial artery – 
FMD, aorta/pulmonary arteries – MRI) compared to healthy age-matched controls 
Hypothesis 2: Children with SDB will have increased markers of inflammation compared with 
healthy aged-matched control. Children with increased markers of inflammation will have 
altered vascular response. 
Hypothesis 3: Children with worst vascular responsiveness will have increased markers of 
sympathetic activity (sympathetic nerve fibre density measured using immunofluorescence for 
tyrosine hydroxylase, platelet aggregation (a marker of endothelial damage), and altered pupil 





Flow mediated dilatation, using time course data shows 






The following chapter investigates the normal dilation response during hyperemic stress in the 
brachial artery, using flow-mediated dilatation (FMD) in children aged 6 – 15 years. Flow 
mediated dilatation has only recently been used in children, however there are no papers on the 
vessel temporal dilation dynamics in normal children under the age of 14yrs. Only one paper 
looks at the temporal differences in dilation response in FMD at brachial site and its 
relationship to age, gender and body habitus, however this study used a vast age range starting 
at 14 years until 75+ years.  
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Flow mediated dilatation is a tool widely used to measure arterial responsiveness to sheer 
stress.  However, there is scant literature to show how the peripheral arterial response changes 
as the vascular system mature. One reason for this is that the feasibility of measuring flow 
mediated dilatation in younger children has not been established. The aim of this study was to 
assess brachial artery function during flow mediated dilatation response after 4 minutes of 
ischemia of the forearm in children aged 6-15 years. Time to reach flow mediated dilatation 
maximum was found to correlate with age (r = 0.4, p < 0.05), resting brachial artery diameter 
(r = 0.4, p < 0.05), height (r = 0.4, p < 0.05), BMI (r = 0.45, p < 0.05), body surface area (r = 
0.44, p < 0.05) and resting blood flow (r = 0.37, p < 0.05). However, no correlation between 
the traditional flow mediated dilatation response at 60s and for flow mediated dilatation 
maximal dilation was evident with age, resting brachial artery diameter, height, weight, BMI, 
body surface area, resting blood flow.   
In conclusion, the time taken to reach maximal dilation response is related to age and brachial 
artery luminal diameter and body habitus but not the traditional measures: FMD response at 
60s or the maximal dilatation percentage. 




Early detection of impaired cardiovascular function is prerequisite for the prevention of future 
hypertension, atherosclerosis and cardiac disease. An integral component in that task is the 
assessment of vascular responsiveness before disease develops. A common non-invasive 
method for assessing vascular responsiveness is the measurement of flow-mediated dilatation 
(FMD). FMD measures endothelial response to an increase in sheer stress induced by increased 
blood flow in a peripheral conduit artery following the induction of ischemia, commonly in the 
brachial artery (348). The physiology underlying the FMD response has been well described 
(226, 349). The initial vascular dilation following forearm occlusion in FMD measurement is 
dependent on intact endothelial stretch receptors, which respond to the increased blood flow 
and the resultant sheer stress by the release of vasodilators, in particular nitric oxide.  The latter 
induces relaxation of the smooth muscle cells surrounding the endothelial layer of the vessel 
thereby increasing luminal diameter.  The magnitude of the vessel dilation (349) and time taken 
to maximal dilation (348, 350-352) are the two key parameters measured with the FMD 
technique. 
Traditionally, maximal vessel dilation has been thought to occur at 60s following cuff deflation 
(FMDmax) and reflect the health of endothelial cells (EC).  While the 60s time point has been 
used in many studies (230, 353-355) it may not adequately describe all of the important 
characteristics of the dilating vessel wall. Age related changes in blood vessel distensibility 
and therefore time to maximal blood vessel dilatation have been reported in adults (350, 352). 
Whether the same is true in young children is unknown. Only one study has assessed time to 
maximal brachial artery dilation, in healthy children but this was restricted to older children 
aged 9 – 16 years(356). It showed that most maximal dilations occurred at approximately 70s 
post cuff deflations.  In order to comprehensively assess shear stress response throughout 
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childhood it is important that FMD responses be examined both over a longer time period than 
the currently accepted 60s and also over a wider age range. Specifically, the aim of this study 
was therefore to assess FMD responses over 180s in healthy young children aged 6 - 15 years. 
 
 
Table 2.1: Blood Flow Dynamics recorded or derived during FMD measurements  
 
 
VTi Velocity time integral  Mean blood flow velocity during ejection time for one 
cardiac cycle (Peak systolic velocity x ejection time) 
PSV Peak systolic velocity The fastest velocity during ejection time of one 
cardiac cycle  
Q Brachial Artery Blood 
flow 
Amount of blood travelling through the brachial 
artery per second 
Q = SV x HR,  (Blood Flow = Stroke Volume x HR) 
 SV = (Cross Section Area of the artery x VTi). 
 
SR Shear Rate  (8 x VTI)/diameter of the artery is a measure of 






2.4.1 Anthropometrics  
Preliminary analyses revealed no gender differences in anthropometrics and therefore gender 
was not included in the analyses. The final group consisted of 12 males and 18 females aged 
6.3 to 15.7 years.  
2.4.2 Brachial Artery Dimension and Blood Flow Dynamics 
As expected, brachial artery diameter was strongly correlated with age, height, weight, body 
surface area, BMI and moderately to resting blood flow. Also a moderate inverse relationship 
was evident between rHR and resting brachial artery diameter, and body surface area. Whole 
group data is reported in Table 2, while correlation results are presented in Table 2.3. Resting 
HR demonstrated a moderate inverse relationship with hVTi, resting blood flow, age, height, 
weight and body surface area. A moderate positive correlation was observed between hVTi and 
variables, age, height, weight, resting heart rate, and BMI. Resting blood flow was moderately 
correlated with resting brachial artery diameter, resting VTi, BMI, body surface area and body 
weight and weakly with age and height. 
A moderate positive correlation between rVTi, weight, and BMI was reported but there was no 
association between rVTi and height.  A strong negative relationship between rHR and hVTi 
was also observed. 
 
2.4.3 FMD Response 
The correlation between FMD and anthropometric parameters are reported in Table 2.3. The 
time to reach FMDmax was moderately correlated with age, BMI, resting brachial diameter and 
body surface area. Most of the younger children had reached peak dilation and were returning 
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to baseline by 45 seconds post-cuff deflation while the brachial artery of older children 
continued to dilate up to and beyond 60 seconds post-cuff deflation (Fig 2.1).  No significant 
relationship was observed between both FMD60s and FMDmax and age, brachial artery diameter, 
height, BMI, and body surface area.  
Table 2.2: Anthropometric, Blood vessel dimensions and flow dynamics details for the 
combined sample (n = 30). 
 
 




Age (years)  10.9 2.70 6.25 15.7 
Height (cm)  145.5 16.0 118.5 177.0 
BMI (cm/kg2) 18.9 2.5 15.2  26.0 
Weight (kg) 41.2 12.7 21.7 67.8 
Waist/Hip Ratio 0.87 0.05 0.78  0.96 
Body Surface Area (m2) 140 57 583 272 
Vascular parameters 
Vessel Resting Diameter (cm) 0.255  0.030 0.200 0.343 
Resting PSV (m/s) 103.2 21.0 65.4 156.8 
Resting VTi (m2) 17.32 8.72 9.00 50.00 
Resting HR (bpm) 72.8 9.3 57.0 95.0 
Hyp PSV (m/s) 168.7 24.1 120.7 222.5 
Hyp VTi (m2) 67.76 16.18 26.40 97.70 
Hyp HR (bpm) 76.2 10.4 57.8 100.5 
Resting Blood Flow(Q) 
(ml/min) 
66.6 39.4 23.8 170.4 
Resting Shear Rate (rSR) 407 85 270 590 
FMD60S (%) 6.81 4.52 -0.40 17.11 
FMDMax (%) 8.39 4.04 0.81 17.11 






































Resting brachial artery diameter 0.70**** 0.75**** 0.72*** 0.73**** 0.48** 
Resting heart rate -0.57*** -0.56*** -0.51*** -0.46* -0.18 
Resting VTi 0.25 0.23 0.42* 0.37* 0.59*** 
Resting blood flow1 0.37* 0.38* 0.53*** 0.49** 0.64**** 
Hyperaemic heart rate -0.56** -0.53*** -0.46* -0.48** -0.21 
Hyperaemic VTi 0.47** 0.40* 0.36* 0.35 0.27 
Hyperaemic minus resting VTi 0.36 0.30 0.15 0.16 -0.06 
Resting peak systolic velocity 0.31 0.34 0.32 0.46* 0.53*** 
Hyperaemic peak systolic velocity 0.42* 0.37* 0.49** 0.41* 0.47** 
Resting shear rate -0.15 -0.19 -0.19 -0.01 0.21 
FMDMax -0.01 0.00 0.24 0.03 0.17 
Time to FMDMax 0.40* 0.41* 0.46* 0.44* 0.45* 
FMD60S 0.06 0.08 0.05 0.14 0.28 
 









This study investigated the time to maximal FMD response in healthy children ranging 
from 6 – 15 years. Our results demonstrate that the time needed for the brachial artery 
to fully dilate in response to sheer stress and ischemia is related to age and body habitus 
(weight, height, and body surface area). This is consistent with the proposition that as 
children grow the vasodilation response of the peripheral arteries becomes slower over 
time and complements previous work by Herrington and associates (2001), who found 
the same relationship between time to FMDmax and age in large group of participants 
ranging from 14 to 80 years.  
Arteries increase in size to keep up with the metabolic requirements associated with 
increased tissue mass, explaining the relationship that we found between both age and 
BMI and time to FMDmax. Arterial responsiveness is maintained through a series of 
complex interactions, some of which are short-term and activated through the central 
nervous system and/or direct cellular mechanisms (226). Other determinants are long-
term, involving both the size of the lumen and wall of blood vessels, which are made 
up of vascular components such as extracellular matrix proteins, collagen and elastin, 
and smooth muscle cells. Together these elements alter the compliance of blood vessels, 
and compliance in turn is a critical determinant of vasomotor function and arterial 
capacity to dilate (254, 357). Jourdan et al., (2005) reported an increase intima-media 
thickness (IMT) of systemic arteries (e.g. carotid and femoral arteries) with age and 
height (358). They suggest the gain in IMT is due to increased smooth muscle cell and 
extracellular matrix protein formation.  
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As there are numerous long-term and short-term changes in the anatomical and 
physiological properties of blood vessels as children mature it is likely that the delay in 
reaching FMD maximal dilation we observed in older children is associated with 
changes in some, if not all, of these parameters and importantly the effect that a 4 
minute hypoxic state has on the blood vessels distil to the cuff at different ages.  
In the present study no significant linear correlations were observed between both 
FMD60S and FMDmax and any of the anthropometric variables (i.e. age, weight, height, 
BMI and body surface area). The mean FMD60s and FMDmax observed in this study are 
consistent with those of other studies showing the capacity for brachial artery dilation 
is between 8-11% in normal, non-obese subjects and independent of age (359). 
Consistent with other studies, we also observed a large variability in FMDmax (4-18%).  
Over 50% of participants in this study reached peak dilation either before or after the 
60 s time point, which traditionally other studies have used as the measurement end-
point. This is consistent with the distribution of maximal dilation times reported by 
Black et al. (2008), Palinkas et al. (2002) and Järvisalo et al. (2002), with the majority 
of maximal dilation measurements occurring outside the standard window of 
assessment in normal adults, patients with coronary artery disease and healthy children 
(350, 351). Black and colleagues stressed that FMD taken at the traditional 60 s time 
point may result in difference outcomes reported when comparing groups (350). These 
studies did not examine the relationship between BMI or age and time to FMD maximal 
dilation.  Contrary to previous reports (352, 360, 361) we did not find a relationship 
between FMD60s and FMDmax and resting brachial artery diameter.  The lack of 
association maybe to due to the small range in brachial artery diameter in our group. 
The diameter ranged between 2mm to 3.43 mm with a difference of only 1.4mm, where 
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as the Herrington et al., (2001) study the brachial artery diameter ranged from 2mm up 
to 8mm.  
Our results support previous reports that heart rate decreases while the brachial artery 
diameter increases as children mature (362). At rest, the volume of blood passing 
through the resting brachial artery (resting brachial blood flow) increases with age and 
BMI, but not shear rate. Shear rate is a measure of frictional force on the luminal wall, 
which is dependent on the luminal diameter and the volume and rate of blood flowing 
through the vessel. We showed the brachial artery diameter and resting blood flow 
increases as children mature. As both variables increase by the same factor shear rate 
remained constant across ages. The consistent correlations between interrelated 
variables and brachial diameter adds to the accuracy of the measurement conducted by 
both the ultrasonographer and the echocardiologist in this study.  
The temporal differences in FMD response and the relationship to age and body habitus 
may not seem important in normal children, but this may be critical in differentiating 
responses between normal children and those with disorders likely to affect vascular 
response. In conditions such as juvenile diabetes and obesity it is well established that 
vasculature is affected when measuring standard FMD response in older children.  If 
time to FMDmax, age and body habitus are measured and accounted for, more subtle 
abnormal vascular responses may be found both earlier in those disorders with 
established changes and other disorders not currently associated with abnormal 
vascular response. Changes in affected groups, which show reduced dilation at 60s such 
as FMD studies involving children with type 1 diabetes mellitus (353); 
hypercholesterolemia or Kawasaki disease (355) does not mean the blood vessel does 
not fully dilate, it may be that the vessel dilates quickly and by 60s is returning to 
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normal baseline diameter or that the initial dilation is slow and the kinetic mechanisms 
between the smooth muscle is somehow interrupted. Again, these would have different 
causes and yet give the same values. Continuous measurements need to be performed 
to establish the nature of vascular response dynamics with time.  
2.5.1 Limitation 
One limitation to this study is that the estimated time to FMD maximal dilation does 
not accurately reflect the time of full dilation to the second. Although current 
recommendations specify the use of edge detection software to determine second by 
second dilation response rather than manual determination using caliper manipulation, 
the supersedence of the manual method does not invalidate the results of previous 
studies, of which the majority have used and reported the manual method.  To our credit 
unlike most studies using the manual method that only report dilation at 60s to compare 
two distinct group of participants, this study used multiple time points per participant 
(maximum of 33 points), which produces a more accurate account of the progression 
of dilation of the brachial artery. Although we acknowledge that the small sample size 
maybe seen as a limitation we wish to reinterate that the study is not a comparative 
assessment but a rather an indication of how the brachial artery response to induced 
shear stress develops as healthy children grow. 
 
2.5.2 Conclusion 
The results of this study suggests that continuous FMD reporting over 3 minutes, would 
give a more accurate assessment of early changes to vascular function.  We also 
demonstrated that FMD can be used in children as young as 6 years old and that the 
time taken to reach maximal vessel dilation increases with age and body habitus in 
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healthy children. As a research procedure FMD measured continuously maybe a more 
useful in determining early vascular changes between groups of healthy children and in 
those where vascular abnormalities might be expected.  
2.6 Methods 
Ethics approval for this study was granted by the Human Research Ethics Committee 
of the Women’s and Children’s Health Network. Healthy children aged between 6 - 15 
years were recruited from the local community. Parents of participants completed a 
comprehensive child’s health and behaviour questionnaire. Results of the questionnaire 
were used to screen children known to have genetic conditions, respiratory disorders 
(e.g. asthma) and developmental disorders (e.g. ADHD). The final sample consisted of 
12 males aged 10.71 (2.02) years (Mean (standard deviation)) and 18 females aged 
10.96 (2.86) years.  
Children were weighed wearing minimal clothing using an electronic scale with a 
resolution of 0.1kg and height was measured using a wall mounted stadiometer. BMI 
and percentile was calculated using the Baylor College of Medicine website tool 
(http://www.bcm.edu/cnrc/bodycomp/bmiz2.html). Body surface area was calculated 
using the Du Bois formula:  
Body surface (cm2) = weight (0.425) (kg) x height(0.725) (cm) x 71.84 (363) 
2.6.1 Vascular function ultrasound assessment  
Children attended the Medical Imaging department between 7.30 and 8.30am. The 
ambient room temperature was maintained at 23°C throughout the FMD procedure. 
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The standard protocol adopted by the WCH imaging department over the past 12 years 
is to measure the diameter of the brachial artery using a two dimensional longitudinal 
ultrasound image of a section of the brachial artery at 2-15 cm above the elbow while 
the participant lies supine on an examination couch (353). The image is captured by a 
professional pediatric ultrasonographer of 20 years experience using a 10.0 MHz linear 
array transducer (Advanced Technology Laboratories (ATL), Bothel, WA), and an 
ATL HDI 3000 ultrasound system and recorded to a high quality VHS cassette. An 
electrocardiogram was also recorded simultaneously during the scan.  
To ensure that the brachial diameter is measured in the same location during each scan, 
a reproducible site for vessel imaging is determined using standardized identifiers such 
as venous valves or vessel bifurcations. A resting scan of the vessel diameter was taken 
for 30 s. Subsequently, the blood flow to the lower forearm was occluded for four 
minutes using a sphygmomanometer to 250 mmHg. Deflation of the cuff then induces 
reactive hyperemia and the conduit arteries dilate in response to the increased blood 
flow. This physiological response is dependent on the presence of an intact 
endothelium. Thus the measurement of flow-mediated dilatation in vivo has been 
widely adopted as an assessment of endothelial function.  A second scan (reactive 
hyperemia) was taken from 30 s after cuff deflation until 180 seconds. After 10 minutes 
a third recovery scan was made.  
In addition, blood flow velocity was determined during resting scan and for the first 15 
s post cuff deflation, using the pulse Doppler signal at less than 60° to the brachial 
artery (364). The ultrasound measuring parameters remained unchanged during the 
whole study.   
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A different second experienced echocardiographer used ultrasonic calipers to determine 
the arterial diameter during the R wave of the electrocardiogram. At each time point 
the average vessel diameter was derived from four cardiac cycles. This value was then 
used to calculate the percentage difference from resting vessel diameter from the first 
scan at 30 s and every subsequent 15 s intervals post cuff deflation (FMD30 - FMD180). 
Estimated maximal dilation (FMDmax) was calculated as the 
Difference between Maximal and resting baseline vessel diameter value divided 
by resting baseline diameter and expressed as a percentage.  
The time to maximal dilation was estimated as the time taken to reach FMDmax after 
cuff deflation (350)). In cases where FMDmax values were constant for multiple time 
points the first point was considered FMDmax.  
Brachial artery resting diameter (rD), peak systolic velocity (rPSV), velocity time 
integral (rVTi) (the area under the curve value of the mean systolic velocity during 
cardiac ejection time) (365) and heart rate (rHR) was calculated during the resting scan. 
Hyperemic PSV, VTi, and HR was measured immediately after cuff deflation (hPSV, 
hVTi, hHR).  The average of PSV, VTi, and HR for four cardiac cycles was determined 
for both at rest and during hyperemia.  
Resting blood flow (rQ) was calculated as previously described in Black et al., (350), 
using rD, rVTI and rHR: 
rQ = rSV x rHR 
 rSV = π r2 x VTi, 
 137 
Shear rate was a measure of the frictional force at the surface of the endothelium. 
Resting Shear rate (rSR) was also determined based on the following equation (366): 
rSR = (8 x rVTi )/ rD 
 A summary of the FMD blood flow parameters is given in Table 1.  
Data were analysed using SPSS (version 19). Values are presented as mean and 
standard deviations. Correlations were determined using the Pearson’s correlation 
coefficient, p–values < 0.05 were considered statistically significant. 
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Delayed brachial artery dilation response and increased resting 




This chapter compares FMD in young children with SDB to healthy age-matched 
control children. It also looks at the relationship between brachial blood flow velocity 
during baseline and hyperemia scans and PSG generated variables, including the OAHI, 
SaO2 nadir and oxygen desaturation. This is the first study to look at FMD in children 
with SDB compared to healthy aged matched controls, exclusively between 5-9 years 
of age.  
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To evaluate whether the vascular dysfunction detected in adults with sleep disordered 
breathing (SDB) is also evident in children with snoring referred for evaluation of 
clinically suspected SDB. 
3.2 Objectives 
This study compared flow mediated dilatation (FMD), measured at the brachial artery, 
at rest and during hyperemic stress between children who snore (n = 23; mean (SD) age 
= 7.51 (1.3) years) and healthy, non-snoring children (n = 11; age = 8.0 (1.3) years).  
3.3 Methods 
Children with suspected obstructive sleep apnoea  (OSA) and healthy non-snoring 
controls underwent overnight polysomnography (PSG). Non-invasive FMD and 
brachial arterial blood flow velocity during rest and hyperemia were subsequently 
measured by ultrasound imaging using standard techniques.  
3.4 Measurements 
Resting and hyperemic velocity time integral (area under the curve of mean systolic 
velocity x ejection time), maximal dilation response (highest percentage difference 
from baseline diameter) and the time taken to reach maximal dilation were calculated. 
3.5 Results 
Children awaiting adenotonsillectomy compared to healthy non-snoring control 
children had higher velocity time integrals at rest (14±3m vs 20±8m, p < 0.01) and 
during hyperemic stress (56±6m vs 63±13m, p < 0.01) despite having only mild SDB 
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on polysomnographic assessment.  Lower nadir oxygen saturation values during non-
rapid eye movement sleep were negatively associated with higher resting (r = -0.58, p 
< 0.001) and hyperemic (r = -0.36, p < 0.05) velocity time integrals.  Maximal FMD 
dilatation response was not significantly different between snoring and non-snoring 
groups but the estimated time to reach maximal dilation was significantly delayed in 
children that snored (60.7±28.4 vs 39.2±13.2 s, p < 0.05).  
3.6 Conclusions 
Children with mild SDB showed increased blood flow velocity at rest and during 
hyperemic stress suggesting altered cardiovascular and haemodynamic function. The 
delay in time to maximal vessel dilatation in snoring children also suggests possible 
reduced vascular compliance in response to hyperemic sheer stress.  Mild SDB appears 
to alter the peripheral vascular response in young children. The long-term vascular 
implications of these changes in the growing child are unknown and warrant further 
investigation.    





In adults, sleep disordered breathing (SDB) is an independent risk factor for 
cardiovascular disease (367), including left ventricular diastolic abnormalities (368), 
ischaemic cardiac events (369) and systemic hypertension (370-372). Cardiovascular 
abnormalities are also evident in children with SDB.  These have been well documented 
at the severe end of SDB spectrum, i.e. obstructive sleep apnoea syndrome, and include 
right and left ventricular hypertrophy, pulmonary hypertension, cor-pulmonale, and 
cardiac failure (135, 191, 203). What is less well appreciated however is that 
cardiovascular abnormalities have also been shown in children with mild SDB, i.e. 
primary snoring, and include elevated sympathetic tone, raised blood pressure and 
increased cerebral blood flow velocity (147, 210, 309, 313).  Children with mild SDB 
constitute the majority of SDB patients (84) and at present, knowledge of the potential 
impact of mild SDB on large blood vessel function is unknown. 
Changes in large blood vessel function in children with SDB can be assessed using the 
non-invasive technique of flow-mediated dilation (FMD). FMD employs high-
resolution ultrasound to measure dilatation of the artery in response to hyperemic shear 
stress induced by ischemia upon downstream vessels. Vascular dysfunction is reflected 
by an impaired FMD response in either the magnitude of vessel dilatation (373) or the 
time taken to reach maximal dilation post-cuff deflation (226). Two previous studies 
have reported that children with SDB have minor reductions in FMD response at the 
standard time-point of 60s (229, 230). However, recent literature has shown that 
measurements at 60s do not fully encapsulate the true overall functional dynamics of 
the vessels’ response to shear stress and that extending the measurement time permits 
a more complete assessment of vascular compliance (348, 350).  
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This study evaluated blood flow and FMD parameters over an extended period of 180s 
and measured both the magnitude (i.e. FMD at 60s and FMD maximum) and temporal 
FMD response of the brachial artery (i.e. time to FMD maximal dilation) in children 
aged between 5 and 9 years with snoring referred for clinical ENT assessment 
compared to healthy non-snoring controls.  
3.4 Methods 
3.4.1 Subjects 
Children with a history on parental report of snoring more than three nights per week, 
and who were referred by their primary physician for the evaluation of SDB to the 
Otolaryngology Clinic at the Women’s and Children’s Hospital Adelaide, Australia 
were recruited as participants (n=23).  The control group (n=11) was comprised of 
healthy non-snoring children recruited from the community via advertisement and 
through friends of the children with SDB. The study was approved by the Child, Youth 
and Women’s Health Services and University of South of Australia Human Research 
Ethic Committees. 
Potential participants were limited to between 5-9 years of age to minimize the possible 
influence of pubertal developmental on sleep, neurovascular development and upper 
airway dynamics (131, 226, 374-377).  
Exclusion criteria included a history of significant asthma, previous 
adenotonsillectomy, significant craniofacial abnormality, medications that affected 
sleep or respiration, developmental/psychiatric disorders and English as a second 
language. Given the evidence of an association between obesity and FMD, children 
with a body mass index > 95%ile were excluded (376). 
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3.4.2 Polysomnography     
Overnight polysomnography (PSG) was conducted using the Compumedics E-Series 
Sleep System (Melbourne, Australia). The following standard parameters were 
measured:  electroencephalogram (EEG; C3-A2, C4-A1, and F3-A2 F4-A1, O1-A2 and 
O2-A1), left and right electrooculogram (EOG), sub-mental, diaphragmatic and leg 
electromyogram (EMG), heart rate by electrocardiogram (ECG), oronasal airflow by 
thermistor and nasal pressure, respiratory movements of the chest and abdominal wall 
using uncalibrated respiratory inductive plethysmography (RIP), and arterial oxygen 
saturation (SpO2) by pulse oximetry (Nellcor N-595; two second averaging 
time).  Children were continuously monitored via infrared camera by a pediatric sleep 
technician who also documented observations of sleep behavior, which included the 
presence or absence of snoring.  
3.4.3 Ultrasound Assessment of Endothelial and Artery Function 
Once awoken from the PSG and while still fasting, children had a FMD assessment as 
previously described (378). Briefly, a resting scan measuring brachial artery diameter 
and blood flow dynamics was initially undertaken and, subsequently, blood flow to the 
lower forearm was occluded by inflation of a sphygmomanometer cuff to 250mmHg 
for 4min.  In brief, the resultant ischaemia and post-cuff deflation induces reactive 
hyperaemia by lowering the vascular resistance within the vascular bed supplied by the 
brachial artery. The reactive hyperaemia, in turn, induces an increase in sheer stress 
within the brachial artery supplying the ischaemic area thereby causing dilatation. This 
physiological response is dependent of the presence of an intact endothelium where 
vasodilators, especially nitric oxide are released in response to the sheer stress. The 
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measurement of flow-mediated dilatation in-vivo has been widely adopted as an 
assessment of endothelial function (349, 379). 
Using the pulse Doppler signal at 60° to the brachial artery, blood flow velocity was 
determined during the resting scan and for the first 15s post cuff deflation. The second 
scan (reactive hyperemia) was taken from 30s before until 180s after cuff deflation. A 
third recovery scan was made 10min after the cuff deflation scan.   
3.4.4 Data Analysis 
An experienced sleep technician blinded to subject status scored PSGs according to 
established sleep stage (10) and 2007 American Academy of Sleep Medicine (AASM) 
ventilatory criteria (11).  All obstructive apnoeas ≥2 respiratory cycles in duration were 
scored even if not associated with cortical arousal or oxygen desaturation.  All other 
respiratory events were scored if ≥2 respiratory cycles in duration and associated with 
a minimum 3% SpO2 desaturation and/or an arousal or awakening within two breaths 
of event termination. Obstructive apnoeas were defined as a >90% reduction in airflow 
associated with continued chest and abdominal wall movement. Obstructive hypopneas 
were defined as a ≥50% reduction in airflow signal associated with paradoxical 
chest/abdominal wall movement or increase in RIP. Central apnoeas were scored if 
there was an absence of respiratory effort, as determined by RIP and diaphragmatic 
EMG, in association with an absence of airflow. Central apnoeas were also scored if 
the event lasted ≥20s. Central hypopneas were defined as a ≥50% reduction in airflow 
from baseline in association with a ≥50% reduction in respiratory effort from baseline. 
Apnoea events that included both central and obstructive components were scored as a 
mixed apnoea. The obstructive apnoea/hypopnea index (OAHI) was calculated as the 
total number of obstructive apnoeas, mixed apnoeas and obstructive hypopneas per 
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hour of total sleep time. The central apnoea/hypopnea index (CAHI) was calculated as 
the total number of central apnoeas and central hypopneas per hour of total sleep time. 
As described by Katz et al. (380),  obstructive apnoea-hypopnea index (OAHI) was 
used to assess SDB severity. 
Spontaneous and respiratory cortical arousals were scored according to the criteria of 
the American Sleep Disorders Task Force (272). Spontaneous arousal index (SAI) 
was expressed as the total number of spontaneous arousals per hour of total sleep time 
and respiratory arousal index (RAI) as the total number of respiratory arousals per 
hour of total sleep time.  
An echocardiographer blind to subject group assessed arterial diameter during the R-
wave of the electrocardiogram using ultrasonic calipers. The mean vessel diameter was 
calculated over four cardiac cycles.  The percentage difference from the resting 
diameter was calculated at 30s post-cuff release and then every subsequent 15s until 
180s. Estimated maximal dilation (FMDmax) was the greatest percentage of dilation in 
the individual’s data set from the resting baseline diameter. The estimated time to 
maximal dilation (FMDtime-to-max) was determined as the time taken to reach FMDmax 
after cuff deflation (350).  
Brachial artery resting diameter (rD), peak systolic velocity (rPSV), velocity time 
integral (rVTi) (the area under the curve value of the mean systolic velocity during 
cardiac ejection time) (365) and heart rate (rHR) were taken during the resting scan. 
Hyperemic VTi, PSV and HR were measured immediately after cuff deflation (hVTi, 
hPSV and hHR, respectively).  The PSV, VTi and HR values were averaged over four 
cardiac cycles. 
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Kolmogorov-Smirnov test was used to assess the normality of data. In the case of 
normally distributed data, group differences were tested using Student t-tests and 
Mann-Whitney U tests for non-normally distributed data. Mean (SD) values are 
reported for normally distributed data and median (interquartile range) for non-
normally distributed data. Pearson-r correlations were used to test the relationship 
between normally distributed data and significance was tested using r-z 
transformations. Spearman-Rho correlations were used to the test the relationship 
between non-normally distributed data.  
3.5 Results 
3.5.1 Anthropometric and Polysomnography 
The SDB and control group were matched on anthropometric measures and had similar 
sleep stage percentages and sleep duration values, but consistent with expectations, 
children with SDB had significantly higher obstructive apnoea hypopnea index (OAHI) 
and lower NREM sleep oxygen saturation levels (Table 1). Sixteen children in the SDB 
group were classified as primary snorers (OAHI < 1) and seven as mild OSA (OAHI < 
5: three children had an OAHI < 2 and three < 3). To test whether SDB severity 
influenced outcome variables we undertook additional analysis separately examining 
children with primary snoring compared to those with mild SDB.  This analysis 
revealed no significant group differences in any variables apart from OAHI. Therefore 
both primary snoring and SDB groups were combined for analyses. All children in the 
control group had an OAHI < 1 and no history of habitual snoring (< 3 nights a week).  
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Table 3.1: Mean (SD) anthropometric and polysomnographic variables together with 
p-values from Student t-test comparisons (median and interquartile range are reported 
in parentheses for non- normally distributed data). 
 




Anthropometric    
Males (%) 57 60 ns (Chi-square) 
Age (years) 8.0 (1.3) 7.5 (1.31) ns 
BMI z-score 0.61 (0.66) 0.59 (0.58) ns 
Height (cm) 128.8 (0.3) 125.7(8.4) ns 
Weight (kg) 28.7 (3.9) 27.2 (4.7) ns 
Waist/Hip Ratio 0.90 (0.04) 0.90 (0.04) ns 
BMI 17.2 (1.3) 17.0 (1.3) ns 
Polysomnographic    
Total Sleep Time (min) 418.4 (31.2) 416.2 (53.1) ns 
NREM 1 (%TST) 2.3 (0.8) 3.4 (2.0) ns 
NREM 2 (%TST) 37.5 (8.0) 46.6 (25.4) ns 
SWS (%TST) 43.2 (8.4) 38.3 (8.3) ns 
REM (%TST) 17.0 (2.6) 17.0 (3.7) ns 
Arousals/h sleep time 11.2 (2.0) 12.6 (3.0) ns 
Spontaneous Arousals/h sleep time 10.6 (2.1) 10.8 (2.5) ns 
Respiratory Arousal/h sleep time 1.00 (0.70) 1.77 (1.67) ns 
Central Apnoea Hypopnea Index 1.47 (0.40) 1.60 (1.20) ns 
Obstructive Apnoea Hypopnea Index 0.17 (0.30) 1.17 (1.50) < 0.05 
Nadir SpO2 (%) 93.1 (0.7) 92.0 (2.5) < 0.01 
REM Nadir SpO2  (%) 93.8 (1.2) 93.7 (2.5) ns 
NREM Nadir SpO2   (%) 94.0 (0.8) 92.4 (2.3) < 0.05 (Mann-Whitney U) 
 (94 (93-95) 93(91-94))  
Average SpO2desat (%TST) 3.00 (0.44) 2.78 (1.48) ns (Mann-Whitney U) 
 (3 (3-3) 3 (2-4))  
  




3.5.2 FMD  
Blood velocity variables were comparable between groups apart from rVTI and hVTi, 
which were significantly higher in children with SDB (Table 3.2). Although no 
significant group difference were observed in FMDmax, the FMDtime-to-max was 
significantly longer in children with SDB (Table 3.2). The mean percentage dilation 
time for the interval FMD30s to FMD75s was similar in both groups, however dilation 
was significantly greater at FMD90s in the SDB group (Figure 3.1).  
 
Table 3.2: Mean (SD) Flow mediated dilatation and blood flow variables together 
with p-values from Student t-test comparisons (median and interquartile range are 
reported in parentheses for non-normally distributed data). 
Variable 
Controls   
(n = 11)  
 Mild SDB 
(n = 23)  
p-value 
Blood flow dynamics   
Resting Diameter (cm) 0.233 (0.020) 0.229 (0.026) ns 
Resting PSV (m/s) 95.8 (9.1) 104.0 (20.8) ns 
Resting VTi (m) 13.9 (3.3) 19.7  (8.0) < 0.01 
Resting HR (b/m) 78.2 (8.8) 89.6 (9.8) ns 
Hyperemic PSV (m/s) 155.6 (12.3) 158.9 (22.5) ns 
Hyperemic VTi (m) 56.0 (6.2) 63.0 (12.9) < 0.05 
Hyperemic Heart Rate (b/min) 82.5 (7.8) 81.7(9.9) ns 
FMDMax (%) 8.2 (4.7) 10.2 (4.8) ns 




< 0.05 (Mann-Whitney U) 
 
 






Figure 3.1:  Mean (SE) temporal FMD response curve for 23 children with mild sleep 
disordered breathing (solid line) and 11 aged matched non-SDB children (dotted line). 
The mean time taken to reach mean maximal dilatation is shown by the corresponding 
circles on the x-axis. Asterisk denotes significant group differences at 90s post cuff 
release. 
 
3.5.3 Correlation Between Polysomnographic and FMD Variables  
A lower SaO2 nadir during NREM sleep was associated with a higher rVTI and hVTi 
(r = -0.58, p < 0.01 and -0.36, p < 0.05; respectively).  As well, a higher hVTi was 
associated with a greater FMDtime-to-max (r = 0.42, p < 0.05).  Also the average of the 
number of oxygen desaturation events (SaO2 ≥ 3% + SaO2 ≥ 4% + SaO2 ≥ 5%) per total 
sleep time was positively correlated with both rVTi (r = 0.34, p <0.05) and FMDtime-to-
max (r = 0.42, p < 0.05). 
 154 
3.6 Discussion 
In this study young children with primary snoring and mild SDB demonstrated altered 
baseline vascular characteristics and FMD responses. They had higher brachial artery 
blood flow velocity both at rest and during hyperemic stress; and the brachial artery 
took approximately twenty seconds longer to fully dilate to maximum size after cuff 
release compared to controls. Lower nadir oxygen saturation during NREM sleep, 
evident in the SDB group, was correlated with increased blood flow velocity both at 
rest and during the hyperaemic FMD response. Children with a higher hyperaemic 
velocity time integral were also more likely to exhibit a delayed maximal dilation 
response.  
The rVTi increase observed in the brachial artery of children with mild SDB is 
consistent with either increased blood viscosity or reduced blood vessel compliance or 
an increased inotropic response (381). The latter two are known to be augmented with 
increased sympathetic activity.  As the resting brachial diameters were similar between 
children with SDB and controls, we hypothesize that the increase in resting blood flow 
velocity may be best explained by increased sympathetic activity and its subsequent 
impact on vascular resistance/compliance and cardiac contractibility. Noradrenaline 
(NA), a potent vasoconstrictor neurotransmitter and inotropic factor released by 
sympathetic nerves, has been shown to be increased in morning samples of plasma, 
urine and serum of both children and adults with SDB (311-313, 382).  As the resting 
VTi was taken on waking, our results may reflect this previously reported increase in 
circulating morning NA levels in children with SDB (reflecting increased sympathetic 
activity). The increase in resting velocity also mirrors the findings of Hill and associates 
who reported increased cerebral blood flow velocity in young children with mild SDB 
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compared to non-SDB children using Transcranial Doppler (147).  Similar 
pathophysiological mechanisms have been reported in other disorders. Increased blood 
flow velocity in both retinal arteries and veins has been observed in patients with 
diabetes mellitus (383) and hypothyroidism (384), both of these disorders are associated 
with cardiovascular dysfunction (385) and changes to peripheral resistance (386, 387).  
It is unclear whether VTi is predictive of cardiovascular disease later in life. However, 
Lee and associates (388) using digital peripheral tonometry (PAT) have shown that a 
higher pulse volume amplitude (PVA) in the fingertip of adult participants is associated 
with a higher resting brachial artery VTi.  Increased PVA as assessed by digital PAT is 
also predictive of cardiovascular disease in adults (389-391). Furthermore, Jarhult and 
associates have shown a significant and positive relationship between both systolic and 
diastolic hyperaemic mean blood flow velocity and ejection fraction in the brachial 
artery, and more importantly, increased mean blood flow velocity was evident in adults 
with ‘concentric left ventricular remodeling’ (392). Both of these independent studies 
in adults suggest that the increase in blood flow velocity measured at the brachial artery 
both at rest and during hyperemia in the present study of snoring children may be 
potentially predictive of cardiovascular remodeling in adult life and merits further 
evaluation.  
Traditionally, studies in FMD report the percentage change in brachial vessel diameter 
from resting baseline to the diameter at 60s post-cuff deflation, with the value at 60s 
typically taken to be the time of maximum dilation. Attenuated FMD responses are 
associated with endothelial damage, atherosclerosis and coronary artery disease (379).  
Two studies in children have shown slightly reduced FMD60S values of approximately 
0.6% in primary snorers (230) and 0.4% reduction in moderate to severe SDB (OAHI 
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> 5/h) compared to controls (229, 230). However at the FMD90s time point our results 
clearly demonstrate that the brachial arteries of children with SDB remains dilated, 
while in healthy children the vessels have started to contract.  The FMDtime-to-max values 
of the children with SDB in the present study are comparable to those previously 
reported by our group in older non-snoring healthy children (378). Gozal et al. (222) 
also reported a time delay in reaching maximal dilation in metacarpal blood flow of 
young children with moderate to severe OSA.  
The present findings support the utility of examining FMD response time longer than 
the recommended 60s (349). Black and associates (2008) note that the majority of true 
maximum dilation occurs outside of these designated post-deflation diameter 
assessments. They advocated that best practice for endothelial function assessment 
requires prolonged continuous assessment of arterial diameter so as to determine the 
true time to peak and maximal dilation response (226).  The present results indicate that 
a single measure at 60s may not be a good guide as to vascular health in children with 
mild SDB.  
During NREM sleep, sympathetic activity decreases and parasympathetic vagal activity 
increases slowing both respiratory and heart rates. Furthermore cutaneous vessels are 
dilated in response to inhibition of the sympathetic efferents reducing vascular 
resistance with resultant reduction in global cerebral blood flow (77). As NREM sleep 
constitutes 75-80% of sleep, and slow wave sleep (SWS) constitutes up to 50% of 
NREM sleep, upper airway obstruction with resultant oxygen desaturation and increase 
in sympathetic tone during this period may have a greater impact on peripheral vascular 
physiology than previously thought. Reduced oxygen concentration activates central 
and peripheral chemo-reflex mechanisms resulting in increased heart rate, respiration 
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and constriction of resistance vessels (393). A greater level of sympathetic neural 
response is likely to be required to constrict vessels that are usually dilated during 
NREM compared to REM sleep where cutaneous vessels are already semi-constricted.   
The finding in this study that children with mild SDB had the capacity to significantly 
lower their oxygen concentrations without arousing, indicated by their reduced nadir 
oxygen saturation compared to non-snoring children suggests attenuated 
chemosensitivity and specifically during NREM sleep. We recognize that the nadir is 
but a single moment and does not fully reflect the extent of the oxygen desaturation 
across the whole night, it does however, indicate a tendency to tolerate lower oxygen 
saturation levels before arousing and maybe a indirect marker of chemoreceptor 
sensitivity. 
The positive association between average SpO2 desaturation (%TST) and both rVTi and 
FMDtime-to-max further suggests that there is an augmented sympathetic response with 
reduced blood vessel compliance secondary to altered chemoreceptor sensitivity. This 
potential increase in sympathetic tone we believe underlies the change in FMD response 
that we have demonstrated in children with mild SDB. We have recently shown 
significant differences in chest wall biomechanics during periods free of scored 
obstructive events in all sleep stages in children with sleep disordered breathing (394). 
Taken together these results suggest that children with SDB may be significantly more 
obstructed than the standard PSG scoring criteria would suggest and may have 
developed attenuated chemoreceptor sensitivity in response, particularly in NREM 
sleep. 
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In conclusion, our results suggest that the brachial vascular response is altered in young 
children with only primary snoring/mild SDB. We propose that this may be explained 
by a sustained increase in sympathetic tone, which alters downstream vascular 
compliance. It will also be important in future studies to examine this relationship in 
children with severe SDB. The unanswered and critical question is whether these 
changes increase cardiovascular morbidity as the child matures through adulthood.  
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Increased aortic blood flow velocity and associated 
inflammatory response in children with primary 




Changes in ventricular thickness and cardiac function have been demonstrated in 
children with severe SDB, however there are no studies comparing children with 
primary snoring and healthy aged matched controls for cardiac structure and function 
using MRI. TNFα and IFNγ are markers known to be increased in children and adult 
with SDB and are also increased in cardiovascular disease. Hence, the purpose of this 
study was to examine the relationship between cardiovascular measures derived from 
cardiac MRI data and known markers of inflammation that are evident in cardiovascular 
disease. In addition this study looks at the relationship between PSG derived measures 
associated with SDB including OAHI, SaO2 nadir and also the parental questionnaire, 
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4.1 Abstract  
Study Objectives: In children, sleep disordered breathing (SDB) results in a 
generalised inflammatory response and also adversely affects endothelial function of 
small and medium sized vessels. It remains to be established whether major blood 
vessels are similarly affected. 
Methods and Results: Seven controls and twelve children with mild SDB (aged 5-
14y) underwent overnight polysomnography, cardiac magnetic resonance imaging 
(cMRI) and intracellular cytokine analysis of T-cells by flow cytometry. Children with 
mild SDB exhibited increased ascending aortic peak systolic velocity and an increased 
percentage of T-cells producing interferon gamma (IFNγ) and tumor necrosis factor 
alpha (TNFα) producing CD8+ cells. The increased ascending aorta peak blood flow 
velocity was positively correlated with the increased CD8+ cells TNFα and IFNγ 
productivity, and negatively with the oxygen saturation (SpO2) nadir. 
Conclusion: Children with mild SDB demonstrated increased ascending aortic peak 
systolic velocity which correlated with an increase in the proportion of CD8+ TNFα 
and IFNγ expressing cells compared to non-snoring children. The data suggests that 
mild SDB alters vascular function and the inflammatory response. 
Keywords: sleep disordered breathing, inflammation, arterial, velocity, children 
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4.2 Introduction 
Sleep disordered breathing (SDB) varies in severity from primary snoring to obstructive 
sleep apnoea syndrome (OSA) and is estimated to affect up to a quarter of all children. 
(84)  At the severe end of the spectrum it adversely affects cardiovascular health 
resulting in pulmonary and systemic hypertension, left and right ventricular dysfunction 
and cor pulmonale (201, 203). In adults, the mechanisms proposed to explain the 
association between SDB and cardiac morbidity, endothelial dysfunction and arterial 
disease include intermittent hypoxia leading to increased oxidative stress, systemic 
inflammation and increased sympathetic activity and, furthermore, arousal induced up-
regulation of the sympathetic nervous system (370).Similar mechanisms are likely to 
be involved in children particularly in the moderate to severe range of SDB. More 
recent evidence suggests that vascular changes are also present in children at the mild 
end of the SB spectrum with reported increases in daytime systemic blood pressure and 
reduced peripheral arterial distensibility (148, 334). In addition, children with mild 
SDB are reported to have increased cerebral blood flow velocity and increased brachial 
artery blood flow velocity both at rest and during the hyperaemic phase of flow 
mediated dilatation (147, 395). In the latter study significant hypoxia was absent 
suggesting that arousal induced up-regulation of the sympathetic nervous system is the 
more likely explanation for these reported vascular changes in small to medium vessels. 
Whether the compliance and function of major vessels such as the aorta are similarly 
impacted in children with primary snoring/mild SDB is unknown. In a recent study in 
adult mice, Carreras et al. (2014) found that sleep fragmentation without hypoxia 
resulted in the disorganization of elastic fibres in the aortic wall suggesting reduced 
vessel compliance, and an increase in the number of macrophages and foam cells in the 
aortic wall suggesting up-regulation of inflammatory pathways (296).  
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Inflammation also occurs in conjunction with cardiovascular disease in adults with 
SDB (396, 397). Increased inflammatory cytokine expression has also been reported in 
children with SDB (331) and evidence of alterations occurring in both vascular and 
inflammatory responses have been observed in smaller blood vessels. For example, 
Kheirandish-Gozal et al., (2014) reported in children with severe SDB that 
inflammatory up-regulation was associated with a delayed post-occlusion hyperaemic 
response in the microvasculature of the hand (345). Whether inflammatory up-
regulation is associated with changes to endothelial function of larger vessels such as 
the aorta and, moreover, in children with primary snoring/mild SDB has yet to be 
established.  
We hypothesise that children with primary snoring/mild SDB will demonstrate reduced 
aortic wall compliance which will be associated with evidence of increased 
inflammatory response.  
4.3 Material and Methods 
4.3.1 Participants 
Twelve children aged 5 to 14 years referred to the Ears, Nose and Throat (ENT) 
Department of Women’s and Children’s Hospital, Adelaide, Australia for evaluation of 
SDB and who were subsequently scheduled for adenotonsillectomy, were invited to 
participate in this study. All child snored in excess of three times per week. Seven 
healthy age and body mass index (BMI) matched children from the community who on 
parental report did not snore or rarely snored were recruited as controls.  Exclusion 
criteria included significant craniofacial abnormalities, current use of medications 
known to affect sleep or respiration, developmental/psychiatric disorders, 
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contraindications to cardiac Magnetic Resonance Imagining (cMRI)  (e.g. internal 
metal object or claustrophobia) and inability to give informed consent.  
This study was approved by the Human Research Ethics Committees of the Women’s 
and Children’s Hospital, the Royal Adelaide Hospital, and the University of Adelaide, 
Australia. 
4.3.2 Apparatus 
4.3.2.1 Sleep Disturbance Scale for Children, 
The Sleep Disturbance Scale for Children (SDSC) was used to assess sleep in the prior 
six months (161). The SDSC contains 26 items and generates six subscales (Disorders 
of Sleep Breathing, Initiating and Maintaining Sleep, Disorders of Arousal, Sleep-
Wake Transition, Excessive Daytime Somnolence and Sleep Hyperhydrosis) and a 
composite Total Sleep Problem score.  The SDSC is reported to have good test-retest 
reliability and construct validity (160). 
4.3.2.2 Polysomnography 
A polysomnogram (PSG) was performed under infrared camera supervision by a sleep 
technician, who also documented sleep behaviour (165).  The following montage was 
employed: electroencephalogram (EEG; C4-A1, C3-A2 and F3-A2 F4-A1 and O2-A1), 
electrocardiogram (ECG), electrooculogram, sub-mental and diaphragmatic and leg 
electromyogram (EMG), nasal pressure and oronasal flow by thermistor, respiratory 
movements of the chest and abdominal wall using uncalibrated respiratory inductive 
plethysmography (RIP). The data were collected using the Compumedics E-Series 
Sleep System (Melbourne, Australia). Oxygen saturation was monitored by pulse 
oximetry (Nellcor N-595). A sleep technician blinded to the subject’s condition scored 
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the studies based on a standard sleep stage (398) and paediatric ventilatory criteria (11). 
The severity of SDB was determined using obstructive apnoea hypopnoea index 
(OAHI) (380) (11).   
4.3.2.3 Cardiac and Arterial Function Analysis 
A Siemens Sonata 1.5 Tesla MRI scanner (Siemens Medical Solutions, Erlangen, 
Germany) equipped with a phase array coil was used to acquire cMRI images. Long 
axis reference imaging was used to position 8 to 12 short axis imaging slices (Figure 
1A). Images were acquired by a trained technician during 8-10 breath-holds, with 
prospective ECG-gated steady state free precision (SSFP) sequences. Qmass MR 
version 7.2 (Medis, Leiden, The Netherlands) was used to calculate the ejection fraction 
(EF). The arterial flow at the ascending aorta and pulmonary artery was determined by 
Argus software (Siemens Medical Solutions, Erlangen, Germany). 
Based on the methodology described by Teo et al. (399), left ventricular ejection 
fraction (LVEF) was derived using manual traces of endocardial and epicardial 
contours from short axis images (Figure 1B) at the end diastolic and systolic.  Due to 
inconsistencies in image acquisition, ejection fraction analysis was only available on 
15 subjects (SDB = 10, control = 5). 
To obtain measures of arterial blood flow velocity, phase contrast images consisting of 
phase and velocity encoded cine cross sectional images of the artery were recorded 
throughout the cardiac cycle (Figures 1A and B). Regions of interest (ROI) were then 
traced on phase encoded cross sectional images containing the artery of interest (Figure 
1C). The ROI trace (in the phase encoded image) were then reflected on the velocity-
encoded image to determine blood flow velocity, direction and volume (Figure 1D).  
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4.3.2.4 Leucocyte Stimulation  
Blood aliquots in lithium heparin of 1ml volumes were diluted 1:2 with RPMI 1640 
medium (Gibco, NY,USA) supplemented with 125 U/ml penicillin and 125 U/ml 
streptomycin (Gibco) in 10 ml sterile conical PVC tubes (Johns Professional Product, 
Sydney, Australia) Phorbol myristate (25 ng/ml) (Sigma, Sydney, Australia) and 
ionomycin (1 μg/ml) (Sigma, Sydney, Australia) were added for T-cell cytokine 
stimulation (400). Brefeldin A (Sigma, Sydney, Australia) (10 μg/ml) was added as a 
‘Golgi block’ and the tubes re-incubated in a humidified 5% CO2/95% air atmosphere 
at 37°C. 
4.3.2.5 Cytokine determination  
Cytokine determination was conducted on 250μL of blood sample following leucocyte 
stimulation. (400) 100μL 20mM EDTA/PBS was added to one of the whole blood 
culture tubes, which was vortexed vigorously for 20 seconds to remove adherent T-
cells. To lyse red blood cells, 2mL of FACSlyse solution (BD, Biosciences, Sydney, 
Australia) was added and tubes incubated for 10 minutes at room temperature in the 
dark. After centrifugation at 500xg for 5 minutes and decanting, 0.5ml 1:10 diluted 
FACSPerm (BD, Biosciences, Sydney, Australia) was added to each tube, mixed and 
incubated a further 10min at room temperature in the dark. Two ml 0.5% bovine serum 
albumin (Sigma, Sydney, Australia) in Isoton II (Beckman Coulter, Sydney, Australia) 
was then added and the tubes centrifuged at 300xg for 5min. After decanting 
supernatant, Fc receptors were blocked with 10μL human immunoglobin (Intragam, 
CSL, Parkville, Australia) for 10 min in at room temperature. Five μL of appropriately 
diluted anti-CD8 and anti-CD3 PC5 (Beckman Coulter, Sydney, Australia) PE-
conjugate anti-cytokine monoclonal antibodies to IFNγ and TNFα (BD) or isotype 
control monoclonal antibody (BD) was added for 15min in the dark at room 
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temperature. Two ml of 0.5% bovine serum albumin was then added and the tubes 
centrifuged at 300xg for 5min. After decanting, cells were analysed within 1h on a 
FACS Calibur flow cytometer using CellQuest software (BD, Biosciences, Sydney, 
Australia). Samples were analysed by live gating using FL3 staining versus side scatter 
(SSC). A minimum of 10,000 CD3 positive, low SSC events were acquired in list-mode 
format for analysis. Control staining of cells with anti-mouse IgGi-PE/IgG-PC5 was 
performed on each sample and background readings of < 2% were obtained. 
Unstimulated and unstained cells were also used to determine quadrant marker settings.  
Examples of the gating strategy and dot plots are shown in Figure 4.2A and B. Cytokine 
expression for IL2, IL4, IL6, IL8, IL10, IL12 and TGFβ were also determined. 
4.3.3 Protocol 
The SDSC and additional questions were completed by parents at screening. The 
overnight polysomnogram (PSG) was performed in a hospital sleep unit with fasting 
blood samples collected in the morning for inflammatory cytokines. The cMRI was 
completed within a week of PSG.  
4.3.4 Data Analysis 
Data were analysed using SPSS (IBM SPSS Statistics for Windows, Version 21.0. 
Armonk, NY), and GraphPad Prism version 5.00 (GraphPad Software, San Diego, 
USA). Unpaired Student’s t-test (two tailed, 95% confidence interval) were used to 
determine group differences in continuous variables and Fisher’s exact test for 
categorical variables. BMI values were adjusted for age and gender 
(https://www.bcm.edu/cnrc-apps/bodycomp/bmiz2.html). All data are represented as 
mean (SD) with a p-value < 0.05 considered statistically significant.  
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The relationship between SDB severity (PSG and SDSC) and cMRI variables were 
tested using Pearson-r correlations and significance was tested using r-z 
transformations. We restricted the correlational analyses to those SDB and cMRI 
variables, which were significantly different between children with SDB and controls. 
Pearson-r correlation was used as we anticipated an association between inflammatory 
up-regulation and aortic function. As previously, we also restricted the correlational 
analyses to those inflammatory and cMRI variables, which were significantly different 
between children with SDB and controls. 
4.4 Results  
4.4.1 Demographics, SDSC and PSG 
No significant group differences were observed in demographic values between 
children with SDB and controls (Table 4.1). However, as expected children with SDB 
on recruitment had a significantly higher frequency of snoring on parental report. No 
significant group differences were observed in PSG variables apart for the SpO2 nadir 
which was significantly lower in the children with SDB (Table 4.1). All SDSC scores 
were elevated in children with SDB with scores for Disorders of Sleep Breathing, 
Initiating and Maintaining Sleep and Excessive Somnolence and Total Sleep Problem 
reaching significance (Table 4.1).  
4.4.2 Cardiac and Arterial Function 
No significant group differences were observed with respect to both left and right 
ventricular function. However, the peak ascending aortic blood flow velocity was 
significantly higher (120%) in children with SDB compared to controls (Table 4.2).   
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4.3.3 Inflammatory Markers 
Children with SDB had significantly higher percentage of CD8+ T-cell expressing 
TNFα and IFNγ compared to controls but no increase in the percentage of CD4+ T-cell 
expressing TNFα and IFNγ values (Table 4.3). There were no significant differences in 
expression of IL2, IL4, IL6, IL8, IL10, IL12 and TGFβ between groups.  
4.3.4 Correlational Results 
Examination of correlational values with a magnitude r > 0.30 revealed that a higher 
ascending aortic peak blood flow velocity was associated with a higher percentage of 
CD8+ T-cells producing TNFα, IFNγ, Disorders of Initiating and Maintaining Sleep 
and Total Sleep problem score and a lower SpO2 nadir (Table 4.4, Figure 4.3). A higher 
percentage of CD8+ T-cells expressing TNFα value was associated with a higher 
percentage of CD8+ T-cells expressing IFNγ, Disorders of Initiating and Maintaining 
Sleep and Total Sleep Problem score. Higher CD8+ T-cell IFNγ values were associated 
with higher Disorders of Initiating and Maintaining Sleep and Total Sleep Problem 
score but a lower SpO2 nadir. A lower SpO2 nadir was associated with higher Sleep 
Breathing Disorder, Disorders of Initiating and Maintaining Sleep and Total Sleep 
Problem score (Table 4.4).   
As expected there was a moderate but significant correlation between ascending aorta 
average blood flow per min and BMI (r = 0.53, p < 0.05) and BMI z-score (r = 0.49, p 
< 0.05). Also, pulmonary peak and mean velocity were both positively correlated to 
BMI and BMI z-score (r = 0.51, p < 0.05), (r = 0.56, p < 0.05), respectively.  
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4.4 Discussion 
In children with primary snoring/mild SDB compared to non-snoring controls we 
observed alterations in cardiovascular function and inflammatory response. In 
particular, peak systolic blood flow velocity in the ascending aorta was significantly 
higher as were both the percentage of CD8+ T-cell lymphocytes producing TNFα and 
IFNγ. Moreover these variables were inter-related with increased ascending aortic peak 
systolic blood flow velocity being associated with a higher percentage of CD8+ T-cell 
lymphocytes producing TNFα and IFNγ values but not CD4+ T-cells lymphocytes.  
The present findings of increased blood flow velocity in the ascending aorta are 
consistent with those reported by Hill et al. (2006) who reported increased blood flow 
velocity in the middle cerebral artery (147) and previous findings by our group (395) 
demonstrating increased resting blood flow velocity in the brachial artery in children 
with primary snoring/mild SDB. In adults, increased brachial artery blood flow velocity 
has been associated with left ventricular hypertrophy and coronary heart disease (392) 
while increased blood flow parameters, including systolic velocity are considered the 
most powerful promoters of vascular remodelling (235). Nonetheless, in support of the 
hypothesis of reduced compliance as an explanation for the increased peak systolic 
blood flow velocity in the ascending aorta, evidence of reduced vessel wall compliance, 
measured as a delay in dilation response, have been reported in the brachial artery and 
metacarpal vessels in children with mild and severe SDB, respectively (395) (222). In 
the latter study, the delay in dilation response in the brachial artery was positively 
associated with increased blood flow velocity both at rest and during hyperaemia.   Of 
note we did not find a significant difference in measures of left and right ventricular 
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function, which have been reported in children with severe SDB in some (192, 194) but 
not all studies (196). 
The mechanism underlying increased ascending aortic peak systolic velocity is likely 
to be explained by increased periodic sympathetic activation, and its vasoconstrictive 
effect in the peripheral vessels. The vasoconstriction increases peripheral resistance, 
causing the central redistribution of blood into the major vessels, organs and muscle 
and increases shear stress on the endothelial cells, particularly on the peripheral and 
minor vessels, (401).  Periodic changes to shear stress throughout sleep, via the 
activation of vascular sympathetic nerves, promotes vascular remodelling and pro-
inflammatory signalling (402). Sympathetic over activity has been well documented in 
both adults and children with SDB (28, 307).  The increased sympathetic activation can 
be attributed to either sleep fragmentation or hypoxia, with the former most likely to be 
the explanation in children with primary snoring/mild SDB such as those in the present 
study. This is consistent with the findings by Carreras et al (296) in adult mice without 
infection or nocturnal hypoxia where sleep fragmentation was associated with 
increased sympathetic activity, disruption of elastic fibres in the aortic wall, and an 
increase in the number of foam cells and macrophages in the aorta wall. We suspect 
that the increase in sympathetic activity over time, given that children may snore for 
years, may result in substantial vascular changes, increasing the elastic resistance of the 
aorta. The elastic properties of the aorta allow it to act as a buffering chamber, absorbing 
50% of left ventricular stroke volume during systole (233). Increased aortic stiffness 
results in greater systolic blood pressure and reduced blood diastolic pressure, increased 
systolic blood flow velocity and left ventricular afterload (233). The potential long-
term effects of such changes in the maturing childhood vasculature, even if mild, is all 
unknown.  
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Reduced vessel wall compliance and the associated increase in blood flow velocity 
increases shear stress on vascular endothelial cells which results in endothelial cell 
activation and  up-regulation of adhesion molecules and chemoattractants for 
circulation leucocytes, leading to systemic inflammation (403). Altered endothelial 
cells and up-regulated inflammatory pathways are reported in adults with SDB (228) 
and emerging evidence suggests that inflammatory markers are also up-regulated in 
children with severe SDB (332, 338, 404). The potential impact of these inflammatory 
changes in the genesis of early atherosclerosis is unknown but given there is evidence 
of early atherosclerotic plaque formation reported in seminal studies of the coronary 
arteries of both children and young adults (405) the impact of chronic childhood SDB 
(which is often underdiagnosed) on cardiovascular health and the inflammatory process 
merits further evaluation..  
We found that the percentage of CD8+ T-cell lymphocytes expressing both TNFα and 
IFNγ but not CD4+ T-cell lymphocytes were elevated in children with primary 
snoring/mild SDB. Increased TNFα has been demonstrated in both children and adults 
with OSA, while IFNγ has been shown to be increased in children with OSA compared 
to healthy controls (331). TNFα and particularly IFNγ play an important role in host 
defense against infection as well as adaptive immune response (406).  IFNγ may also 
play a role in cardiac remodeling, while IFNγ and TNFα are important signals required 
for macrophage activation and may be involved in macrophage foam formation in 
atherosclerosis (407).  The strong positive correlation we observed between the 
inflammatory markers TNFα and IFNγ and the ascending aorta peak velocity, suggests 
that even primary snoring/mild SDB in young children may exacerbate the 
inflammatory response and alter vascular function simultaneously.  Children with 
elevated TNFα and IFNγ values also had a greater number of sleep problems on parental 
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report and especially problems with initiating and maintaining sleep, further potentially 
supporting the role of sleep fragmentation in up-regulating inflammatory pathways.  
Increased fluid shear stress (blood flow velocity) promotes arteriogenesis and the 
increase in the formation of conducting vessels, (collateral arterioles) (408). The 
processes in collateral formation is complex requiring coordinated proliferation of the 
different vascular cell types including the endothelial cells, smooth muscle cells, 
fibroblasts, and myofibroblast, mediated in response to the increase in shear stress. Part 
of this process also requires the activation of CD8+ T-cells, whether the increased 
number of CD8+ T-cells expressing IFNγ and TNFα is part of this process is yet to be 
determined. However, the correlation between the ascending aorta systolic blood flow 
velocity and increase in the number of activated CD8+ T-cells maybe evidence of this 
adaptive mechanisms of collateral formation. 
More recently, Kheirandish-Gozal et al., demonstrated that children with delayed 
hyperemic dilation response and OSA, were more likely to exhibit reduced CD14+ 
monocytes and increased CD16+ cells and hence reduced CD14:CD16 (ratio). In 
addition they found that CD16+ cells expressed higher levels of the chemokine, 
Fractalkine (CX3CL1) monocytes, which induces chemotaxis in monocytes in children 
with the delayed dilatation response (192, 345). Also noted was a strong inverse 
correlation between the CD14:CD16 and the time to maximal dilation during the 
hyperemia test (Tmax). What is interesting is that  in vitro studies using isolated 
peripheral blood monocytes incubated with activated CD8+ cells (409) or monocytes 
and macrophages exposed to high concentrations of IFNγ (410) show down-regulation 
of soluble CD14, highlight the interrelationship between these cell types and particular 
cytokine expression and possible vascular irregularities. Our data complements this 
previous work by Kheirandish-Gozal et al., and collectively suggests systemic vascular 
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irregularities both in minor and major vessels and an emerging pattern of inflammatory 
response that maybe central to SDB in children. 
 
The increase in the percentage of cells expressing IFNγ was specific to CD8+ T-cells 
and not CD4+ T-cells. This may arise because of the effector function acquisition in 
these cell types require different processes. For example CD4+ undergo a complex 
process to produce IFNγ requiring specific interaction with other cytokines with cell-
signaling proteins, transcription factors and hence chromatin remodeling (411). As well 
CD4+ cell differentiation requires IL12 production from antigen-presenting cells in 
response to Toll-like receptor stimulation with signaling and transcription factors 
including signal transducer and activator of transcription 4 (STAT4) and T-bet (the 
main transcription factor required for T helper cell differentiation) to induce a 
functional T helper 1 response for them to produce IFNγ. CD8+ T-cells require only 
short-term primary stimulation to readily develop into effector cells that express IFNγ. 
T-bet, IL12 and IL4 have been shown to have little effect on the generation of IFNγ 
from CD8+ T-cells. Also the stimulus required to activate differentiation has been 
shown to produce different profile for different stimuli in naïve CD4+ and CD8+ T-
cells.  Mice exposed to lymphocytic choriomeningitis virus (LCMV) (412), Sendau 
(413) and vaccinia (414) show increased number of CD8+ T-cells producing IFNγ 
compared to CD4+ IFNγ producing T-cells.  In humans, Epstein-Barr virus exposure 
also results in an increase in CD8+ IFNγ producing T-cells compared to CD4+ T-cells 
(415). One possible reason for the difference other than the required substrate specific 
pathway processes previously mention, is the differences in replication between the two 
naïve cells types. CD8+ T-cells have a faster rate of cell division than CD4+, (411) with 
CD8+ T-cells replicate approximately 15 times within the first week of LCMV exposure 
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(412) hence the type of stimulus may alter the cell proliferation rate and cause the 
imbalance.   
In the present study SpO2 nadir was associated with increased ascending aortic peak 
systolic velocity. This is consistent with earlier findings by our group that SpO2 nadir 
was associated with increased blood flow velocity in the brachial artery (Kontos et al., 
2015) and supports the idea that blunted chemosensitivity, independent of OAHI values 
is associated with cardiovascular changes.  
4.4.1 Limitation 
A limitation of the present study was the technical requirement of undertaking a cMRI 
and blood tests in young children. Despite this limitation we obtained sufficient number 
of age and body mass matched children with a history of snoring and non-snoring 
controls. Also, this study looked at the percentage of cells that produced a particular 
cytokine, we recognise that it would have also been beneficial to have recorded 
concentration levels, however as previously mentioned, other studies have shown 
increased concentration of both TNFα and IFNγ in children with SDB.  Previous studies 
have measured cytokine levels in children with SDB using ELISA quantification from 
serum and rtPCR of cytokine mRNA levels.  These techniques have their limitations 
and in particular, do not indicate which cell types produce which cytokine. This study 
is novel as it uses flow cytometry to assess intracellular pro and anti-inflammatory T-
cytokines from different T-cell types (400, 416, 417). This is important as cell specific 
cytokine production is becoming more evident in profiling different disorders (411).   
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4.4.2 Conclusion 
In conclusion, although the pathophysiology of the development of cardiovascular 
sequelae in SDB is not as yet clearly defined, the balance of current evidence suggests 
that SDB affects multiple physiological pathways that are interdependent (145). The 
consensus in the literature is that the major pathways involved include the autonomic 
nervous system, in particular the sympathetic branch and inflammatory and metabolic 
pathways (lipid and insulin) (418). The results of this current study add to the growing 
evidence that these same pathways are affected in children with even the least severe 
form of SDB, i.e. primary snoring/mild SDB. 
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Table 4.1: Mean (SD) Demographics, Polysomnographic and Sleep Disturbance Scale 
for Children scores and p-values from t-test results. 
 
Variable Controls  (n=7)  SDB (n=12)  p-value 
Anthropometric    
Males (%) 3:4 5:7 ns (Fisher exact analysis) 
Age (M:F) 10.3 ± 2.4 9.3 ± 3.0 ns 
Height (cm) 139.8 ± 14.5 135.8 ± 18.0 ns 
Weight (kg) 35.7 ± 12.6 37.9 ± 14.4 ns 
BMI 17.8 ± 2.6 19.6 ±5.3 ns 
BMI Z-score 0.1 ± 0.6 0.7 ± 0.9 ns 
Snoring severity1 1.3 ± 0.5 3.8 ± 1.0 < 0.001 
Polysomnographic    
Total Sleep Time (min) 448.4 ± 29.9 433.3 ± 34.0 ns 
Non Rapid Eye Movement Sleep (%TST) 81.4 ± 4.0 81.6 ± 3.1 ns 
Slow Wave Sleep (%TST) 36.1 ± 6.2 37.2 ± 9.5 ns 
Rapid Eye Movement Sleep (%TST) 18.6 ± 4.0 18.4 ± 3.1 ns 
Arousals n/h 10.1 ± 3.05 12.5 ± 4.5 ns 
Spontaneous Arousals n/h 9.0 ± 2.4 11.3 ± 4.2 ns 
Respiratory Arousal n/h 0.9 ± 0.6 1.0 ± 1.3 ns 
Obstructive Apnoea Hypopnea Index 0.3 ± 0.3 0.6 ± 1.5 ns 
Nadir SpO2 (%) 94.4 ± 1.6 92.3 ± 2.7 < 0.05 
REM Nadir SpO2 (%) 93.6 ± 2.1 93.6 ± 3.0 ns 
NREM Nadir SpO2 (%) 93.6 ± 1.1 92.7 ± 1.9 ns  
Average SaO2desat (%TST) 2.6 ± 1.1 2.9 ± 1.1 ns  
Sleep Disturbance Scale for Children    
Total Sleep Problem Score 37.0 ± 4.1 54.3 ± 10.3 < 0.005 
    Disorders of Initiating and Maintaining Sleep 12.2 ± 1.8 18.5 ± 4.2 < 0.005 
    Sleep Disordered Breathing 3.3 ± 0.5 7.2 ± 2.5 < 0.001 
    Disorders of Arousal 3.2 ± 0.5 3.9 ± 1.0 ns (< 0.09) 
    Disorders of Sleep-Wake Transition 12.2 ± 1.8 18.5 ± 4.2 ns (< 0.08) 
    Disorders of Excessive Somnolence 6.9 ± 1.1 10.7 ± 2.8 < 0.01 
    Sleep Hyperhydrosis  2.3 ± 0.5 4.0 ± 2.7 ns (< 0.06) 
 NB: ns denotes non-significant. 1Five point scales with 1 =  Never to 5 = Always 
(daily). 
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Table 4.2: Mean (SD) cardiac and arterial function values together with results from t-
test analyses. 
  
Parameter Control  SDB p-value 
 (n = 7) (n = 12)  
Systolic Blood Pressure (mmHg)  107.4 ± 9.8 113.2 ± 17.0 ns 
Diastolic Blood Pressure (mmHg) 69.1 ± 6.9 70.6 ± 8.7 ns 
Ascending Aortic Peak Blood Flow Velocity (cm/sec) 101.5 ± 16.3 120.0 ± 18.0 < 0.05 
Ascending Aortic Mean Blood Flow Velocity (cm/sec) 24.43 ± 3.9 22.7 ± 3.6 ns 
Ascending Aortic Mean Blood Flow (l/min) 5.0 ± 1.5 4.75 ± 1.2 ns 
Pulmonary Artery Peak Blood Flow Velocity (cm/sec) 76.5 ± 17.6 84.2 ± 7.4 ns 
Pulmonary Artery Mean Blood Flow Velocity (cm/sec) 22.9 ± 6.3 21.3 ± 4.2 ns 
 (n = 5) (n = 10)  
Left Ventricular Ejection Fraction (%) 67.1 ± 4.4 64.9 ± 8.7 ns 
Left Ventricular End Diastolic Volume (ml) 69.9 ± 14.2 61.1 ± 18.2 ns 
Left Ventricular End Systolic Volume (ml) 22.7 ± 4.4 23.4 ± 6.2 ns 
Left Ventricular Mass (g) 46.9 ± 4.2 47.0 ± 7.6 ns 
Right Ventricular Ejection Fraction (%) 67.1 ± 4.4 63.4 ± 10.1 ns 
Right Ventricular End Diastolic Volume (ml) 70.0 ± 14.2 43.6 ± 6.1 ns 
Right Ventricular End Systolic Volume (ml) 47.1 ± 11.6 23.4 ± 6.2 ns 
Right Ventricular Mass (g) 46.9 ± 4.2 44.6 ± 6.6 ns 
NB: ns denotes non-significant 
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Table 4.3: Mean (SD) Inflammatory marker values and p-values from t-test results. 
 
Inflammatory Markers Controls (n = 7) SDB (n = 11) p - values 
CD8+ T-cell IFNγ (% of cells) 23 ± 10 42 ± 18 < 0.05 
CD8+ T-cell TNFα (% of cells) 20 ± 8 32± 12 < 0.05 
CD4+ T-cell IFNγ (% of cells) 22 ± 6 26.2 ± 5 ns 
CD4+ T-cell TNFα (% of cells) 32.9 ± 12 36.7 ± 8 ns 





Table 4.4:  Correlations between, cardiovascular, inflammatory markers and Sleep 


















CD8+ T-cell IFNγ  0.63***  0.84*** -  -0.32 
Nadir SpO2  -0.48* -0.05 -0.32 - 
SDSC: Sleep Disordered Breathing  0.14  0.15  0.26 -0.53** 
SDSC: Disorders of Initiating and Maintaining Sleep  0.31  0.55**  0.52** -0.35 



























Figure 4.1: A) Representative long axis view (sagittal plane) in systole. RV and LV 
indicates right and left ventricle respectively whilst yellow lines illustrates cross 
sectional imaging slices acquired on the transverse plane. Red line indicates imaging 
slice of interest. B) Slice of interest depicted in short axis view. Green and red line 
illustrates left ventricular epicardial and endocardial contours respectively. Yellow line 
indicates right ventricular endocardial contour tracing. C) Phase encoded single image 
of the ascending aorta taken from a series of images acquired during the cardiac cycle. 
Yellow circle illustrates region of interest (ROI). PA indicates pulmonary artery. D) 
Velocity encoded image of the specific phase encoded image shown in Figure 1C. The 
respective ROI traced on the ascending aorta on the phase-encoded image was reflected 
on the velocity-encoded image seen here.  
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Figure 4.2: A) Representative dot plot showing CD3+ T-cell gating strategy. T-cells 
were identified as CD3PC5 positive low side scatter (SSC) events. B) Representative 
dot plots of CD3+ T-cells staining with CD8 FITC and intracellular cytokine IFNγ of 
a patient with SDB and control subject. There was an increase in CD8+ T-cells 








Figure 4.3: Scatterplots of the relationship between ascending aortic peak velocity measured 
using cMRI, and IFNγ (A) TNFα (B) expression from CD8+ T-cells using flow cytometry and 












This chapter looks at the relationship between the changes in blood flow velocity 
measured at the brachial artery using ultrasound Doppler and autonomic function 
measured using pupillary light reflex (digital pupillometry) and also endothelial 
integrity using platelet aggregation (whole blood impedance aggregation). In addition 
it compares the above parameters to sympathetic nerve fibre density (SNFD) of the 
dorsal lingual artery (confocal imaging, tyrosine hydroxylase antibody 
immunofluorescence staining) removed from the tonsillar tissue of children with SDB 
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Background: Sleep disordered breathing (SDB) in children is associated with 
increased blood flow velocity and sympathetic overactivity. Sympathetic overactivity 
results in peripheral vasoconstriction and reduced systemic vascular compliance which 
increases blood flow velocity during systole. Augmented blood flow velocity is 
recognised to promote vascular remodeling. More importantly, increased vascular 
sympathetic nerve fibre density and innervation in early life plays a key role in the 
development of early onset hypertension. As yet whether these functional changes 
which include increased sympathetic activity, reduced vascular compliance and 
increase blood flow velocity are associated with changes to vascular structure in 
children are unknown.  This can be addressed by an examination of the vasculature of 
the tonsillar tissue in children undergoing adenotonsillectomy for treatment of SDB. 
Methods: Thirteen children (6.3 – 17.3 years; 6 males, 7 females) scheduled for 
adenotonsillectomy to treat SDB, underwent, pupillometry, polysomnography, flow-
mediated dilation (FMD) (including resting brachial artery blood flow velocity (VTI)) 
and platelet aggregation studies. The dorsal lingual artery of the tonsil was dissected 
and stained for tyrosine hydroxylase using immunofluorescence techniques to identify 
sympathetic nerve fibres.  The arterial sympathetic nerve density (SNFD) was 
determined using a ratio algorithm from confocal images.   
Results:  Children with increased SNFD had increased vascular resistance in the 
brachial artery and higher sympathetic tone on pupillometry. SNFD was correlated with 
increased resting VTI (r = 0.63, p < 0.05) and a lower Neuronal Pupillary IndexTM (r = 
- 0.71, p <0.01), a smaller percentage change in pupillary diameter from baseline (r = - 
0.70, p < 0.05), a slower mean and peak pupillary constriction velocity (Mean: r = - 
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0.64, p < 0.05; Peak r = - 0.63, p < 0.05). A faster resting VTi was associated with a 
slower peak pupillary constriction velocity (r = - 0.77, p < 0.01) and higher platelet 
aggregation to collagen antigen (r = 0.64, p < 0.05). A slower mean and peak pupillary 
constriction velocity were associated with higher platelet aggregation scores (r = - 0.60, 
p < 0.05; r = - 0.77, p < 0.01, respectively).   
Conclusion: These results indicate that sympathetic overactivity is associated with 
changes in both the function (FMD and platelet aggregation) and structure (dorsal 




In adults, sympathetic tone is an important factor in vascular health with increased tone 
adversely affecting vascular function and leading over time to hypertension and 
vascular remodelling (419).  Increased sympathetic tone is also a feature of several 
disorders (420, 421) including sleep disordered breathing (SDB) (306, 309, 422). SDB 
affects an estimated 10% of children, but is often underdiagnosed and is associated with 
hypertension which is thought to reflect the effect of a persistent increase in 
sympathetic tone (203). In adults with SDB there is evidence that the effects of the 
sympathetic overactivity on blood vessels is systemic (185).  Our group and others have 
postulated that some children with SDB also develop systemic changes in vascular 
compliance, which arise in direct response to increased sympathetic activity (307, 395). 
In SDB, partial or total collapse of the upper airway leads to increased respiratory effort, 
intra-thoracic pressure swings, intermittent hypoxia, sleep fragmentation and increased 
arousals (145). These factors lead to sympathetic over-activation with the release of 
noradrenaline from vascular sympathetic nerve fibre terminals and a consequent 
increase in heart rate, inotropy and peripheral vasoconstriction (423).  In turn, the 
reduced vascular compliance and concomitant increase in total peripheral resistance 
(401) leads to an increase in blood flow velocity during systole and, thereby, also 
increases luminal shear stress (254, 357, 424, 425). A persistent increase in shear stress 
damages the vascular endothelial cells surrounding the lumen and increases platelet 
aggregation (426). Sympathetic overactivation is also known to promote vascular cell 
proliferation (smooth muscle cells) and increases the production of extracellular matrix 
proteins such as elastin and collagen (245, 427). Importantly, in rats, early exposure to 
sympathetic hyperactivity is associated with  the development of early onset 
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hypertension (296) and increased recruitment of peripheral vascular sympathetic 
neuronal fibers (density) in early development (296, 428-430).  
We have previously reported altered cardiovascular function in children with SDB 
including: an accelerated heart rate response to cortical arousals (431); and a delayed 
hyperemic dilatation response and increased blood flow velocity both at rest and during 
hyperemia in the brachial artery suggestive of reduced vascular compliance (395). 
Others have also reported abnormal vascular function in all severity levels of the 
disorder compared to non-snoring children including reduced dilation capacity, reduced 
vascular compliance and increased blood flow velocity (147, 210, 223, 231).  But, to 
date, the relationship between sympathetic activity and its effects on vascular function 
(blood flow velocity, arterial dilation capacity and endothelium integrity) and vascular 
structure in children with SDB are unknown. This question may be answered by an 
examination of tonsillar blood vessels from children undergoing adenotonsillectomy 
for SDB, who have also previously undergone vascular functional testing (brachial 
artery blood flow velocity, flow-mediated dilation (FMD) and platelet aggregation). 
We hypothesize that the functional changes associated with sympathetic overactivation 
in children with SDB will be associated with changes in vascular structural— i.e. 
increased tonsillar artery sympathetic nerve fibre density. Adenotonsillectomy offers a 
unique opportunity to address this limitation by histologically evaluating tonsillar blood 
vessels for evidence of changes in sympathetic innervation and to match the histological 
findings with accepted functional markers of altered autonomic tone (432-434).  
In summary, the aim of this study was to utilize vascular sympathetic nerve density as 
a structural measure of sympathetic innervation and to correlate this with a functional 
measure of autonomic tone (pupillometry) and the functional vascular response seen in 
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flow mediated dilatation and platelet aggregation in children who were scheduled for 
adenotonsillectomy for the treatment of SDB.  
 
5.5 Methods 
Children with a history on parental report of snoring more than three nights per week, 
and who were referred by their primary physician for the evaluation of potential SDB 
by experienced otolaryngologists at the Women’s and Children’s Hospital Adelaide, 
Australia and who were subsequently scheduled for adenotonsillectomy were recruited 
as participants (n=15). Children with a history of significant asthma, previous 
adenoidectomy, evidence of recent tonsillar infection, craniofacial abnormalities, 
medications that affect sleep or respiration, and English as a second language were 
excluded from the study. The study was approved by the Women’s and Children’s 
Hospital and University of Adelaide’s Human Research Ethics Committees. 
5.5.1 Anthropometrics 
Children were weighed wearing minimal clothing using an electronic scale with a 
resolution of 0.1kg and height was measured using a wall-mounted stadiometer. BMI 
and percentile was calculated using the Baylor College of Medicine website tool 
(http://www.bcm.edu/cnrc/bodycomp/bmiz2.html). 
5.5.2 Polysomnography  
As previously reported, overnight polysomnography (PSG) was conducted using the 
Compumedics E-Series Sleep System (Melbourne, Australia (395). In brief, the 
following standard measures were collected: electroencephalogram (EEG; C3-A2, C4-
A1, and F3-A2 F4-A1, O1-A2 and O2-A1), left and right electrooculogram (EOG), 
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sub-mental, diaphragmatic and leg electromyogram (EMG), heart rate by 
electrocardiogram (ECG), oronasal airflow by thermistor and nasal pressure, 
respiratory movements of the chest and abdominal wall using uncalibrated respiratory 
inductive plethysmography (RIP), and arterial oxygen saturation (SpO2) by pulse 
oximetry (Nellcor N-595; two second averaging time). Children were continuously 
monitored via infrared camera by a pediatric sleep technician who also documented 
observations of sleep behavior, which included the presence or absence of snoring. 
5.5.3 Pupillometry 
The pupillary light reflex was used to evaluate autonomic tone (303, 434-437). 
Pupillary response was measured using the handheld NeurOptics device (NeuroOptics, 
Irvine, CA). The device consists of an infrared illumination source and a digital camera 
to capture pupillary images and an onboard processor with summary data output to a 
liquid crystal display.  The device delivers a light pulse to stimulate the eye and then 
analyses subsequent changes in pupil diameter from a succession of digital images. On 
completion of the set-up for the overnight PSG the room light was dimmed to a standard 
lux (8-9 lux), and children were instructed to lie supine in their beds for 5 min. Children 
were then instructed to focus on a fixed point on the ceiling and their pupillary response 
to a 180 μW, 33ms light pulse was sampled at 30 frames per second (FPS) for three 
seconds in each eye consecutively (Figure 1). Children where then allowed to go to 
sleep. The pupillary light reflex was measured prior to sleep onset at a time when the 
sympathetic nervous system is quiescent and parasympathetic vagal control is dominant 
(434, 438).  
The following pupillary parameters obtained from the NeurOptics device are outlined 
in Table 5.1. : (i) baseline pupillary diameter (Maximal Diameter)  (ii) constricted 
diameter at peak of the light reflex, (Minimal Diameter) (iii) percentage change in pupil 
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diameter from baseline, (iv) constriction latency (time difference between initiation of 
retinal light stimulation and onset of pupillary constriction), (v) average constriction 
velocity (amount of constriction/duration of constriction mm/sec), (vi) maximal 
constriction velocity (peak value of velocity during constriction) and post constriction 
velocity (dilation velocity post after peak constriction). Using proprietal software the 
above variables were compared to a normative pupillary light reflex dataset to derive a 
Neurological Pupil IndexTM (NPi) graded on 1-5 point scale with a score < 3 being 
indicative of an abnormal pupillary response (439). 
5.5.4 Flow Mediated Dilatation 
The measurement of flow-mediated dilatation (FMD) in-vivo has been widely used to 
assess endothelial function [27, 28]. A detailed explanation of the FMD protocol used 
in the present study can be found in our earlier study [26]. In brief, FMD was measured 
upon waking following overnight PSG and while still fasting. The brachial artery 
diameter was determined from a 30s resting scan measured perpendicular to the 
brachial artery and 10cm proximal to the elbow. The transducer was then set on B mode 
and positioned at a 60° angle to the vessel and subsequent blood flow dynamics were 
collected (resting peak systolic velocity (PSV), velocity time integral (VTi) and heart 
rate (HR)). A minimum of six image sets were taken and averaged values were used to 
determine resting blood flow dynamics. The lower forearm was then occluded by 
inflating a sphygmomanometer cuff to 200 mmHg for four minutes. A subsequent 3min 
scan was taken, begining 15s before cuff removal. This scan captured the changes in 
vascular diameter as diacom files. 
Platelet Function Testing – Whole Blood Impedance Aggregation  
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Blood flow is an important mediator influencing the platelet aggregation process. It has 
been previously proposed that different shear conditions provide distinct patterns of 
aggregation. Whole blood impedance aggregometry is based on the principle that 
activated platelets stick via their surface receptors to artificial surfaces of two electrodes 
within the whole blood sample positioned at a determined distance between them (440). 
Hence, platelet aggregation was evaluated using Multiplate analyser (Dynabyte, 
Munich, Germany) within 45 minutes post venipuncture as previously described(441). 
The device is considered a valid, rapid and complete measure of platelet function. 
Platelet aggregation was simultaneously measured using independent sensor units, for 
four different antagonists. The rate of aggregations was measured by detecting the 
increase in electrical impedance generated by the aggregation of the platelets upon 
those fixed to the electrodes. The degree of the increase in impedance was recorded in 
Ohms. (440) 
 
15l of CaCl/NaCl2 (37°C) solution was used as a diluent for low dose adenosine 
diphosphate (ADP) (1:4 dilution), high dose ADP, thrombin receptor activating peptide 
(TRAP-6) and collagen (COL) aggregation, while, saline solution was used as a diluent 
for arachidonic acid (ARA) tests. All agonists were purchased from Multiplate 
Dynabyte, Munich, Germany). 150L of whole blood was then added to the impedance 
channels containing diluent and incubation (2mins, 37°C) before addition of 20L of 
respective platelet agonist to achieve the following final concentrations, 1.6M low 
dose ADP, 6.5M high dose ADP, 32M TRAP-6 and 3.2g COL aggregation and 
0.5mM ARA test. Measuring time was 6 mins for all reactions, aggregation units (AU, 
Ohms) plotted against time (mins). 
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5.5.5 Vascular Histological Examination  
Tonsils were resected using a cold steel procedure and the inferior lobes of both tonsils 
sutured to aid orientation. Dorsal lingual arteries were micro-dissected from tonsils 
within 30min of removal and immersed in modified Zambonis fixative for 24h (0.2% 
saturated picric acid in 2% paraformaldehyde in 0.1 olL-1 phosphate buffer). Vessels 
where then permeabilized by 3 x 10min washes with dimethylsulphoxide (DMSO) 
followed by 3 x 10min washes with phosphate-buffered saline (PBS) and then stored 
in PBS with 0.01% sodium azide at 4°C (442). 
5.5.6 Immunohistochemisty  
Vessels were blocked in PBS with 10% inactivated horse serum (Sigma) for 60 min at 
room temperature. Following removal of blocking solution, vessels were then placed 
into a solution of primary antibodies diluted in PBS with 0.1% Triton X and 5% horse 
serum for 60min at room temperature. Antibodies and dilutions included: anti-mouse 
alpha Smooth Muscle Actin (SMA) conjugated to Alexa Fluor-555 (Abcam: 1:500) 
and anti-rabbit Tyrosine Hydroxylase (Millipore: 1:200). Samples were then washed 
three times with PBS prior to addition of donkey anti-rabbit Alexa Fluor-488 
conjugated secondary antibodies (Thermo Fisher: 1:200) for 60min at room 
temperature. Whole vessels were subsequently mounted in NT_Prolong Gold anti-fade 
reagent containing DAPI (Thermo Fisher) on glass slides. All vessels were imaged 
using the same laser settings on Zeiss LSM 700 Confocal microscope at 5x 
magnification with Z-stacks set to a depth of 2.25-2.85 µm. Images were captured using 
Zen Black software (Zeiss) and converted to PNG files for image data processing. 
(Figures 5.4, 5.5, 5.6) 
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5.6 Data Analysis 
5.6.1 Sleep Disordered Breathing  
PSG records were scored by an experienced sleep technician blind to subject status and 
according to established sleep stage [29] and ventilatory criteria [30],  details see 
Kontos et al. (2015) (395) (Chapter 3).   
5.6.2 Flow Mediated Dilatation Analysis 
A custom made program using Matlab (software details) was used to determine regions 
of interest (ROI) from the whole brachial vessel. The ROI window was manually 
manipulated for each individual vessel so that it remained within the ROI window for 
the duration of the scan (3 min/ 935 frames). The pixel to mm ratios were determined 
via the hardcoded dicom millimeter key (Figure 5.2). Ten perpendicular, evenly spaced 
interrogation points along the interior of the vessel were used for averaging the dilation 
response per frame. A pixel intensity threshold (40 from 8bit intensity values) was 
chosen via visual analysis of intensity gradients at the borders of the vessels (note: 
images have high spatial intensity homogeneity, and consistent intensity between 
individuals).  At each of the 10 interrogation points the dilation of the vessel was 
measured by extending a line along the positive and negative y axis until the threshold 
value was reached, indicating the end of the vessel interior (Figure 2).  Vessel dilation 
measurements in mm were calculated using the dicom and mm:pixel ratio. The interior 
of the vessel was then measured again from the same location in the following frame 
and compared to the previous measurement. To exclude values attributed to movement 
artifacts, measurements which exceeded the previous corresponding measurement by 
10% were included as ‘not a number’ (NAN) in analysis until a subsequent 
measurement fell within the threshold of the last valid measurement, as they were 
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considered outliers.  A two-dimensional matrix consisting of 10 rows, one per 
interrogation point, and columns determined by the number of frames was used to hold 
all the vessel measurements generated from one dicom image set. A mean dilation for 
each frame (10 vessel measurements/10) was then determined.  These values were then 
plotted against a time axis, and used to determine the maximal diameter (FMDMax), the 
diameter at 60s post cuff deflation (FMD60) and time to maximal dilation (FMDtime to 
Max) (Figure 5.3). 
5.6.3 Tyrosine Hydroxylase Nerve Fibre Density 
5.6.3.1 Metrics Derivation    
Raw microscope data (Figure 4) was exported in PNG format and then analysed in a 
custom algorithm (python script; Numpy for matrix analysis, Scipy for image support). 
Images were internally represented as three-dimensional matrices (x, y, rgb). The red 
and blue channels were discarded before immunofluorescence in the green channel was 
determined at three points along the vessel using circular interrogation regions (Figure 
4) to avoid issues with rotational impartiality.  
Interrogation regions were chosen using an heuristic approach and evenly spaced along 
clearly imaged portions of the vessel (Figure 5.5). The person picking the region of 
interest was unaware of the participant’s results in their functional tests.  Total green 
values were calculated using a simple sum function of the elements in the circular 
region of the matrix and the average ratio of green pixels per region of interest (ROI) 
of three circles was used as a measure of sympathetic nerve fibre density (SNFD). 
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5.6.4 Statistics Analysis 
Data were analysed using SPSS (IBM SPSS Statistics for Windows, Version 21.0. 
Armonk, NY), and GraphPad Prism version 5.00 (GraphPad Software, San Diego, 
USA).  BMI values were adjusted for age and gender (https://www.bcm.edu/cnrc-
apps/bodycomp/bmiz2.html). All data are represented as mean (SD). The relationship 
between FMD, Pupillometry, SNFD, Platelet Aggregation and PSG variables were 
tested using Pearson-r correlations and significance was tested using r-z 
transformations, and p value of 0.05 was considered significant. 
5.7 Results 
Of the original 15 tonsil sets, the lingual arteries of 13 (6 females, 7 males) 
demonstrated immunoreactivity to TH antiserum (Examples are given in Figure 5.4, 
5.5, 5.6). Preliminary Chi square and t-test analyses revealed no significant gender 
differences in any variable. The variable means, standard deviations and ranges are 
reported in Table 5.2. 
5.7.1 Correlational Analyses 
5.7.1.1 Sympathetic Nerve Fibre Density (SNFD) 
A greater SNFD was moderately and significantly correlated with a higher resting VTi 
(Figure 5.6) (Figure 5.7A) and resting peak systolic velocity (Figure 5.7B). A greater 
SNFD was moderately and significantly correlated with a lower Neuronal Pupillary 
Index (Figure 5.9A), smaller percentage change from baseline pupil diameter (Figure 
5.9D) and slower constriction latency, mean pupil constriction velocity (Figure 5.9C), 
peak pupil constriction velocity (Figure 5.9E) and post constriction dilation velocity 
(Figure 5.10C) (Table 2). 
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5.7.1.2 Flow Mediated Dilatation (FMD) 
Apart for a strong positive relationship between resting VTi and FMDTime to Max, (r = 
0.71, p < 0.01). no significant relationship were observed between remaining FMD 
(FMDmaximal dilation, FMD60s)  and VTi and any of the other variables (Pupillometry, 
Platelet Aggregation, SNFD)  (all r  < 0.30). 
5.7.1.3 Pupillometry  
A faster maximal constriction velocity was significantly associated with a reduced rVTI 
and rPSV (Table 5.3) (Figure 5.8). A similar strong relationship was also evident 
between post constriction dilation velocity and rVTi  (r = - 0.79, p < 0.01) (Figure 
5.10A), rPSV (r = -0.78, p < 0.01) (Figure 9B) and also FMDtime to max  (r = 0.66, p < 
0.05) (Figure 5.10D). There was no relationship between age, BMI, BMI (z-score), 
weight, height, and percentile with any of the pupillometry variables 
5.7.1.4 Platelet Aggregation 
No significant relationship was observed between FMD60, FMDmax with any of the 
platelet aggregation variables. However, resting VTI showed a significant positive 
association with COLauc and COLagg (r = 0.64, N = 12, p < 0.05; r = 0.64, N = 12, p 
< 0.05) and a trend to significance between COLauc and FMDttm, (r = 0.54, N = 12 p 
= 0.07). There were no relationships observed between any brachial artery vascular 
function test and the other four aggregation test results. SNFD was positively associated 
with increased platelet aggregation velocity variables (the rate at with aggregation 
occurred) with COL, and ADP (Table 5.4). 
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Significant correlations between pupillometry variables and platelet aggregation results 
are listed in Table 5.4. In brief, NPI, mean and peak pupillary constriction velocity were 
inversely associated with collagen; IADP; ASP and ADP aggregation. There were no 
significant relationship between any of the pupillometry variables and TRAP 
aggregation data. There was a positive relationship with constriction latency and all but 
TRAP aggregation variables (Table 5.4). 
5.8 Discussion 
This study is the first study to evaluate the relationship between functional and 
structural vascular parameters in children with SDB. We observed a significant 
relationship between sympathetic nerve fibre density (SNFD) of the dorsal lingual 
artery of children with SDB and resting blood flow velocity (rPSV/rVTI) measured at 
the brachial artery using FMD. We found that the SNFD was not related to 
anthropometric characteristics such as age, sex or BMI.  Furthermore, we showed that 
increased SNFD was correlated with augmented autonomic function during the 
pupillary light reflex.  This was measured using an automated pupillometry technique 
just before sleep onset and demonstrated an increased latency in pupillary constriction, 
reduced mean and peak constriction velocity and reduced constricted pupillary 
diameter.  It is also the first study to show that increased resting blood flow velocity 
(rPSV/rVTI) measured at the brachial artery in children is associated with increased 
time to maximal dilation response using FMD. Taken as whole these results suggest 
that some children with SDB exhibit increased sympathetic activity. This activity is 
associated with the measured proliferation of autonomic nerve fibers of the dorsal 
lingual arteries of the lingual tonsil and an alteration in both the resting brachial blood 
flow velocity and dilatation response to hyperemia.  Whether this proliferation in 
sympathetic nerve fibers that we have demonstrated affects the totality of the systemic 
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vascular system requires further investigation but our results do suggest that the effect 
is more widespread. The significant inter relationships between vascular functional 
parameters e.g. brachial artery resting VTI and peak systolic blood velocity and changes 
in autonomic tone as measured by the pupillary responses and the relationship of both 
to sympathetic nerve density of the dorsal lingual artery suggests that augmentation of 
sympathetic tone in this group of children with SDB is affecting blood vessel structure 
and function in a systemic response.  The unanswered question is what are the long-
term consequences of such an effect at a time when the child’s vessels are rapidly 
developing? 
 
5.8.1 Blood Flow Velocity 
Our group has previously reported increased brachial artery blood flow velocity, both 
during rest and hyperemia in non-obese children with mild SDB compared to healthy 
non-snoring children.  In addition, in a different cohort of children, we observed 
increased peak systolic velocity in the ascending aorta using cardiac magnetic 
resonance imaging also in children with SDB compared to controls.  This adds to the 
findings of by Hill et al., who showed increased blood flow velocity in the middle 
cerebral artery in primary snorers compared to control children. Our group and others 
have postulated that children with SDB develop systemic changes in vascular 
compliance, which arise in direct response to increased sympathetic activity. The strong 
positive correlation between brachial artery resting VTi and the trend in FMDtime to max 
with SNFD of the dorsal lingual artery in children with SDB provides supportive 
evidence that systemic changes are occurring in these children. These changes could be 
a significant precursor to future cardiovascular complications.  
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5.8.2 Blood flow velocity and Windkessel function 
During systole the aorta and proximal larger vessels act as an elastic buffering chamber, 
storing approximately 50% of stroke volume, while in diastole elastic properties of the 
aortic wall push the excess volume to the peripheral circulation in a continuous circuit 
of peripheral blood flow (233). Known as the Windkessel function, it influences 
peripheral blood flow, and cardiac function as it reduces left ventricular afterload and 
relaxation and also improves coronary circulation. As resistance in the major vessels 
increases with aging i.e. become less elastic/less compliant, the reservoir associated 
with systolic distention decreases leading to increases in systolic blood flow velocity, 
left ventricular afterload and systemic blood pressure (233). Sympathetic nerves are 
continuously active and hence vessels are under a continuous and varying level of  
constricted  (443)  while a proportion of arterial sympathetic nerves are also auto-
depolarizing (spontaneously active) requiring no stimulus to constrict the vessels. The 
variability observed in SNFD on the dorsal lingual arteries of children may dictate the 
level of vascular compliance at rest, with more SNFD associated with less compliance 
and hence increased VTi.  The relationship that we have observed between the SNFD, 
arterial blood flow velocity and vascular kinetics (FMDtime to max) may represent a 
reduction in the Windkessel effect, systemically. This is potentially supported by the 
results of our previous work using cardiac MRI imaging in children with SDB 
compared to non-snoring controls which showed increased peak systolic velocity in the 
ascending aorta in the children with SDB.  
 
5.8.3 Pupillary Light Reflex 
The pupillary light reflex is considered a valid measure of autonomic nervous system 
function (436) and in particular reduced peak constriction velocity and delayed time to 
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minimum constriction are considered evidence of abnormal pupillary and hence 
autonomic nervous system function. (434, 438)  Our results showed that the children 
with increased SNFD at the dorsal lingual artery were the ones who had delayed pupil 
constriction onset (constriction latency), reduced percentage diameter change to the 
light stimulus and indeed showed reduced capacity to constrict in response to the a light 
stimulus. This suggests that autonomic balance is altered in children with increased 
SNFD and the involvement of the eye and tonsillar vessel suggests the effect is systemic 
in nature.  Further supporting systemic vascular effects is the demonstration of delayed 
dilation response to hyperemia in metacarpal ‘microvasculature’ in children with OSA 
(222).  
5.8.4 Platelet Aggregation and Blood Flow 
Blood flow is an important mediator influencing the platelet aggregation process. It has 
been previously proposed that different shear conditions provide distinct patterns of 
aggregation (426). Increased platelet aggregation is considered a marker of vascular 
dysfunction. Our results showed that the children with increased VTi also exhibited 
increased platelet aggregation in response to the collagen antigen. Platelets are crucial 
in the clotting process and also regulate angiogenesis.  In short, collagen sensitive 
aggregation suggests that platelets have had contact with collagen. In health subjects 
collagen in the vessel wall is concealed by the endothelial cells that line the lumen. 
When there is injury to the vessel wall (possibly from increased shear stress) these 
collagens come in contact with circulating platelets and interact with the receptor on 
the platelets cell surface, thereby increasing their sensitivity to collagen.  That there 
was such a strong association between the pupillary light reflex variables and the 
platelet aggregation, in particular to the collagen antigen, further suggests that the 
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underlying cardiovascular changes in children with SDB may stem from increased 
sympathetic activity.  
 
As increased sympathetic tone is an integral factor in hypertension, both in adults and 
children and as most children with SDB remain underdiagnosed and untreated, we 
postulate that this may well be an unrecognised risk factor for hypertension in adult life. 
While we acknowledge that sympathetic activity has been shown to be regionalised, the 
high correlation between the altered FMD parameters, altered sympathetic nerve density 
on dorsal lingual arteries and sympathetic upregulation as measured on digital 
pupillometry in children with SDB suggests the effects of SDB are generalised. Our   
results may imply   that SDB has a more deleterious effect on children’s vascular health 
than previously recognised. Whether the chronicity of SDB or its severity are the more 
important contributors to increased vascular sympathetic innervation is unknown.     
Increase density of vascular sympathetic fibres has been shown in rats, exposed to 
hypoxia in utero. These rats went on to development early onset arterial hypertension 
as animals matured (430). In mice, sleep fragmentation has been shown to induce 
changes in peak blood flow and dilation response in the dorsal tail vein, and significant 
elastic fibre disruption and disorganization in both the aortic arch and thoracic aorta 
(296).  Importantly we have demonstrated that techniques such as pupillometry and 
FMD are very helpful in identifying vascular changes in children both with SDB and 
may become important screening tests. 
 
The range of brachial VTi both at rest and during hyperemia in our previous study 
varied from normal to high suggesting that not all children with SDB exhibited the 
increased VTi phenotype.  This heterogeneity in vascular response has been noted in 
 211 
studies looking at the effects of aging, disease and therapeutic interventions on vascular 
response and suggests the possibility of underlying genetic factors that may protect 
vascular integrity in some with SDB. Using VTi and pupillary light reflex could provide 
the basis of possible stratification of SDB subgroups into lesser of greater vascular 
changes in future exploratory genetic studies.   
5.9 Limitations 
The main limitation to this study is the low number of participants and the wide age 
range between youngest and the oldest participant (378). Further studies will be 
required to optimize these findings so that these techniques may be used as part of a 
clinical assessment.  
5.10 Conclusion 
This is the first time that arterial structural changes have been correlated with functional 
vascular changes (measures of resting blood flow velocity on FMD) and both shown to 
be significantly associated with increased sympathetic tone. Blood flow velocity 
variables using standard ultrasound techniques and pre-sleep pupillometry maybe a 
useful tools to measure vascular changes and increased sympathetic activity in children 
with SDB and other disorders which involve autonomic dysfunction. The long-term 
implications of increased resting blood flow velocity and potentially and increase in 
shear stress on a child’s developing vasculature may be a harbinger of the accelerated 
cardiovascular disease in their middle years.  Given that many children with SDB are 
not diagnosed and do not receive the appropriate treatment, the vascular changes 
described in this study are concerning. 
 
 212 
Table 5.1: Index of Pupillary Light Reflex, provided by NeurOptics, (NeuroOptics, 
Irvine, CA), Information Guide.  
Variable Definition/Calculation Units 
Neurological Pupil Index TM 
(NPI) 
Algorithm that compares all 
variables to normative models – 
results in a composite score of 
pupillary response. 
Scalar value 
0 - 5 
Baseline Diameter (Max) Resting Pupillary Diameter mm 
Constricted Diameter (Min) Pupillary diameter at peak 
constriction 
mm 
Diameter Percentage Difference  Percentage change from baseline 
(Max-Min/Max)  
% 
Constriction Latency  Latency = time difference 
between initial light stimulus 
presentation to onset of pupillary 
constriction 
sec 
Constriction Velocity Average constriction velocity = 
(constriction/duration of time) 
mm/sec 
Maximum Constriction Velocity Peak value of velocity during 
constriction 
mm/sec 
Post Constriction Dilation 
Velocity (post constriction return 
to baseline) 
Amount of pupil size recovery 
(after constriction) divided by 





Table 5.2: Shows the means, standard deviation and range of anthropometrics, brachial 
artery blood flow, sympathetic nerve fibre density, pupillary light reflex and platelet 
aggregation.  
Variable Mean  
Standard 
Deviation 
Range (Min - Max) 
Anthropometric    
Age (years) 11.13 4.10 6.25 – 17.25 
Height (cm) 148.23 22.54 118.00 – 183.00 
Weight (kg) 54.41 30.69 21.60 – 103.60 
BMI 22.58 6.79 14.4 – 35.0 
Percentile 76.67 31.61 16.6 – 99.3 
Flow Mediated Dilation    
Brachial Artery Diameter (cm) 0.29 0.06 0.20 – 0.40 
FMD60 (%) 5.5 5.9 0.0 – 16.6 
FMDMax (%) 9.22 5.90 2.3 – 20.0 
FMD time to maximum (s) 68.4 30.6 38.1 – 144.5 
Peak Systolic Velocity mm/s 113.4 34.1 83.0 – 197.0 
Velocity Time integral (mm2) 20.4 12.9 7.5 – 53.6 
Heart Rate (bpm) 72.1 8.71 58.5 – 84.0 
Pupillary Light Reflex    
Neuronal Pupillary Index TM 4.26 0.22 3.70 – 4.50 
Baseline Pupillary Diameter 6.98 0.41 6.44 – 7.98 
Constricted Diameter 4.41 0.43 3.82 – 5.18 
Percentage change from baseline 
diameter 
0.37 0.04 0.29 – 0.43 
Constriction Latency 0.24 0.37 0.22 - 0.34 
Mean Constriction Velocity 3.41 0.44 2.26 – 3.90 
Peak Constriction Velocity 5.43 0.63 4.12 – 6.22 
Dilation Velocity 1.48 0.13 1.20 – 1.73 
Platelet Aggregation     
Collagen Area Under the Curve 42.92 11.02 26.00 – 60.00 
Collagen Aggregation 97.13 16.81 67.90 – 123.40 
Collagen Velocity 14.25 3.43 8.00 – 21.80 
IADP Area Under the Curve 19.20 11.15 2.00 - 37.00 
IADP Aggregation 35.78 18.25 6.00 – 62.30 
IADP Velocity 5.23 1.92 2.40 – 8.10 
ASP Area Under the Curve 46.42 17.38 4.00 – 76.00 
ASP Aggregation 74.93 24.90 9.80 – 106.90 
ASP Velocity 13.35 5.22 3.00 – 24.10 
ADPArea Under the Curve 43.41 12.00 20.00 – 67.00 
ADPaggregation 71.82 18.38 38.60 – 102.00 
ADP velocity 11.69 3.17 5.30 – 19.30 
Mean Tyrosine Hydroxylase 
density 




Table 5.3: Correlations results between brachial artery blood flow velocity and 
pupillary light reflex variables.  
 












rVTi (mm2) r = - 0.31, 
p = 0.32 
r = - 0.20, 
 p < 0.60 
r = - 0.40,  
p < 0.11 





r = -0.29 
p = 0.40 
r = 0.13, 
 p = 0.7 
r = - 0.47,  
p = 0.12 
r = -0.64* r = -0.78**      
NB   * p < 0.05, **p < 0.005 
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Table 5.4: Correlations results between platelet aggregation, sympathetic nerve fibre 
density and pupillary light reflex variables.  
 










Under the Curve 
r =  0.43    
p < 0.17 
r = - 0.63*  r = 0.67*  r = - 0.63*  r = - 0.84**  
Collagen 
Aggregation 
r =  0.47    
p = 0.12 
r = - 0.60*  r = 0.65* r = - 0.57,     
p < 0.07 
r = - 0.77**  
Collagen 
Velocity 
r =  0.67*  r = - 0.67* r = 0.70* r = - 0.59, p 
< 0.06 
r = - 0.66*  
IADP Area 
Under the Curve 
r =  0.48    
p < 0.12 




r =  0.49   
p < 0.10 
r = - 0.57, 
p < 0.07 
r = 0.63,     
p < 0.06 
r = - 0.39 r = - 0.52 
IADP Velocity r =  0.33    
p < 0.29 
r = - 0.56, 
p < 0.08 
r = 0.66* r = - 0.38     
p < 0.3 
r = - 0.53     
p < 0.1 
ASP Area Under 
the Curve 
r =  0.46     
p < 0.14 
r = -0.77**  r = 0.76*  r = - 0.69*  r = - 0.67*  
ASP Aggregation r =  0.34    
p < 0.28 
r = - 0.67*  r = 0.69*  r = - 0.61*  r = - 0.75**  
ASP Velocity r =  0.57   
p < 0.06 
r = -0.75**  r = 0.73*  r = - 0.63*  r = - 0.46  
ADPArea Under 
the Curve 
r =  0.52   
p < 0.09 
r = -0.75**  r = 0.83**  r = - 0.60    
p < 0.06 
r = - 0.64*  
ADPaggregation r =  0.43   
p < 0.17 
r = - 0.65*  r =  0.79**  r = - 0.54   p 
< 0.09 
r = - 0.63*  
ADP velocity r =  0.65*  r = -0.79**  r =  0.83**  r = - 0.59   p 
< 0.07 
r = - 0.51 
SNFD  r = -0.72** r = -0.65* r = -0.65* r = -0.63* 






Figure 5.1: Shows the NeurOptic output variables from a participant, Max = baseline 
pupil diameter, Min = constricted pupil diameter, %CH = percentage difference of 
diameter from baseline, LAT = constriction latency, CV = mean constriction velocity, 






Figure 5.2: The sonogram of the brachial artery, 10cm proximal from the elbow, green 
box determines the region of interest, 10 equidistant red lines are used to determine the 







Figure 5.3: Example of the mean dilatation response from a participant. The computer 
program generates a graph with both the raw data is shown in blue and the averaged 





Figure 5.4: Shows two dorsal lingual arteries from different children. The red 
immunofluorescence indicated smooth muscle actin green is tyrosine hydroxylase, 











Figure 5.5: Immunofluorescence for tyrosine hydroxylase on the dorsal lingual artery, 
white circles indicate the three region of interest picked by the analyst for green 














Figure 5.7: Shows the scatterplots of the brachial artery variables (velocity time 
integral, peak systolic velocity and flow-mediated dilatation - time to maximal dilation) 







Figure 5.8: Shows the scatterplots of the brachial artery variables (velocity time 







Figure 5.9: Shows the scatterplots of the pupillary light reflex variables versus 









Figure 5.10: Shows the scatterplots of post pupillary constriction recovery (return to 
baseline) versus brachial artery blood flow variables (velocity time integral, peak 















The studies in this thesis suggest that there are significant changes in the underlying 
physiological systems in children with SDB, including changes to ANS function, 
vascular function and inflammation. These changes occur in children as young as six 
years old with evidence of reduced vascular compliance in both major and minor 
arteries as demonstrate by increased blood flow velocity at the brachial artery (Chapter 
3) and ascending aorta (Chapter 4). The changes were coupled to changes in vascular 
dilation response (delayed dilation during FMD) (Chapter 3 and 5) and also in 
autonomic function (altered pupil light reflex) and structure (sympathetic nerve fibre 
density) (Chapter 5) and inflammatory response (increased CD8+ T cells producing 
TNFα and IFNγ) (Chapter 4). The results support the hypothesis that the burden of SDB 
affects the development of the underlying integrated physiology and is evidence of 
established adaptive processes that result from allostatic overload. This new set-point 
will determine the trajectory of the underlying systems. Whether these changes are 
associated with the onset of early cardiovascular disease requires further 
longitudinal/cross-sectional studies to ascertain the long-term effects of untreated SDB 
associated vascular remodeling and its impact on the future health of the child as he/she 
matures. 
 
This research supports previous limited reports, which suggest that even the mildest 
form of SDB (primary snoring), in children, is associated with remodeling of 
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cardiovascular response (148) (147) and vascular structure. This implies that the current 
gold standard measure to determine severity of SDB using PSG derived measures 
proposed in the AASM is severely limited in respect to predicting cardiovascular 
physiological changes, in children traditionally thought to not warrant treatment 
(primary snorers). Considering the majority (75%) of children with SDB present as 
primary snorers, it may be the case that the current dependence on a rigid OAHI as 
severity score obfuscates the potential alteration in the child’s physiological response. 
Even if one accepts that a RDI/OAHI of 5 merits intervention, equally important from 
our data is the degree to which the obstructive events are associated with desaturations, 
e.g. a nadir of 85% compared to a desaturation to 95% which may indicate reduced 
chemosensitivity and a reduced capacity to arouse.   
 
Although the use of parental questionnaires alone to diagnose SDB in children has been 
critised in the literature, the relationship between the SDSC questionnaire factors and 
the cardiovascular measures (increased blood flow velocity in the ascending aorta) and 
inflammatory markers (Chapter 4) suggests that parents are able to ascertain the degree 
of abnormal changes in their children’s sleep behaviour that correspond to changes in 
their underlying physiology. Parental report using validated tests, such as the SDSC 
may be a valuable tool to aid in the identification of a specific pathological, behavioural 
profile that is possibly associated with cardiovascular disease risk. Our data suggests 
that all studies in paediatric SDB, in addition to the PSG measures may benefit from 
the use of parental questionnaires such as the SDSC as used in this study, especially 
when also assessing measures of autonomic and inflammatory function. 
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The widely adopted measure of FMD calculated at 60s has been reported in most 
studies as a measure of vascular endothelial integrity in adolescent and adult studies. 
More recent debate suggests that more parameters, other than this single time point be 
used to better understand the origin of changes in mechanisms driving the total dilation 
response (348, 444). These include observing the blood flow velocity and resting 
variables, such as heart rate, intima-media thickness, FMD time course data and arterial 
diameter. This thesis corroborates their recommendations. Chapter 2 highlights the 
relationship between the brachial artery dilation response and age and size (particularly 
height) in young healthy control children, with the time to maximal dilation increasing 
with both size and age but no relationship between FMD at the 60s time point. This has 
implications when we compare two groups with similar ages but with different degrees 
of vascular health, such as children with SDB (Chapter 3). Most healthy non-snoring 
children aged less than 10 years included in this study reached maximal dilation 
between 30-45s and were returning to baseline by 60s post cuff deflation. When we 
compared FMD at 60s between snoring and normal groups there was no significant 
difference, but when we looked at the 90s time point the two groups had diverged with 
most children in the control group returning to baseline, while children in the snoring 
group where still dilating. When we determined time to maximal dilation we 
demonstrated that children with SDB were only just reaching maximal dilation at 60s 
and beyond, while diameters in the control group where returning to baseline. This 
disparity would have been missed and no difference would have been reported between 
groups had we used the popular FMD at 60s. Both values would look the same but 
actually be measurement of different parts of the time course data. How non-endothelial 
mechanisms impact on vessel dilation is less well understood. By looking at the whole 
response curve after cuff release we may better understand and assessed the burden of 
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disease and hence develop targeted therapies. Continuous dilation response 
measurements are now considered the optimum evaluation in relation to the vascular 
response, both in adults and in children (348).  
 
6.2 Systemic Changes to Vasculature and Loss of Windkessel Effect  
The separate studies (Chapter 3 - FMD, Chapter 4 – MRI/Inflammation and Chapter 5 
– FMD/Pupillometry/Platelet Aggregation/Histology) conducted in different cohorts of 
both healthy, non-snoring, control children versus children who were awaiting 
treatment for SDB provides evidence of physiological changes to vascular response. 
First, it was demonstrated that children with SDB exhibited delayed dilation response 
after a hyperemic stress at the brachial artery, 10cms proximal to the elbow. The 
children with SDB took approximately 20s longer than age-matched controls to reach 
their full dilation capacity.  The initial dilation response was not different between 
groups suggesting that the mechanisms driving the dilation, (NO and vasodilators 
released from endothelial cells) are preserved but that as time progresses the cell-to-
cell signaling is impaired in some way.  In itself this decay in signaling suggests that 
structural changes have occurred in peripheral arteries in children with SDB and that 
these changes begin in the outer layers of the vessel, (medial/adventitia) where the 
interface between the smooth muscle cells and sympathetic nerve terminals occurs and 
is the site where extracellular matrix proteins (collagens) are primarily produced. A 
post endothelial NO release reduction in cell-to-cell connectivity would explain both 
the phenomenon observed in this study and would fit the model of reduced vascular 
compliance in these children. Furthermore it fits the model which is currently been 
suggested by some groups (248) (445, 446) that arterial pathology begins at the 
medial/adventitia interface, where the influence on precursor cells, such as fibroblasts 
 230 
and myofibroblasts are significantly influenced by the activation of sympathetic nerves, 
and may lead to inward eutropic remodeling of the smaller arterial vessels (See 
Vascular Remodeling, Chapter 1). 
 
We saw varying degrees of sympathetic nerve fibre density on the dorsal lingual artery 
of children with SDB which correlated with autonomic function measured during pupil 
light reflex and brachial artery blood flow velocity.  Noradrenaline, the main 
vasoconstrictor neurotransmitter released by sympathetic nerves has been shown in 
vitro studies to promote extracellular matrix proteins secretion from both smooth 
muscle and fibroblasts (245) and the adventitia is only now being recognized to play an 
integral part of vasomotor function/tone, through its interaction with cells in the medial 
layer, and the involvement of precursor and immune cells. Increased sympathetic 
activity during sleep, a time when the sympathetic nervous system is more quiescent 
compared to the awake state may amplify the production of these proteins. This may 
result in an inward remodeling of the vessels and over time reduces their compliance if 
sympathetic overactivity persists. The reduction in compliance would reduce the 
Windkessel effect and the capacity of these vessels to expand during systole and hence 
reduce dilation in response to hyperemia. Reduced compliance would not alter luminal 
size measured at the top of the R wave, at the end of systole (as is the case for the 
baseline measurement of luminal diameter used in FMD Chapter 2 & 3), however the 
blood flow velocity and cardiac contractility (VTi = area under the curve (peak systolic 
velocity/ejection time)/2)) would increase and thereby increase shear stress on 
endothelial cells, without dramatically increasing heart rate. In severe OSA, children 
exhibit changes in ventricular thickness and left ventricular ejection fraction, which can 
result from the reduced vessel compliance and their limited capacity to act as a 
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buffering chamber during systole.  This results in ‘increased blood flow velocity’ 
during systole, increased blood pressure and affects both the forward and back blood 
flow dynamics, putting increased pressure at the vessel wall but also to the heart which 
is trying to expel blood against a stronger reverberated wave. This requires the heart to 
pump with an increased inotropic force to extend left ventricular ejection fraction to 
maintain blood flow required to meet tissue perfusion.  Over time, this leads to 
increased sympathetic activation to the heart to increase force of contraction and results 
in increased cell proliferation of myocardiocytes, and extracellular matrix proteins and 
the eventual thickening of the ventricular walls.  At the vascular level however the flow 
on effect of ongoing, increased shear stress would include both inward eutrophic 
remodeling in small vessels, hypertrophic remodeling in the larger vessels and changes 
to endothelial NO production and release, making them less responsive, prone to 
leukocyte adhesion and hence unable to function properly.   
 
Endothelial damage reported by other groups (230) (229) (231) maybe later stage 
changes that occur with more severe OSA and/or longer periods of exposure to 
sympathetic over-activity once vessels have remained under a constant increased shear 
stress, which eventually remodels the endothelial cells themselves. In support of this 
theory Loffredo et al., showed that children with primary snoring had 25% reduction 
FMD dilation response at 60s compared to healthy control children and that the 
reduction increased to 50% in children with OSA. This suggests that the children with 
primary snoring/mild SDB, may be an intermediate state of SDB or that members of 
this group may be underdiagnosed.  
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There are many possible molecular mechanisms that would change the vascular 
compliance at the medial/adventitial interface. In particular the interaction of 
Endothelin 1 (ED1) and its relationship to extracellular matrix proteins and cells types 
in media and adventitia layers may explain the delay in dilation response we observed 
in Chapter 3. ED1, a potent vasoconstrictor, and mediator of vascular remodeling (See 
Chapter  1.11.6.2) is produced by vascular endothelial cells and also adventitial 
fibroblasts (447). ED1 is also increased in plasma concentrations both in children and 
adults with SDB and concentrations have been shown to normalize after treatment for 
SDB both in adults and children.  ED1 expression is influenced by adrenaline, TGF-b, 
Ang II and shear stress which are all influenced by sympathetic activity. In support of 
the theory that changes are occurring at the interface of the media and adventitia, in 
vivo studies in cerebral arteries of the feline and canine, have shown that the 
vasoconstrictive effect of ED1 occurs at the site of the adventitia and not at the lumen 
(endothelial cells), and that the constriction is long lasting (249). The effect of 
adventitial fibroblast ED1 expression may also explain the delay we observe in dilation 
response during FMD.  ED1 has been shown to induce expression of proteins associated 
with a contractile phenotype, including smooth muscle actin, ezrin, moesin and paxillin 
in lung myofibroblasts and promotes the contraction of ECM, especially collagen 1 
fibres (448). Whether adventitial fibroblasts/myofibroblasts produce more ED1 and 
hence cause a contraction and reconfiguration of adventitial collagen fibres, resulting 
in reduced vessel compliance, leading to increased resting blood flow velocity and 
delayed dilatation response would need further evaluation.   
 
Increased blood flow velocity is an indicator of reduced vascular compliance and 
evidence of reduced Windkessel effect. Both the resting and hyperemic blood in the 
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brachial artery was increased in children with SDB compared to controls (Chapter 3). 
The increase in velocity was associated with delayed dilation response induced by 
hyperemia (Chapter 3).  The results of the cMRI study (Chapter 4) further support this 
reduction in vascular compliance as it showed that resting peak systolic velocity 
measured in the ascending aorta, considered the most elastic of arteries, is also 
compromised.  A sustained reduction in vascular compliance increases shear stress at 
the luminal surface and is reported to skew endothelial cell alignment and shape and 
promotes leucocyte adhesion at the luminal surface further hindering the function of 
the arteries.  The site of the ascending aorta, requires the elastic properties and capacity 
to absorb the largest amount of blood propelled from the aortic valve during systole and 
has significant arching and branches which increases flow turbulence. Over time the 
effects of shear stress at this site may remodel and even weaken the aorta making it 
prone to ‘inflammation’ and ‘aortic aneurysm’. The effects of prolonged sympathetic 
overactivity on peripheral vessels may have a more deleterious effect at the ascending 
aorta compared to the descending and pulmonary where blood flow is less turbulent. 
Hence, it is not surprising that the incident of aortic aneurysm is significantly increased 
in adults with OSA (187) and that we found increased peak systolic velocity consistent 
with decreased vascular compliance at the same site.  
 
Further supporting the idea that reduced vascular compliance in children with SDB is 
demonstrated by the relationship between increased platelet aggregation in response to 
collagen antigen in children with higher brachial artery blood flow velocities (Chapter 
5). This corroborates the deleterious effect of increased shear stress on the endothelial 
cells as it demonstrates that there is contact between the circulating platelets and the 
inner layers of the blood vessels, in children with the least compliant vessels. Increased 
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blood flow velocity would impact most at points of bifurcation and anastomosis, where 
flow is most turbulent. Over time the impact of the increased blood flow velocity would 
cause the greatest damage to the endothelial cells leading into the smaller 
arteries/arterioles and expose the medial layer to the circulating platelets and hence 
activate them to collagen. Increased platelet aggregation induced by collagen is the 
earliest ‘outside-in’ signals following injury to the vessel wall and is a predictor of acute 
coronary syndromes (449). Our results suggest that children with SDB are already 
experiencing significant endothelial damage.  
 
6.3 Sympathetic Overactivity Vascular Changes 
Sympathetic overactivity is considered a key driver of hypertension in adults and has 
been shown to be increased in adults and children with SDB (306, 307).  The increase 
in sympathetic activity is proposed to arise from increased arousals/sleep 
fragmentation, increased respiratory drive and /or intermittent hypoxia associated with 
the disorder. To determine if the increased blood flow velocity we observed in the FMD 
study (Chapter 3) is associated with sympathetic overactivity we measured 
pupillometry just before sleep onset in children with SDB (Chapter 5). Sleep onset is a 
time where sympathetic activity is decreased while parasympathetic is increased. Hence 
any difference in autonomic nervous system control would be easily identifiable at this 
time compared to other times throughout the day where ultradian fluctuations of 
sympathetic nerve activity cannot be accounted for.  In addition, we measured the 
sympathetic nerve fibre density on the dorsal lingual artery, removed from the 
participants’ tonsil tissue.  As predicted the blood flow velocity in the brachial artery 
was strongly associated to increased sympathetic nerve fibre density on the dorsal 
lingual artery. This was also correlated with variables of the pupillary light reflex, 
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which are measures considered to be primarily under autonomic nervous system 
control.  Whether these extra sympathetic nerve fibres accrue because of sympathetic 
overactivity to the peripheral vessels in response to increased arousal, respiratory effort, 
hypoxia or vibration of snoring is yet to be examined but would require animal studies 
to ascertain the impact of each stimulus independently on vascular sympathetic nerve 
fibre density and the interaction between SNFD and other known contributors of 
vascular tone, namely Ang II and ED1. Studies that examine the role that these 
cytokines play in the changes in vascular compliance would be particularly beneficial 
as there are current pharmaceutical options that reduce their effect, especially in the 
event that current treatment in children with SDB, T&A does not reduce the vascular 
response.  
 
In a series of elegant experiments using peripheral arterial tonometry (PAT) in adult 
patients with OSA, O’Donnell et al. showed reduced amplitude in PAT is associated 
with brief periods of airflow obstruction, a small reduction of arterial oxyhemoglobin 
saturation, with no arousal indicated in the EEG signal (450). Reduced PAT amplitude 
is an indicator of vasoconstriction in the minor vessels in the fingers. The reduction in 
amplitude was dependent on the degree of airflow obstruction with greater obstruction 
to flow associated with more reduced PAT amplitude. The presence of obstruction 
followed by an arousal in NREM sleep showed an even greater reduction in the PAT 
signal amplitude in the finger microvessels compared to reduced airflow without an 
arousal. Their data suggests that the effects of both reduced airflow with and without 
EEG recorded arousal is associated with sympathetic nervous system activation and 
peripheral vasoconstriction in the digital vascular bed, but that an arousal significantly 
potentiates the effect. Whether the vasoconstriction arises from the small reduction in 
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oxygen desaturation, micro-arousals not currently measured using EEG or other neural 
reflexes (pulmonary associated – stretch/chest wall mechanoreceptors) could not be 
clarified. Given that most children in our studies were classified at the mild end of the 
spectrum with mostly evidence of upper airway resistance and little to no obstruction, 
our data supports this previous work as it highlights the potential risk of sympathetic 
overactivity related peripheral vascular changes with upper airway resistance without 
evidence of a cortical arousal or obstructive event compared to ‘non-snoring’ controls.  
6.4 Chemosensitivity and Vascular Compliance 
Our results (Chapter 3 and 4) suggest that children with increased resting blood flow 
velocity, either at the brachial artery or in the ascending aorta are also the children that 
have the greatest capacity to reach lower oxygen saturations throughout the night 
regardless of how many obstructive events scored on the night of the PSG. Peripheral 
chemoreceptor activation is coupled with sympathetic nerve activity and chronic 
intermittent hypoxia has been demonstrated to be associated with systemic blood 
pressure increases (451).  Increased intermittent hypoxia has also been shown to 
remodel the nucleus ambiguus projects to the cardiac principal neurons and alter the 
functional tonic parasympathetic inputs and vagal outputs. Considering 
chemosensitivity is at its peak during childhood, the children with SDB who reached 
lower SpO2 nadirs may have developed adaptive peripheral chemoreceptor response so 
as to preserve the sleep state. This capacity to reach lower SpO2 would increase the 
circulating CO2 level, further dilating blood vessels and cause a greater global reduction 
in vascular resistance. An arousal from this state, particularly during NREM sleep 
would require an acute change to vascular compliance, via the activation of the 
peripheral vascular sympathetic nerves to push blood flow back to the core and brain 
to elicit a correction to posture and/or increase in upper airway patency to normalize 
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blood gas concentrations. Berthon-Jones and Sullivan, using a CO2 rebreathing test to 
evoke an arousal, noted that (i) during NREM there were no changes during test sleep 
state (as CO2 concentrations increase) until an arousal was evoked which was ‘always 
abrupt and clear-cut’, with associated changes occurring in the EMG and EEG 
(disappearance of SWS) and in ventilation (68). However they observed that during 
REM sleep the process was more complex. During REM sleep as the CO2 concentration 
increased so did theta power and sawtooth waves (EEG), phasic burst in EMG and rapid 
eye movements. Also a 2-4s return of alpha activity occurring after 10-30s of 
rebreathing, loss of rapid eye movement with a transient increase in EMG and 
movement arousal were also evident. This suggests that (i) chemosensitivity during 
NREM sleep is less sensitive, but that when a tipping point is reached, a full transition 
from the dormant state occurs and (ii) during REM sleep chemosensitivity is acute 
(possibly similar to the awake state) and that the transition is possibly a low level 
change. Hence at the vascular level an arousal from NREM sleep has a more substantial 
activation required from the brain stem nuclei involved in the sympathetically mediated 
vasoconstriction response than during REM sleep.  
6.5 Thermogenesis, Arousal and Autonomic Function and Cardiovascular 
Changes  
In Chapter 4 we observed that the children who are worse effected, on top of snoring, 
also have evidence of changes to their sleep continuity as reported by their parents on 
the SDSC questionnaire. Children with an increased inflammatory response profile 
were also children whose parent’s reported higher levels of sleep disruption and issues 
in initiating sleep.  
 
 238 
Ultradian changes in temperature occur throughout sleep and are also required to 
initiate sleep, for example, sleep onset only occurs during somatic cooling periods, and 
NREM sleep is associated with a reduction in brain temperature, while the reverse has 
been demonstrated during REM sleep. The cooling arises from sympathetic withdraw 
and vasodilation of peripheral vessels, dissipating heat from the body’s core and brain. 
In the rat, arousal response is coupled with an increase in hippocampal theta power 
signaling, vasoconstriction in the arterial flow to the tail, a rise in sympathetically 
activated brown adipose tissue (BAT) thermogenesis and a consequential rise in brain 
temperature (75). Whether these changes occur in humans in response to upper airway 
resistance activation of sympathetic efferents during sleep is yet to be determined. 
However, given that children have an increased propensity to arouse, and also have 
large amounts of BAT tissue, the relationship this has to their inability to go back to 
sleep or maintain continuous sleep needs to be further evaluated. The effects of ongoing 
upper airway resistance, arousals and obstructive events may hence elevate body and 
brain temperatures to levels experience during wakefulness, causing them to wake from 
sleep and disturbing sleep continuity. The body would then need to cool again to 
activate the associated processes required to return to sleep.  
 
Our flow cytometry work in Chapter 4 implicated a specific inflammatory profile which 
included an increase in the number of CD8+ T-cell producing IFNγ. Interestingly this 
specific profile has been associated with antigens that produce low grade fevers (412), 
(413) (414) and in vitro studies exposing CD8+-T cells to higher temperatures, increases 
their expression of IFNγ (452). More importantly, sympathetic activity alone, without 
infection has been shown to increase the activation and proliferation of CD8+ T-cells. 
Whether the children who had an increase in the number of CD8+ T-cells producing 
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IFNγ are experiencing sympathetically mediated changes in thermoregulation during 
sleep also needs further investigation. If this is indeed the case then it may change the 
way we diagnose and treat the disorder, as it may be a specific profile not experience 
by all children who snore but by children who are attending clinic services. 
6.6 Implications and Recommendations from this Research. 
In adults increased blood flow velocity is a positive predictor of cardiovascular disease 
and autonomic dysfunction, especially sympathetic overactivity, is often reported in 
studies of chronic disorders. This thesis suggests that children with SDB may be 
predisposed to early vascular remodeling, which makes them susceptible to early onset 
systemic hypertension and/or cardiovascular event.  The association we showed 
between the blood flow velocity and platelet aggregation to collagen suggests that there 
is early endothelial damage, a precursor state to cardiovascular disease, occurring in 
many of the children with SDB.  
 
Our results in children classified as primary snorers or mild sleep disordered breathers, 
who exhibited little to no obstruction on the night of testing but were reported to snore 
by both the technician/scorer and parent/caregiver suggests that primary snoring/mild 
SDB may not be a benign sleep process and may be as detrimental to health as the more 
severe categories that are recognized to have cardiovascular implication. Our results 
suggest that the morbidity of mild SDB is underestimated and that studies which utilize 
primary snorers, as assessed by current AASM criteria, as control groups to compare 
children with moderate to severe OSA risk diluting their results, making it difficult to 
determine the real impact of their findings.  
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The association between the vascular changes (increased blood flow velocity and pupil 
light reflex) also has implications on the newly discovered glymphatic system in the 
brain that is proposed to be responsible for the neurotoxin clearance during sleep. The 
children with SDB and increased sympathetic activity may have reduced glymphatic 
clearance (which is increased during sympathetic inhibition and sleep) and hence may 
be prone to neurotoxin accumulation, which may further compromise brain function 





Figure 6.1: Schematic of the effects of SDB on the cardiovascular system by the over-
activation of the sympathetic nervous system, via increased work of breathing, sleep 




We, as have others (453) observed heterogeneity amongst the responses in the vascular 
tests in children with SDB. Why some children demonstrated increased blood flow 
velocity and delayed dilation response may be addressed by their underlying genetics. 
The APOE II and IV alleles have been demonstrated to be increased in adult patients 
with SDB in some studies (454, 455) but not all (456) and we know that not all adults 
and children who snore develop the neurocognitive and/or cardiovascular deficits. The 
APOE IV allele is over represented  in Alzheimer’s Disease (457) and children with 
SDB and the corrupted allele (IV) score lower in IQ tests compared to children with the 
normal alleles (III) and SDB (455).  APOE has been shown to suppress the effects of 
sympathetic overactivity on vascular remodeling (458). The children in this study who 
exhibited higher SNFD, blood flow velocity, autonomic dysfunction and platelet 
aggregation may not necessary be the worst sleep disordered breathers, but may not 
have the capacity to repair the damage caused by the continuous vasoconstriction as 
they have acquired a copy of the corrupted gene. Genetic studies would be required to 
further evaluate this possibility. It may however just be the case that children are at 
different levels of disease with some children at early onset with others at the longer 
term end of the spectrum.  
 
Our results also suggest that either current AASM guidelines and/or a single night PSG 
report is insufficient to determine the ‘severity’ at the pathophysiological level in many 
of these children. Our results highlight the hit and miss approach provided by the PSG 
assessment which, other than HRV and PTT, (both of which are not used as part of the 
child’s SDB assessment) do not provided a clinical risk assessment in 75% (primary 
snorers and mild SDB) of the patients who undergo a PSG.  Though the PSG is good 
at identifying hypoxic events and hence children at the severe end of the scale, its 
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inability to determine any tangible physiological changes in children even in those 
deemed severe suggests that there is either something wrong with the way we test or 
that there are aspects of the disorder and hence measurements that we have not 
accounted for, e.g. the loudness of snoring, open mouth breathing and/or the respiratory 
asynchrony which our group has shown to be increased in children with SDB.  It may 
be the case that the PSG and AASM current lines alone are not good enough to 
determine risk (223).  Perhaps future recommendations will include an assessment of 
blood flow velocity and cardiovascular measures. There are current technologies 
available, that are simple to use, non-invasive, time efficient and cost effective that can 
measure changes in blood flow velocity from the ascending aorta and aortic valve. The 
Ultrasonic Cardiac Output Monitor (USCOM) is a relatively cheap (approximately 
$30,000 per unit) Ultrasound Doppler device that can be used in all age groups to 
measure a range of haemodynamic variables in real time, that is reproducible. Also the 
new Neuroptics Pupillometer, which has only been available for clinical use since 2013 
in Australia could be used in addition to current PSG guidelines just prior to sleep onset 
to ascertain if there is evidence of sympathetic over-activity in patients.  However, a 
baseline activity range of variables in non-snoring, healthy children would need to be 
established prior to the clinical use of such measurements.    
 
Also, given the correlations between the SDSC, and both measures blood flow velocity 
and inflammation, it may be the case that a simple questionnaire, a quick blood flow 
velocity measurement, clinical evaluation (ENT) and an overnight oximetry (which 
could be done in a short visit) may be sufficient to determine which children require 
surgery, especially when there is no PSG facility available.  
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6.7 Conclusion 
Children with SDB present with a range of problems to the general practitioner. These 
problems range from failure to thrive, bad behaviour, poor academic performance, 
speech delay, bed-wetting, obesity, tiredness and a general lack of energy. Given that 
less than 10% of children with SDB are treated, what happens to the rest is a cause of 
great concern. At 10% of all children worldwide, considered a conservative estimate 
the number of children affected in Australia alone equates to more than 250,000. They 
are the children who are attending the health service providers in greater numbers and 
also utilising the speech therapist, occupational therapist, psychologist and teachers 
aids in classrooms. Furthermore they are the children who are prescribed an assortment 
of drug therapies and have more days off of school, when in most cases, a quick low 
risk overnight surgery, adenotonsillectomy, could greatly alleviate most of the 
problems.  
 
Some studies looking at the efficacy of T&A treatment on IQ in children compared to 
untreated children (watch and wait) (see CHAT study) have shown no differences with 
treatment however, these studies did not compare children to non-snoring controls, and 
may demonstrate that once the damage has occurred in the early stages of life, that these 
changes are not reversible. Given that studies in rodents have shown that chronic 
intermittent hypoxia exposure in the first few weeks of life is associated with early 
onset hypertension (265) and that exposure in the womb to chronic hypoxia leads to 
increased vascular sympathetic nerve fibre density in offspring and also the 
development of early hypertension, (430) it may well be the case the these changes are 
not reversible without medication and may require ongoing assessment.   
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Our research implies that SDB has a considerable deleterious effect on children’s 
vascular health previously not recognised. Importantly, we have demonstrated that 
techniques such as pupillometry and flow mediated dilatation are very helpful in 
identifying vascular change in children both with SDB and other conditions where 
increased sympathetic tone may be present. Techniques such as pupillometry and FMD 
have the potential to highlight and monitor children with SDB who may be at future 
cardiovascular risk. It is therefore crucial that the benefit or otherwise of A/T on the 
changes is clarified. Importantly the combination of techniques described is readily 
translatable to other childhood conditions that accelerate the risk of cardiovascular 
disease.  
Appendix 1: Risk Factors for Sleep Disordered Breathing  
App 1.1: The Upper Airway – Muscles and Innervation and Airflow Dynamics 
 
The upper airway is a passage that moves gases, liquids and solids and is required for 
respiration, feeding and speech in humans (131).  At birth the newborns pharynx is 
similar to other primates and mammals. The airway is securely maintained through the 
close proximity of the uvula and epiglottis and allows for independent breathing and 
suckling (131).  By 18 months however, the larynx descends to the 5th cervical vertebrae 
(131), to accommodate the role of pharynx in phonation. The pharynx remains a 
flexible tube consisting of constrictor muscle that in collaboration with the tongue 
muscle force masticated food from the mouth to the esophagus. 
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Comprised of four regions, the nasopharynx (extends from the nasal turbinates to hard 
palate), velopharynx (posterior to the soft palate), oropharynx (extends from hard palate 
to the epiglottis) and hypopharynx (from base of the tongue to the larynx) (25).  
 
The velopharynx is the most vulnerable to obstruction as it is the narrowest cross 
section of the upper airway.  To its anterior is the soft palate, and tongue, posteriorly 
the constrictor muscles (superior, middle and inferior) and to the lateral the 
orophargyngeal muscles (hyoglossus, styloglossus, stylohyoid, stylopharyngeous, 
palatoglossus, palatopharyngeus, pharyngeal constrictor muscles).  As previously 
discussed the palantine and lingual tonsils are located on either side of the oropharynx 
(25).   
 
The static influences of upper airway patency included the surface adhesive forces, 
which cause the soft palate to remain away from the tongue when the mouth is close; 
neck and jaw posture, with neck extension further opening the airway and flexion 
closing off the airway; lung volume, increased lung volume results in caudal 
displacement of the thoracic notch and passively opening the pharynx and tracheal tug 
(25). 
 
Dynamic changes that affect upper airway patency include resistance in the nasal 
passage and pharynx, the Bernoulli effect and the dynamic compliance of the airway. 
Nasal and pharynx resistance results in negative nasopharyngeal intraluminal pressure 
and predispose the airway to obstruction (25). The Bernoulli effect, which refers to the 
conversion of fluid potential energy to kinetic energy in higher resistance regions of 
airway and demonstrates that flow velocity increases when the lumen size decreases, 
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causing a drop in lateral wall pressure and reduces the airway circumferences.  The 
degree of airway narrowing is also determined by airway compliance, as the airway 
becomes more compliant the intraluminal pressure increases and the airway narrows.  
 
SDB is considered a state-dependent disorder, where the level of affect is prominent 
during sleep and more prominent during some stages of sleep than others.  During sleep 
the supraglottic airway resistance increases from 1-2 to 5-10cmH2O/L/s and to 50 
cmH2O in heavy snorers. (25) Autonomic function and muscle tone, including upper 
airway patency cyclically alternates throughout the sleep cycle (every 90-110min). 
During REM sleep where muscle tone is reduced, compliance of the further airway 
decreases and increases the propensity for the airway to collapse.  
 
The upper airway patency also requires feedback from chemosensors and 
proprioceptors to maintain/reset optimal patency. In particular, increased circulating 
CO2 activates the phrenic nerves in the inspiratory muscles and diaphragm and motor 
neurons of the upper airway to counterbalance any increased resistance. If the threshold 
for the receptors is low then the compliance of the airway and ventilatory response may 
be blunted, causing the airway to obstruct (25). 
 
App 1.2: Enlarged Soft Tissues   
Tonsils and Adenoids 
The soft tissue of the upper airway consists of the palantine tonsils, adenoid, fat pads 
(located in the parapharyngeal) and musculature. Although the size and composition of 
soft tissue is primarily determined by genetic factors, inflammation, infection and 
infiltration of various storage/metabolites can alter their size (131). It has been proposed 
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that the mechanical movement (vibration from snoring) of the tonsil may causes 
hypertrophy of the tissue and inflammation of mucosa, increasing the size of the tonsils 
and hence further obstruct the airway in children with SDB (132). 
 
Located at the roof of the nasopharynx, the adenoids are a mass of lymphoid tissues, 
which secrete mucus as part of a protective mechanism, which traps inhaled infectious 
antigens via the nose and transfers them to the pharynx (134). In addition, the lymphatic 
tissues produce antibodies and act as an immune barrier.  They are absent at birth but 
become noticeable by 6 months, reaching a maximal size between the ages of 2-10 
years.  The tissue progressively decreases as children reach adulthood.  Ranging 
between 7 – 12mm adenoids larger than 12mm are considered abnormal and in children 
with SDB, the adenoids are statistically larger (mean = 13.46mm) compared to age 
matched controls. Enlarged adenoids in children can result in mouth breathing, nasal 
obstruction, ongoing nasal congestion, middle ear infection, snoring and fragmented 
sleep.  
 
The palantine tonsils are soft tissues located in between the glossopalantine and 
pharyngopalantine arches. They are aggregated lymphoid tissue encased in mucus 
membrane, which also act as an immune protective barrier. 
 
Adenoid and tonsillar hypertrophy remains the major cause of sleep disordered 
breathing in children (133) as they can narrow the pharynx.  The adenoid and tonsils 
continue to grow throughout childhood and reach maximal size just before the onset of 
puberty, which is also considered the peak age at which SDB is most prevalence in 
childhood. In the clinical setting, children with OSA are more likely to have enlarged 
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palantine tonsils compare to children without OSA.  Inflammation induced 
adenotonsillar hypertrophy leading to clinical OSA has been noted in children under 1 
years (135) and chronic infections are thought to promote lymphoid hyperplasia, and 
increase the size of the adenoid and tonsillar tissues (28). Although the link between 
enlarged T&A and SDB is well accepted, as most children diagnosed with OSA 
enlarged tonsil and adenoid tissue treated with adenotonsillectomy reduces their SDB 
severity, what is less understood is the lack of association between the size of the T&As 
assessed both clinically and using imaging and severity of SDB. Several studies have 
demonstrated the efficacy of T&A to treat snoring and OSA using both parental report 
measures and follow-up polysomnography. (136) However why approximately 33% of 
treated children continue to snore has not been effectively addressed (137). 
 
Complications of T&A surgery for paediatric SDB are as uncommon as for T&A 
surgery performed for other purposes. Delayed discharge has been reported by groups 
in 1.3% - 2.3% of SDB paediatric patients and 3.2% – 3.7 % have secondary 
complications requiring readmission (170). Non-respiratory complications are the least 
reported complications, they include dehydration, hemorrhage and fever. While 
respiratory complications are reported in 5% - 23% of patients post operatively.   
 
App1.3: Reduced Neuromuscular Innervation of the Upper Airway and 
Neurological Disorders 
When innervation to the upper airway muscles is decreased or absent the airway 
becomes more collapsible (131). As previously mentioned, during sleep there is a 
natural loss of both tonic premotor input and neuromuscular compensation and reflex-
driven muscle activation leading to a large decrement in electromyogram and ultimately 
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an increase in airway resistance (more collapsible). There are various neuromuscular 
disorders, including those that effect intracranial pressure and brain stem function 
(compression) such as Arnold Chiari malformations, which predispose children with 
SDB (131).  
 
App 1.4 Tongue Size 
The tongue is the largest soft tissue in the upper airway and consists of the genioglossus, 
hyoglossus and styloglossus muscles. The muscles control the tongues position and 
shape, which can affect the size and shape of the airway.  Macroglossia can reduce the 
size of the airway and predispose children with conditions that result in abnormally 
large tongue mass, such as Down Syndrome, mucopolysaccharidosis and Beckwith-
Wiedemann syndrome. Children with these conditions have an increased risk of SDB 
(131). However a study measuring tongue volume in normal children with SDB 
compared to controls showed not differences in volume (459).  
 
Glossoptosis is characterized as the ‘abnormal posterior motion of the tongue during 
sleep (134). More common in children with macroglossia and micrognathia, it is also 
prevalent in patients with decreased muscular tone, including those with cerebral palsy, 
Down Syndrome and Pierre Robin sequence.  MRI studies have shown that during 
sleep, the tongue in patients with glossoptosis falls posteriorly onto the velum and the 
wall of the pharynx obstructing the airway.  In severe cases total closure of the 
nasopharynx may occurs when the tongue pushes the soft palate closing off the airway.  
Treatment in patients with glossoptosis involves positive pressure airway devices and 
in severe cases may require surgical intervention, tongue volume reduction, jaw 
realignment and even tracheostomy may be required.  
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App 1.5 Craniofacial Features 
There is an increase prevalence of SDB in disorders that results in changes in the 
craniofacial structures and compromise the size of the airway, such as Crouzon, 
Treacher-Collins, Pfeiffer, Apert and Robin syndromes.  However in non-syndromic 
children the link between SDB craniofacial features is not as clear as there are 
inconsistencies in the current literature.  These contradictions maybe explained by the 
use of different methods to assess the size of the jaws and their association the 
oropharyngeal soft tissue.   
 
Early studies using cephalometrics show subtle craniofacial features related to OSA.  
Shintani et al., 2003, showed reduced maxillary protrusion compared to controls on 
children aged 5-9 years and reduced mandible protrusion in children aged 1-2 year and 
a lowering of the hyphoid bone in children aged 3-6 years compared to controls. Most 
children in this study had adenotonsillar hypertrophy suggesting a possible underlying 
genetic component, which may affect both soft tissue growth and upper airway anatomy 
(460).  Supporting this theory, Kawashima et al., also demonstrated retrognathic 
mandibles with enlarged tonsils and OSA (461).  Also, many paediatric 
disorders/syndromes where there is evidence of craniofacial anomalies have higher 
than normal rates of SDB. (See Table, App1.1) 
 
Hyperdivergent growth patterns, with increased craniomandibular, intermaxillary 
goniac and mandibular plane angles were featured in children with OSA (462). 
Conversely, other MRI studies have also shown no difference between SDB and non 
snoring children in airway bony structures (459).  Schiffman et al., found no difference 
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using a comprehensive 3-dimensional reconstruction from MRI and measuring 8 
variable of both upper and lower jaw size, between mild to moderate OSA and controls 
children aged 3 – 7 years (463).  Some studies have even shown reversal of cranial 
facial differences after surgery (464), suggesting the possibility that the reduced jaw 
size may be associated with failure to grow mechanism often reported in the OSA, 
rather than a causal agent for SDB.  A recent study showed that children treated with 
adenotonsillectomy and who continued to snore were more likely to have smaller 
manidibles compared to the normal mandibular size in non-snoring Japanese children 
(465).  
App 1.6 Premature Birth 
Preterm children are twice as likely to snore habitually, 3-5 times more likely to have 
OSA and have increased neurocognitive impairment compared to full term babies (466-
468). The prevalence of SDB in preterm infants decreases by the 43rd week 
postconceptional age (469). The SDB may result from a combination of anatomical 
features, which included reduced muscle innervation and CNS immaturity, increased 
nasal resistance and a highly compliant chest wall (131). One study showed that of the 
76 preterm infants in the study, almost 70% had obstructive events (470). While another 
study observed that 50% of apneic events occurred with periodic breathing resulting 
from upper airway obstruction and closure of the glottis (471). Thach and Stark 
however showed that spontaneous neck flexion was associated with obstructive events 




Table App 1.1: List of craniofacial anomalies, neurological disorders and 
miscellaneous disorders which report higher prevalence of SDB in children (131) 
 
Craniofacial Anomalies Neurological Disorders Miscellaneous Disorders 
Apert syndrome Cerebral Palsy Obesity 
Crouzon syndrome Syringobulbia Prader Willi syndrome 




Myasthenia gravis Sickle cell disease 
Robin sequence Möbius syndrome Laryngomalacia 
Stickler syndrome Arnold-Chiari 
malformation 
Subglottic stenosis 
Nager syndrome Poliomyelitis Airway papillomatosis 
Hallerman-Streiffer 
syndrome 
 Face and neck burns 








Achondroplasia    
Klippel-Feil syndrome   
Marfan syndrome   





App 1.7 Gender 
In adults with SDB, males are more prominently affected than females. This male 
predominance in the paediatric population is not as well define with some studies 
finding no differences between the genders (108, 117, 473), while other showed an 
increase in the number of male affected compared to females (83, 468), particularly in 
the adolescent age group (79). 
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App 1.8 Nasal Congestion 
Nasal obstruction is considered an important mediator of SDB as it increases resistance 
to air flow and increases intrathoracic pressure. The nasal passage counts for half of the 
respiratory system resistance (474).  Partial or total obstruction to the nasal passage 
during inspiration, where intrathoracic negative pressure is produced, causes drag on 
the soft tissues of the upper airway making it more prone to collapse. Ambient 
temperature and humidity, posture, mucus production and nasal vasoconstriction all 
affect nasal resistance (475). Chronic stimulation of the nasal mucosa with an irritant 
(476) and obstruction (477) to the nasal cavity results in recurring episodes of apnoea 
and hypopnea. This suggests the mucosa and nasal passage play an important part in 
modulating resistance in the upper airway. 
 
Infants and young children are obligate nose breathers and hence obstruction in the 
nasal passage can have a detrimental impact on development.  Obstruction leads to 
chronic mouth breathing which can affect the growth of facial features including a 
narrow, high arched palate and poor maxillary growth, narrow dental arches and 
anterior crossbite (478).    Epidemiological studies have shown an association with 
nasal obstruction and habitual snoring in adults (477, 479) and children with mild SDB 
(83) (103). 
 
App 1.9 Tobacco Use 
Several studies have reported a link between SDB severity and tobacco smoke 
exposure. (480, 481) A dose-dependent relationship was demonstrated between serum 
cotinine a measure of tobacco smoke exposure and snoring and reported apnoea in 
children (482).  Tobacco smoke may irritate the lining of the airway making it 
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vulnerable to inflammation. Second hand smoke has been associated with many 
respiratory related disorders, including, asthma and allergic rhinitis.  The cigarette 
smoke exposesure to the nasal and respiratory mucosa with a significant amount of 
endotoxins can cause ciliary dysfunction, inflammation of the airway and increase both 
the number of goblet cells and production of mucus (483). As previously mentioned 
nasal congestion is a considerable risk factor for SDB in young children. The ongoing 
exposure to tobacco smoke may be a significant contributing factor that assaults the 
upper airway and reduces airflow dynamics in children. 
App 1.10 Obesity 
In adults obesity is reported to increase the risk of SDB by 10-14 times (132).  SDB is 
more common in obese children than non-obese, (473, 484) (485) with some studies 
reporting as many as 59% of obese children affected with OSA (486).  SDB is an 
independent risk factor for metabolic syndrome, including dyslipidemia and insulin 
resistance. A positive relationship between severity of SDB and metabolic variables 
has been reported. Recently, Bhushan et al., confirmed previous work by de la Eva 
(487) that fasting insulin levels were increased in young children with increased SDB 
severity, independent of BMI and suggest that OSA was associated with insulin 
resistance. (488) Obese children with SDB are at a higher risk of postoperative 
respiratory complications after adenotonsillectomy (489). Van Eyck demonstrated 
reduced pulmonary function using spirometry (vital capacity, forced expired volume in 
1s), helium dilution and full body plethysmography (total lung capacity, airway 
resistance and residual volume) (490). Flow limitations and lower forced expired 
volume were evident in the obese children with SDB compared to non-obese. They 
suspect that upper airway inflammation may explain a key role in the reduced 
pulmonary function in these children.  
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 Katz et al., recently demonstrated that higher BMI z-scores and neck to waist ratios is 
an independent predictor of OSA in overweight/obese in children older than 7 years 
compared to overweight/obese non-snorers (491). Body fat distribution may play a 
bigger part in OSA with obesity than obesity alone, suggesting the possibility of a 
genetic phenotype that is more prone to OSA and weight gain.   
 
Of concern is the recent report from Nobili et al., who have shown that more than 65% 
of obese and 44% of non-obese children diagnosed with nonalcoholic fatty liver disease 
had OSA (492). They also observed that OSA severity was associated with more severe 
liver histology, independent of whole body/abdominal obesity, metabolic syndrome 
and insulin resistance.  The duration of hypoxia also correlated with liver infiltration 
by leukocytes and activated macrophage/Kupffer cells and makers of hepatocyte 
apoptosis.  
 
Many studies have shown a relationship between reduce sleep duration and obesity. 
Interestingly, the recent study by Moraleda-Cibrian & O’Brien showed that reduced 
total sleep time by > 1hr from the national recommendation for the age, was positive 
associated with obesity, independent of SDB. (493) The association with SDB and 
obesity was not as clearly demonstrated in a recent study, with a large cohort, (> 1000 
participant) (480).  Hyperphasia and increased visceral and subcutaneous adiposity has 
been observed in mice models of sleep fragmentation (494). Collectively the research 
is suggesting that the relationship between SDB is complex and may involve 
interactions between the sleep wake cycle and in particular arousal from sleep, 
metabolism (possibly through thermogenesis) and feeding. 
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App 1.11 Genetic Predisposition  
Evidence of a genetic link to SDB in the literature is yet to be properly addressed, with 
only few studies suggesting a genomic underpinning. Most studies report on familial 
prevalence, (495, 496) an association which has been appreciated for more than 40 
years (497). Risk for SDB is reported to increase with the increase of the number of 
affected family members. One report suggested risk increased by 30 – 58 % with one 
other family member affected and subjects with three or more affected members were 
up to 4 times more likely to have SDB (498). The most compelling evidence for a 
genetic predisposition for SDB arise from ‘twin studies’, which have shown a greater 
concordance within pairs for snoring in monzygotic twin compared to dizygotic twins 
(499) (500).  Ethnic differences have also been reported, with great incidence of early 
onset of OSA affecting adult African Americans, Maori and Pacific Islanders (132), 
however, the effect of BMI could not be delineated from the assessment, as there is a 
higher prevalence of obesity in these communities.  Redline et al., estimated that 
African American children < 18 years were 3.5 times more likely to have SDB 
compared to Caucasian children. More recently, Goldstein et al, reported that African 
American children were 2.5 times more likely to snore and Hispanic 2.3 times more 
likely compared to Caucasian children (501). Similarly, Côté et al also demonstrated 
increased severity of SDB in African American children aged less than 2yrs (502). 
Interestingly, Pinto et al., showed no difference between African American and 
Caucasian children in upper airway collapsibility and upper airway dynamics during 
sleep (503). Authors concluded that the increased prevalence in the children was not 
associated to upper airway physiological difference.  
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A variety of physiological factors that predispose individuals to SDB, have their 
underlying effects based in genomics. Specifically, obesity is now recognized to have 
a heritable component, with multiple candidate genes showing linked evidence to both 
obesity and SDB (132). Twin studies suggest that up to 70% of variance in obesity can 
be attributed to genetics (504). Leptin, a hormone involved in the regulation of body 
weight, is increased in obesity, and has also been shown to influence lung growth, 
respiratory control and also sleep architecture (28). Varying levels of leptin expression 
have been noted, as well as, polymorphs for both the leptin hormome and its binding 
receptors. 
 
Other physiological determinants include, craniofacial morphology, neuromuscular 
innervation and tissue composition of the upper airway and also ventilatory control and 
chemoreceptor sensitivity. A twin study investigating chemo-response to blood oxygen 
saturation demonstrated similar response to hypoxia in monozygotic twins compared 
to dizygotic. Researchers implied inherited traits accounted for between 30-75% of the 
variance, suggesting that genetic factors play a major role in chemosensitivity (505).  
Endothelin-1 (ED1) is a vasoactive (constrictive) peptide that influences blood pressure 
but has also been shown to affect the control of ventilation.  Levels of ED1 are increased 
in adult patients with SDB (28). 
 
Upper airway anatomy, and in particular, cephalic index (ratio of head circumference 
to head length) is completely genetically determined, as is the size of the tongue and 
lateral pharyngeal wall volume with 33% of the variability explained by familial factors 
(261). Patency of the upper airway is controlled by muscle innervation and soft tissue 
structures. Serotonin (5-HT) is a requisite component of upper airway patency, via its 
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innervation both in the brain stem motor neurons and upper airway dilator motor 
neurons in adults. There have been a number of studies looking at polymorph and 
expression level difference, which have not availed any conclusive evidence of 
difference in adults SDB. However one study showed that males with SDB were more 
likely to have a copy of the S (short) allele compared to both male controls and females 
with SDB (506).  As previously mentioned, males are 5-8 times more likely to have 
OSA compared to females. 
 
App 1.12 Apolipoprotein E 
Apolipoprotein E proteins are produced in the brain (astrocytes), liver and macrophages 
and are involved in the transport of cholesterol to neurons via APOE receptors.  APOE 
is polymorphic with 3 alleles, E2, E3, and E4.  The APOE4 allele produces less APOE 
protein and has been associated with increased CVD and Alzheimers’s disease and is 
more prevalent in both adults SDB (507) and specifically in children with SDB who 
exhibit reduced neurocognition (454). A series of elegant experiments by Kothapalli et 
al. showed that a significant role of APOE is ‘cardiovascular protection’ as it was 
shown to mediate mechanosensitive extracellular matrix protein expression in vascular 
smooth muscle cells, reducing its production during periods of increased shear stress 
(458). As the APOE4 allele produces less of the protein, suffers of SDB, whose 
peripheral vessels are vulnerable to increased sympathetic innervation because of 
increased arousals and hypoxic events and hence may more rapidly develop vascular 
stiffening. This would explain the heterogeneity observed in studies where vascular 
changes are not observed in all participants with SDB. 
In 2009, Thakre et al., published meta-analysis of 8 genotype studies representing more 
than 6500 participants (456).  Researchers reported no link between APOE polymorphs 
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and OSA. Their work suggests that studies need to be more unified in their 
methodologies and that more work needs to be carried out to fully understand if the 
association between APOE and SDB really exists. 
 
Identifying ‘causal’ genes has proven to be less effective than observed phenotypical 
similarities and familial linkage studies. Apart from studies in APOE and serotonin 
there are as yet no published full genomic studies and ‘candidate gene’ studies available 
to make any conclusive and consistent pattern of specific genetic anomalies in SDB 
(261). Many studies are underpowered and maybe future meta-analysis will show a 
clearer understanding of the genes involved.  
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Appendix 2 Medical Image Techniques used in Diagnosis 
App 2.1 Medical Imaging 
There are many radiological techniques that have been used to assess the structural 
anomalies associated with SDB and the upper airway.  For a comprehensive evaluation 
of these techniques and their use in assessing SDB, the recent literature review by Slaats 
et al. is recommended (508). See Table App 2.1 for current techniques used to 
determine SDB severity.  
Table App 2.1: Medical Imaging techniques currently used in the diagnosis of SDB in 
children (508). 
 
Lateral Neck Radiography 
 
 consists of a side X-Ray of the head and 
neck,  
 it clearly outlines the bones and soft 
tissues  
 simple, cheap and easily accessible 
 the tonsil and adenoid masses are easily 
identifiable. 
 uses a small amount of 
radiation,  
 only depicts a two 
dimensional image that 




 similar to LNR shows the skeletal, soft 
tissues and upper airway tissues.  
 can measure makers such as distances 
from different tissues and ratios to be 
calculated.   
 limitations to the 
information gained from 
this technique as the 
procedure is conducted 
while participants are 
awake and in the upright 
position.  
 
Magnetic Resonance Imagine 
 
 considered the most advantageous as it 
allows for cross section of the airway via 
multiple planes (axil, saggital and 
coronal planes) 
 can be used while patient is sleeping to 
create moving images and also three 
dimensional images.  
 requires no ionizing radiation.   
 is expensive, and requires 
a longer examination time 
 a greater incidence of 
motion artifacts  
 may require the participant 
to be sedated as the 
experience exacerbate 





 can be used both while awake and 
asleep, 
 is fast and available in most hospitals.   
 A study in OSA children using CT found 
a high correlation between OSA severity 
and imaging parameters but not clinical 
scores of upper airway patency and OSA 
severity. Authors suggested that CT 
imaging may be more accurate at 
measuring patency than clinical 
measures.  
 





Appendix 3: Non-cardiovascular deficits 
App 3.1 Neurocognition 
In adults the link between OSA and neurocognitive deficit is well recognized (509). 
Scientific evidence for reduced neurocognitive performance and impaired behaviour in 
children has also been growing over the past 20 years.  Reduced attentional capacity, 
executive function, academic performance, verbal/language and global IQ have been 
reported (165, 510-512).  Of concern are reports showing deficits in children with 
primary snoring that mirror those with OSA, and in some cases increased in this group 
(513-515). A comprehensive evaluation of studies which show neurocognitive 
impairment in children with SDB is provided by Marcus et al., 2012 (84). 
 
Research in adult SDB has shown significant brain injury occurs in the cerebellar and 
limbic regions/cortex and interconnecting fibres (515-517) and that untreated patients 
show reduced mean diffusivity localized to the medullary and brain stem areas critical 
for cardiovascular and respiratory regulation (518). Loss of regional gray matter and 
fibre injury has also been reported in multiple brain sites in adults (518, 519).  
 
Evidence of altered brain function in children was offered by Halbower et al., who 
demonstrated reduced N-acetyl aspartate and choline levels (brain metabolites) 
expressed both in the hippocampus and right frontal lobe, in children with 
neurocognitive deficits and OSA, using Magnestic Resonance Spectroscopy (MRI) 
(520).  These brain regions are important in executive function, learning and memory.  
This is a similar pattern noted in adult morphological studies, which show structural 




Somewhat contradictory, Jackman et al., showed no neurocognitive deficits in all 
severity levels compared to control and reported difficult behaviour in children 
diagnosed with primary snoring and mild SDB but not severe SDB.  However, children 
with severe SDB were more likely to internalize problems compared to controls but 
were otherwise well behaved (521).   
 
App 3.2 Behavioural Disorders 
There are many studies looking at the effect of SDB on behaviour (84). The most 
common behavioural abnormality reported is hyperactivity and attention 
deficit/hyperactivity disorder (ADHD) is over represented in this group. 
Hypersomnolence, somatization, depression, abnormal social behaviour and aggression 
is also more commonly reported by parents and teachers in these studies (162). The 
results of the recent CHAT study showed that behaviour and quality of life dramatically 
improves after treatment with adenotonsillectomy (522).  
 
App 3.3 Growth 
Failure to thrive/grow has been frequently reported in children with SDB from as far 
back as the 1980s (523, 524).  Studies have shown that delayed growth is more common 
in younger children than older children with rates of 52% reported in one study in 
children < 18 months (525) and similar results in a separate study of children < 36 
months (526). Accelerated growth, in particular in height has also been reported in 
normal size, overweight/obese, infants and failure to thrive children after 
adenotonsiilectomy in some studies but not all (527).  Katz et al., recently demonstrated 
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no significant changes in height between treated children and those on a watch and wait 
list, however they did note a significant increase in weight in the treated group (527). 
 
The association between SDB and reduced growth is yet to be comprehensively 
understood. There is some suggestion that the obstructive events reduce the amount of 
growth hormones secreted during sleep. Growth hormones (GH) are secreted mostly 
(70%) during the first few hours of sleep, where the bulk of slow wave sleep is 
experienced.  Obstructive events change the sleep architecture and may alter the GH 
secretion pattern.  Insulin-like growth factor (IGF-1) a mediator of GH, increases in 





Appendix 4 HRV variables 
Table App 4.1: Time and Frequency Domain HRV Measures (Reproduced from Stein 
& Pu, 2012, (52) 
Time Domain    
AVNN (ms) Average of NN intervals for period of 
interest  
 
Can convert to average HR of 
NN intervals (HR  
60,000/AVNN)   
 
SDNN (ms) Standard deviation of NN intervals for   
period of interest           Average 
coefficient of variance (SD/Mean) for 5-min 
intervals for period of interest  
Total HRV 
SDANN (ms) Standard deviation of AVNN for 5-min 
intervals  for period of interest   
Circadian HRV 
SDNNIDX (ms) Average of 5-min standard deviations of 
NeN intervals  for period of interest 
Short-term HRV, SNS vs PNS 
influences 
pNN50 (%) Percent of NN intervals > 50 ms different 
from previous  (NN) for period of interest 
Vagal activity 
pNN625 (%) Percent of NN intervals different from 
previous by 6.25%  or more of local AVNN 
(NN) for period of interest 
Vagal activity normalized by 
HR 
rMSSD Root mean square of successive differences 
of NN intervals for period of interest   
Vagal activity 
CV   Average coefficient of variance 
(SD/Mean) for 5-min intervals for period of 
interest 
Average short-term HRV 





TP (ms2  
 
Total power over measured period   Averaged 
over 5-min periods or less. 
Reflects total HRV  
ULF (ms2) Ultra low frequency power measures 
rhythms  greater than every 5 min 
Reflects circadian HRV 
VLF (ms2)  
 
Very low frequency power measures 
rhythms  between every 25 sec and every 5 min, 
i.e., 0.0033e0.04 Hz)   
Reflects vagal and renin-
angiotensin system effects on HR. 
Exaggerated by SDB  
 
LF (ms2)    LF measures HR rhythms from 2.5 to 9 
cycles/min,  i.e., 0.04e0.15 Hz). Averaged over 
5-min or less.   
Reflect combination of SNS and 
PNS influences. Captures 
baroreflex rhythms 
HF (ms2)  
 
HF captures variations in HR due to 
respiratory  sinus arrhythmia at 9e24 cycles/min, 
i.e.,  0.15e0.4 Hz. 
Under normal circumstances 
reflects vagal activity 
LF/HF  
 
LF/HF average over 5-min periods or less  [). Purported to reflect SNS/PNS 
balance 
LFnu (%) LF/(TP VLF)] for the measured period (5-min or 
less 
Purported to reflect SNS activity 
HFnu (%)  
 
Some calculate LF/(LF þ HF)  [HF/(TP VLF)] 
for the measured period (5-min or less). Some 
calculate HF/(LF þ HF) 
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